gtx-10q_20200930.htm
false Q3 0001735707 --12-31 false true false true true true true P7Y P5Y P5Y us-gaap:AccountingStandardsUpdate201613Member us-gaap:AccountingStandardsUpdate201613Member us-gaap:OtherAssetsNoncurrent us-gaap:OtherAssetsNoncurrent us-gaap:OtherAssetsNoncurrent us-gaap:OtherAssetsNoncurrent us-gaap:AccruedLiabilitiesCurrent us-gaap:AccruedLiabilitiesCurrent us-gaap:OtherLiabilitiesNoncurrent us-gaap:OtherLiabilitiesNoncurrent P5Y2M23D P6Y3M18D 0001735707 2020-01-01 2020-09-30 xbrli:shares 0001735707 2020-10-26 iso4217:USD 0001735707 2020-07-01 2020-09-30 0001735707 2019-07-01 2019-09-30 0001735707 2019-01-01 2019-09-30 iso4217:USD xbrli:shares 0001735707 2020-09-30 0001735707 2019-12-31 0001735707 2018-12-31 0001735707 2019-09-30 0001735707 us-gaap:CommonStockMember 2018-12-31 0001735707 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001735707 us-gaap:RetainedEarningsMember 2018-12-31 0001735707 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001735707 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001735707 2019-01-01 2019-03-31 0001735707 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001735707 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001735707 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001735707 us-gaap:CommonStockMember 2019-03-31 0001735707 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001735707 us-gaap:RetainedEarningsMember 2019-03-31 0001735707 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001735707 2019-03-31 0001735707 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001735707 2019-04-01 2019-06-30 0001735707 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001735707 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001735707 us-gaap:CommonStockMember 2019-06-30 0001735707 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001735707 us-gaap:RetainedEarningsMember 2019-06-30 0001735707 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001735707 2019-06-30 0001735707 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001735707 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0001735707 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001735707 us-gaap:CommonStockMember 2019-09-30 0001735707 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001735707 us-gaap:RetainedEarningsMember 2019-09-30 0001735707 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0001735707 us-gaap:CommonStockMember 2019-12-31 0001735707 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001735707 us-gaap:RetainedEarningsMember 2019-12-31 0001735707 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001735707 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001735707 2020-01-01 2020-03-31 0001735707 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001735707 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001735707 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0001735707 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0001735707 us-gaap:CommonStockMember 2020-03-31 0001735707 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001735707 us-gaap:RetainedEarningsMember 2020-03-31 0001735707 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001735707 2020-03-31 0001735707 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001735707 2020-04-01 2020-06-30 0001735707 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001735707 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001735707 us-gaap:CommonStockMember 2020-06-30 0001735707 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001735707 us-gaap:RetainedEarningsMember 2020-06-30 0001735707 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001735707 2020-06-30 0001735707 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001735707 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001735707 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001735707 us-gaap:CommonStockMember 2020-09-30 0001735707 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001735707 us-gaap:RetainedEarningsMember 2020-09-30 0001735707 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 iso4217:EUR 0001735707 gtx:TwoThousandAndTwentyAmendmentCreditAgreementMember gtx:TermBLoanFacilityMember 2020-06-12 0001735707 gtx:TwoThousandAndTwentyAmendmentCreditAgreementMember gtx:TermALoanFacilityMember 2020-06-12 0001735707 gtx:TwoThousandAndTwentyAmendmentCreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2020-06-12 xbrli:pure 0001735707 gtx:BendixAsbestosRelatedLiabilitiesMember gtx:TheSubordinatedAsbestosIndemnityAgreementMember gtx:HoneywellInternationalIncMember 2018-09-11 2018-09-12 0001735707 gtx:TheSubordinatedAsbestosIndemnityAgreementMember gtx:HoneywellInternationalIncMember 2018-09-11 2018-09-12 0001735707 gtx:TheSubordinatedAsbestosIndemnityAgreementMember 2018-09-11 2018-09-12 0001735707 gtx:TheSubordinatedAsbestosIndemnityAgreementMember 2020-01-01 2020-09-30 0001735707 gtx:TheSubordinatedAsbestosIndemnityAgreementMember srt:MaximumMember gtx:HoneywellInternationalIncMember 2018-09-12 0001735707 gtx:StalkingHorseBidderMember 2020-09-30 0001735707 gtx:StalkingHorseBidderMember us-gaap:SubsequentEventMember 2020-10-24 2020-10-24 0001735707 gtx:StalkingHorseBidderMember us-gaap:SubsequentEventMember 2020-10-24 0001735707 gtx:StalkingHorseBidderMember 2020-01-01 2020-09-30 0001735707 gtx:StalkingHorseBidderMember us-gaap:SubsequentEventMember 2020-10-19 2020-10-19 0001735707 gtx:StalkingHorseBidderMember us-gaap:SubsequentEventMember 2020-10-19 0001735707 gtx:StalkingHorseBidderMember us-gaap:SubsequentEventMember srt:MaximumMember 2020-10-19 0001735707 gtx:CreditAgreementMember gtx:ConsentingLendersMember 2018-09-27 0001735707 gtx:CreditAgreementMember gtx:TermBFacilityMember gtx:SeniorSecuredCreditFacilitiesMember 2018-09-27 2018-09-27 0001735707 gtx:CreditAgreementMember gtx:TermBFacilityMember gtx:SeniorSecuredCreditFacilitiesMember 2018-09-27 0001735707 gtx:CreditAgreementMember gtx:TermAFacilityMember gtx:SeniorSecuredCreditFacilitiesMember 2018-09-27 2018-09-27 0001735707 gtx:CreditAgreementMember gtx:TermAFacilityMember gtx:SeniorSecuredCreditFacilitiesMember 2018-09-27 0001735707 gtx:CreditAgreementMember us-gaap:RevolvingCreditFacilityMember gtx:SeniorSecuredCreditFacilitiesMember 2018-09-27 2018-09-27 0001735707 gtx:CreditAgreementMember us-gaap:RevolvingCreditFacilityMember gtx:SeniorSecuredCreditFacilitiesMember 2018-09-27 0001735707 gtx:FivePointOneTwoFivePercentSeniorNotesDueTwoThousandTwentySixMember 2018-09-27 0001735707 gtx:TermLoansMember 2020-09-30 0001735707 gtx:TermLoansMember 2019-12-31 0001735707 us-gaap:RevolvingCreditFacilityMember 2020-09-30 gtx:Claim 0001735707 us-gaap:SubsequentEventMember 2020-10-26 0001735707 us-gaap:SubsequentEventMember gtx:CitibankNAAndDebtorInPossessionLendersMember gtx:DebtorInPossessionTermLoanFacilityMember 2020-10-06 2020-10-06 0001735707 us-gaap:SubsequentEventMember gtx:CitibankNAAndDebtorInPossessionLendersMember gtx:DebtorInPossessionTermLoanFacilityMember srt:MaximumMember 2020-10-09 0001735707 us-gaap:SubsequentEventMember gtx:CitibankNAAndDebtorInPossessionLendersMember gtx:DebtorInPossessionTermLoanFacilityMember 2020-10-09 0001735707 us-gaap:SubsequentEventMember gtx:CitibankNAAndDebtorInPossessionLendersMember gtx:DebtorInPossessionTermLoanFacilityMember 2020-10-22 0001735707 gtx:DebtorInPossessionTermLoanFacilityMember gtx:CitibankNAAndDebtorInPossessionLendersMember 2020-01-01 2020-09-30 0001735707 gtx:DebtorInPossessionTermLoanFacilityMember us-gaap:SubsequentEventMember gtx:CitibankNAAndDebtorInPossessionLendersMember 2020-10-06 0001735707 gtx:DebtorInPossessionTermLoanFacilityMember gtx:CitibankNAAndDebtorInPossessionLendersMember 2020-09-30 0001735707 gtx:DebtorInPossessionTermLoanFacilityMember gtx:CitibankNAAndDebtorInPossessionLendersMember us-gaap:SubsequentEventMember 2020-10-09 2020-10-09 0001735707 gtx:DebtorInPossessionTermLoanFacilityMember gtx:CitibankNAAndDebtorInPossessionLendersMember us-gaap:SubsequentEventMember 2020-10-22 2020-10-22 0001735707 gtx:DebtorsMember 2020-07-01 2020-09-30 0001735707 gtx:DebtorsMember 2019-01-01 2019-09-30 0001735707 gtx:DebtorsMember 2020-09-30 0001735707 gtx:DebtorsMember 2020-01-01 2020-09-30 0001735707 gtx:DebtorsMember 2019-12-31 0001735707 us-gaap:AccountingStandardsUpdate201613Member 2020-09-30 0001735707 us-gaap:AccountingStandardsUpdate201813Member 2020-09-30 0001735707 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-01-01 0001735707 country:US gtx:OriginalEquipmentManufacturersMember 2020-07-01 2020-09-30 0001735707 country:US gtx:AftermarketMember 2020-07-01 2020-09-30 0001735707 country:US gtx:OtherMember 2020-07-01 2020-09-30 0001735707 country:US 2020-07-01 2020-09-30 0001735707 srt:EuropeMember gtx:OriginalEquipmentManufacturersMember 2020-07-01 2020-09-30 0001735707 srt:EuropeMember gtx:AftermarketMember 2020-07-01 2020-09-30 0001735707 srt:EuropeMember gtx:OtherMember 2020-07-01 2020-09-30 0001735707 srt:EuropeMember 2020-07-01 2020-09-30 0001735707 srt:AsiaMember gtx:OriginalEquipmentManufacturersMember 2020-07-01 2020-09-30 0001735707 srt:AsiaMember gtx:AftermarketMember 2020-07-01 2020-09-30 0001735707 srt:AsiaMember gtx:OtherMember 2020-07-01 2020-09-30 0001735707 srt:AsiaMember 2020-07-01 2020-09-30 0001735707 us-gaap:NonUsMember gtx:OriginalEquipmentManufacturersMember 2020-07-01 2020-09-30 0001735707 us-gaap:NonUsMember gtx:AftermarketMember 2020-07-01 2020-09-30 0001735707 us-gaap:NonUsMember 2020-07-01 2020-09-30 0001735707 gtx:OriginalEquipmentManufacturersMember 2020-07-01 2020-09-30 0001735707 gtx:AftermarketMember 2020-07-01 2020-09-30 0001735707 gtx:OtherMember 2020-07-01 2020-09-30 0001735707 country:US gtx:OriginalEquipmentManufacturersMember 2020-01-01 2020-09-30 0001735707 country:US gtx:AftermarketMember 2020-01-01 2020-09-30 0001735707 country:US gtx:OtherMember 2020-01-01 2020-09-30 0001735707 country:US 2020-01-01 2020-09-30 0001735707 srt:EuropeMember gtx:OriginalEquipmentManufacturersMember 2020-01-01 2020-09-30 0001735707 srt:EuropeMember gtx:AftermarketMember 2020-01-01 2020-09-30 0001735707 srt:EuropeMember gtx:OtherMember 2020-01-01 2020-09-30 0001735707 srt:EuropeMember 2020-01-01 2020-09-30 0001735707 srt:AsiaMember gtx:OriginalEquipmentManufacturersMember 2020-01-01 2020-09-30 0001735707 srt:AsiaMember gtx:AftermarketMember 2020-01-01 2020-09-30 0001735707 srt:AsiaMember gtx:OtherMember 2020-01-01 2020-09-30 0001735707 srt:AsiaMember 2020-01-01 2020-09-30 0001735707 us-gaap:NonUsMember gtx:OriginalEquipmentManufacturersMember 2020-01-01 2020-09-30 0001735707 us-gaap:NonUsMember gtx:AftermarketMember 2020-01-01 2020-09-30 0001735707 us-gaap:NonUsMember 2020-01-01 2020-09-30 0001735707 gtx:OriginalEquipmentManufacturersMember 2020-01-01 2020-09-30 0001735707 gtx:AftermarketMember 2020-01-01 2020-09-30 0001735707 gtx:OtherMember 2020-01-01 2020-09-30 0001735707 country:US gtx:OriginalEquipmentManufacturersMember 2019-07-01 2019-09-30 0001735707 country:US gtx:AftermarketMember 2019-07-01 2019-09-30 0001735707 country:US gtx:OtherMember 2019-07-01 2019-09-30 0001735707 country:US 2019-07-01 2019-09-30 0001735707 srt:EuropeMember gtx:OriginalEquipmentManufacturersMember 2019-07-01 2019-09-30 0001735707 srt:EuropeMember gtx:AftermarketMember 2019-07-01 2019-09-30 0001735707 srt:EuropeMember gtx:OtherMember 2019-07-01 2019-09-30 0001735707 srt:EuropeMember 2019-07-01 2019-09-30 0001735707 srt:AsiaMember gtx:OriginalEquipmentManufacturersMember 2019-07-01 2019-09-30 0001735707 srt:AsiaMember gtx:AftermarketMember 2019-07-01 2019-09-30 0001735707 srt:AsiaMember gtx:OtherMember 2019-07-01 2019-09-30 0001735707 srt:AsiaMember 2019-07-01 2019-09-30 0001735707 us-gaap:NonUsMember gtx:OriginalEquipmentManufacturersMember 2019-07-01 2019-09-30 0001735707 us-gaap:NonUsMember gtx:AftermarketMember 2019-07-01 2019-09-30 0001735707 us-gaap:NonUsMember 2019-07-01 2019-09-30 0001735707 gtx:OriginalEquipmentManufacturersMember 2019-07-01 2019-09-30 0001735707 gtx:AftermarketMember 2019-07-01 2019-09-30 0001735707 gtx:OtherMember 2019-07-01 2019-09-30 0001735707 country:US gtx:OriginalEquipmentManufacturersMember 2019-01-01 2019-09-30 0001735707 country:US gtx:AftermarketMember 2019-01-01 2019-09-30 0001735707 country:US gtx:OtherMember 2019-01-01 2019-09-30 0001735707 country:US 2019-01-01 2019-09-30 0001735707 srt:EuropeMember gtx:OriginalEquipmentManufacturersMember 2019-01-01 2019-09-30 0001735707 srt:EuropeMember gtx:AftermarketMember 2019-01-01 2019-09-30 0001735707 srt:EuropeMember gtx:OtherMember 2019-01-01 2019-09-30 0001735707 srt:EuropeMember 2019-01-01 2019-09-30 0001735707 srt:AsiaMember gtx:OriginalEquipmentManufacturersMember 2019-01-01 2019-09-30 0001735707 srt:AsiaMember gtx:AftermarketMember 2019-01-01 2019-09-30 0001735707 srt:AsiaMember gtx:OtherMember 2019-01-01 2019-09-30 0001735707 srt:AsiaMember 2019-01-01 2019-09-30 0001735707 us-gaap:NonUsMember gtx:OriginalEquipmentManufacturersMember 2019-01-01 2019-09-30 0001735707 us-gaap:NonUsMember gtx:AftermarketMember 2019-01-01 2019-09-30 0001735707 us-gaap:NonUsMember 2019-01-01 2019-09-30 0001735707 gtx:OriginalEquipmentManufacturersMember 2019-01-01 2019-09-30 0001735707 gtx:AftermarketMember 2019-01-01 2019-09-30 0001735707 gtx:OtherMember 2019-01-01 2019-09-30 0001735707 gtx:ResearchAndDevelopmentOfNewProductCostsMember us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0001735707 gtx:ResearchAndDevelopmentOfNewProductCostsMember us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0001735707 gtx:ResearchAndDevelopmentOfNewProductCostsMember us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0001735707 gtx:ResearchAndDevelopmentOfNewProductCostsMember us-gaap:CostOfSalesMember 2019-01-01 2019-09-30 0001735707 gtx:EngineeringRelatedExpensesMember us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0001735707 gtx:EngineeringRelatedExpensesMember us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0001735707 gtx:EngineeringRelatedExpensesMember us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0001735707 gtx:EngineeringRelatedExpensesMember us-gaap:CostOfSalesMember 2019-01-01 2019-09-30 0001735707 us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0001735707 us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0001735707 us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0001735707 us-gaap:CostOfSalesMember 2019-01-01 2019-09-30 0001735707 2019-01-01 2019-12-31 0001735707 us-gaap:EmployeeSeveranceMember 2018-12-31 0001735707 us-gaap:SpinoffMember 2018-12-31 0001735707 us-gaap:EmployeeSeveranceMember 2019-01-01 2019-09-30 0001735707 us-gaap:SpinoffMember 2019-01-01 2019-09-30 0001735707 us-gaap:EmployeeSeveranceMember 2019-09-30 0001735707 us-gaap:SpinoffMember 2019-09-30 0001735707 us-gaap:EmployeeSeveranceMember 2019-12-31 0001735707 us-gaap:SpinoffMember 2019-12-31 0001735707 us-gaap:EmployeeSeveranceMember 2020-01-01 2020-09-30 0001735707 us-gaap:SpinoffMember 2020-01-01 2020-09-30 0001735707 us-gaap:EmployeeSeveranceMember 2020-09-30 0001735707 us-gaap:SpinoffMember 2020-09-30 0001735707 srt:MaximumMember 2020-01-01 2020-09-30 0001735707 srt:MaximumMember 2020-09-30 0001735707 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0001735707 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2020-09-30 0001735707 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2020-09-30 0001735707 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2020-09-30 0001735707 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0001735707 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001735707 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-12-31 0001735707 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-12-31 0001735707 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-12-31 0001735707 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001735707 us-gaap:CarryingReportedAmountFairValueDisclosureMember gtx:TermsLoansAAndBMember 2020-09-30 0001735707 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel2Member gtx:TermsLoansAAndBMember 2020-09-30 0001735707 us-gaap:CarryingReportedAmountFairValueDisclosureMember gtx:FivePointOneTwoFivePercentSeniorNotesDueTwoThousandTwentySixMember 2020-09-30 0001735707 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel2Member gtx:FivePointOneTwoFivePercentSeniorNotesDueTwoThousandTwentySixMember 2020-09-30 0001735707 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001735707 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0001735707 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-09-30 0001735707 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-09-30 0001735707 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0001735707 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-09-30 0001735707 us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-30 0001735707 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-09-30 0001735707 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-09-30 0001735707 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001735707 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0001735707 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0001735707 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-09-30 0001735707 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-09-30 0001735707 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0001735707 us-gaap:AccumulatedTranslationAdjustmentMember 2020-09-30 0001735707 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-09-30 0001735707 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-09-30 0001735707 gtx:TheSubordinatedAsbestosIndemnityAgreementMember 2018-09-12 0001735707 gtx:TheSubordinatedAsbestosIndemnityAgreementMember gtx:HoneywellInternationalIncMember 2020-01-01 2020-03-31 0001735707 gtx:TheSubordinatedAsbestosIndemnityAgreementMember gtx:HoneywellInternationalIncMember 2020-01-01 2020-09-30 0001735707 gtx:TaxMattersAgreementMember gtx:HoneywellInternationalIncMember 2018-10-01 2018-10-01 0001735707 gtx:TaxMattersAgreementMember gtx:HoneywellInternationalIncMember 2020-09-30 gtx:Installment 0001735707 gtx:TaxMattersAgreementMember gtx:HoneywellInternationalIncMember 2018-10-01 0001735707 gtx:HoneywellInternationalIncMember gtx:AsbestosAndEnvironmentalMember us-gaap:SpinoffMember 2019-12-31 0001735707 gtx:HoneywellInternationalIncMember gtx:TaxMattersAgreementMember us-gaap:SpinoffMember 2019-12-31 0001735707 gtx:HoneywellInternationalIncMember us-gaap:SpinoffMember 2019-12-31 0001735707 gtx:HoneywellInternationalIncMember gtx:AsbestosAndEnvironmentalMember us-gaap:SpinoffMember 2020-01-01 2020-09-30 0001735707 gtx:HoneywellInternationalIncMember us-gaap:SpinoffMember 2020-01-01 2020-09-30 0001735707 gtx:HoneywellInternationalIncMember gtx:TaxMattersAgreementMember us-gaap:SpinoffMember 2020-01-01 2020-09-30 0001735707 gtx:HoneywellInternationalIncMember gtx:AsbestosAndEnvironmentalMember us-gaap:SpinoffMember 2020-09-30 0001735707 gtx:HoneywellInternationalIncMember gtx:TaxMattersAgreementMember us-gaap:SpinoffMember 2020-09-30 0001735707 gtx:HoneywellInternationalIncMember us-gaap:SpinoffMember 2020-09-30 0001735707 gtx:BendixAsbestosRelatedLiabilitiesMember 2019-12-31 0001735707 gtx:BendixAsbestosRelatedLiabilitiesMember 2018-12-31 0001735707 gtx:BendixAsbestosRelatedLiabilitiesMember 2020-01-01 2020-09-30 0001735707 gtx:BendixAsbestosRelatedLiabilitiesMember 2019-01-01 2019-12-31 0001735707 gtx:BendixAsbestosRelatedLiabilitiesMember 2020-09-30 iso4217:USD gtx:Claim 0001735707 2018-01-01 2018-12-31 0001735707 2017-01-01 2017-12-31 0001735707 2016-01-01 2016-12-31 0001735707 us-gaap:SecretariatOfTheFederalRevenueBureauOfBrazilMember 2020-09-30 0001735707 us-gaap:PensionPlansDefinedBenefitMember us-gaap:ForeignPlanMember 2020-09-30 0001735707 us-gaap:PensionPlansDefinedBenefitMember us-gaap:ForeignPlanMember 2020-01-01 2020-09-30 0001735707 us-gaap:PensionPlansDefinedBenefitMember us-gaap:ForeignPlanMember 2020-07-01 2020-09-30 0001735707 us-gaap:PensionPlansDefinedBenefitMember us-gaap:ForeignPlanMember 2019-07-01 2019-09-30 0001735707 us-gaap:PensionPlansDefinedBenefitMember country:US 2020-01-01 2020-09-30 0001735707 us-gaap:PensionPlansDefinedBenefitMember us-gaap:ForeignPlanMember 2019-01-01 2019-09-30 0001735707 us-gaap:PensionPlansDefinedBenefitMember country:US 2020-07-01 2020-09-30 0001735707 us-gaap:PensionPlansDefinedBenefitMember country:US 2019-01-01 2019-09-30 0001735707 us-gaap:PensionPlansDefinedBenefitMember country:US 2019-07-01 2019-09-30 0001735707 gtx:GarrettChinaMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2018-09-01 2018-09-30 0001735707 gtx:GarrettChinaMember gtx:HoneywellInternationalIncMember 2020-06-03

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2020

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____ to ______

Commission File Number: 001-38636

 

Garrett Motion Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

82-4873189

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer
Identification No.)

 

 

La Pièce 16, Rolle, Switzerland

1180

(Address of principal executive offices)

(Zip Code)

 

+41 21 695 30 00

(Registrant’s telephone number, including area code)

 

N/A

(Former Name, Former Address and Former Fiscal Year,

if Changed Since Last Report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

None

None

None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes      No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

 

  

Accelerated filer

 

 

 

 

 

Non-accelerated filer

 

 

  

Smaller reporting company

 

 

 

 

 

 

 

 

Emerging growth company

 

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes      No  

As of October 26, 2020, the registrant had 75,788,279 shares of common stock, $0.001 par value per share, outstanding.

 

 

 

 

 


 

Table of Contents

 

 

 

Page

PART I.

FINANCIAL INFORMATION

6

Item 1.

Financial Statements (Unaudited)

6

 

Consolidated Interim Statements of Operations (Unaudited)

6

 

Consolidated Interim Statements of Comprehensive Income (Loss) (Unaudited)

7

 

Consolidated Interim Balance Sheets (Unaudited)

8

 

Consolidated Interim Statements of Cash Flows (Unaudited)

9

 

Consolidated Interim Statements of Equity (Deficit) (Unaudited)

10

 

Notes to Unaudited Consolidated Interim Financial Statements

11

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

34

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

48

Item 4.

Controls and Procedures

49

PART II.

OTHER INFORMATION

50

Item 1.

Legal Proceedings

50

Item 1A.

Risk Factors

50

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

55

Item 3.

Defaults Upon Senior Securities

55

Item 4.

Mine Safety Disclosures

55

Item 5.

Other Information

55

Item 6.

Exhibits

56

Signatures

58

 

 

 

i


 

EXPLANATORY NOTE

On September 20, 2020 (the “Petition Date”), Garrett Motion Inc. (the “Company”) and certain of its subsidiaries (collectively, the “Debtors”) each filed a voluntary petition for relief under chapter 11 of title 11 of the United States Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the Southern District of New York (the “Bankruptcy Court”). The Debtors’ chapter 11 cases (the “Chapter 11 Cases”) are being jointly administered under the caption “In re: Garrett Motion Inc., 20-12212.”

On the Petition Date, the Debtors entered into a Restructuring Support Agreement (the “RSA”) with consenting lenders (the “Consenting Lenders”) holding, in the aggregate, approximately 61% of the aggregate outstanding principal amount of loans under that certain Credit Agreement, dated as of September 27, 2018, (as amended, restated, supplemented or otherwise modified from time to time, the “Prepetition Credit Agreement”) by and among the Company, as Holdings, Garrett LX III S.à r.l., as Lux Borrower, Garrett Borrowing LLC, as U.S. Co-Borrower, Garrett Motion S.à r.l., as Swiss Borrower, the Lenders and Issuing Banks party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent. Pursuant to the RSA, the Consenting Lenders and the Debtors have agreed to the principal terms of a financial restructuring, to be implemented through a plan of reorganization under the Bankruptcy Code (the “Plan”), and is expected to include the sale of all or substantially all of the assets of certain Debtors and of the stock of certain Debtors and other subsidiaries, as further described below.

On the Petition Date, certain of the Debtors also entered into a share and asset purchase agreement (the “Stalking Horse Purchase Agreement”) with AMP Intermediate B.V. (the “Stalking Horse Bidder”) and AMP U.S. Holdings, LLC, each affiliates of KPS Capital Partners, LP, pursuant to which the Stalking Horse Bidder has agreed to purchase, subject to the terms and conditions contained therein, all of the equity interests in each of Garrett LX I S.à r.l., and Garrett Transportation I Inc. (subject to an election by the Stalking Horse Bidder to purchase substantially all of the assets of Garrett Transportation I Inc., instead of its equity), along with certain other assets and liabilities of the Debtors pursuant to the Plan. On October 19, 2020, the Company received a proposal from the Stalking Horse Bidder to revise its bid following the Bankruptcy Court’s entry on October 24, 2020 of an order approving bidding procedures and stalking horse protections to, among other things, increase consideration by $500 million (for total consideration of $2.6 billion) and offer the Company’s existing stockholders the opportunity to co-invest in the reorganized business (the “Stalking Horse Bidder Revised Proposal”). The Stalking Horse Purchase Agreement and the Stalking Horse Bidder Revised Proposal are subject to Bankruptcy Court approval and are intended to constitute a “stalking horse” bid that is subject to higher and better bids by third parties in accordance with bidding procedures approved by the Bankruptcy Court. Such bids by third parties may include proposals for stand-alone plans of reorganization.

On October 6, 2020, the Bankruptcy Court entered an order granting interim approval of the Debtors’ entry into a Senior Secured Super-Priority Debtor-in-Possession Credit Agreement (the “DIP Credit Agreement”), with the lenders party thereto (the “DIP Lenders”) and Citibank N.A. as administrative agent (the “DIP Agent”). On October 9, 2020 (the “Closing Date”), the Company, the DIP Agent and the DIP Lenders entered into the DIP Credit Agreement. The DIP Credit Agreement provides for a senior secured, super-priority term loan (the “DIP Term Loan Facility”) in the principal amount of $200 million, $100 million of which was funded on the Closing Date and $100 million of which was subsequently funded on October 26, 2020, following entry of the Bankruptcy Court’s final order approving the DIP Term Loan Facility on October 23, 2020. The proceeds of the DIP Term Loan Facility are to be used by the Debtors to (a) pay certain costs, premiums, fees and expenses related to the Chapter 11 Cases, (b) make payments pursuant to any interim or final order entered by the Bankruptcy Court pursuant to any “first day” motions permitting the payment by the Debtors of any prepetition amounts then due and owing; (c) make certain adequate protection payments in accordance with the DIP Credit Agreement and (d) fund working capital needs of the Debtors and their subsidiaries to the extent permitted by the DIP Credit Agreement.

See Note 1 Background and Basis of Presentation of the Notes to the Company’s Condensed Consolidated Interim Financial Statements for additional information regarding the Chapter 11 Cases, the RSA, the Stalking Horse Purchase Agreement and the DIP Credit Agreement. The disclosures in this Quarterly Report on Form 10-Q should be read in the context of the Chapter 11 Cases. All documents filed with the Bankruptcy Court are available for inspection at the Office of the Clerk of the Bankruptcy Court or online (a) for a fee on the Bankruptcy Court’s website at www.ecf.uscourts.gov and (b) free of charge on the website of the Debtors’ claims and noticing agent, Kurtzman Carson Consultants LLC at http://www.kccllc.net/garrettmotion.

 

BASIS OF PRESENTATION

On October 1, 2018, Garrett Motion Inc. became an independent publicly-traded company through a pro rata distribution (the “Distribution”) by Honeywell International Inc. (“Former Parent” or “Honeywell”) of 100% of the then-outstanding shares of Garrett to Honeywell’s stockholders (the “Spin-Off”). Each Honeywell stockholder of record received one share of Garrett common stock for every 10 shares of Honeywell common stock held on the record date.

2


 

Unless the context otherwise requires, references to “Garrett,” “we,” “us,” “our,” and “the Company” in this Quarterly Report on Form 10-Q refer to Garrett Motion Inc. and its subsidiaries following the Spin-Off.

3


 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact contained in this Quarterly Report on Form 10-Q, including without limitation statements regarding our future results of operations and financial position, the consequences and outcome of the Chapter 11 Cases, other potential claims against the Debtors related to the Chapter 11 Cases, the impact of the delisting of our common stock from the New York Stock Exchange, the anticipated impact of the novel coronavirus (“COVID-19”) pandemic on our business, results of operations and financial position, expectations regarding the growth of the turbocharger and electric vehicle markets and other industry trends, the sufficiency of our cash and cash equivalents, anticipated sources and uses of cash, anticipated investments in our business, our business strategy, pending litigation, anticipated payments under our agreements with Honeywell, and the expected timing of those payments, anticipated interest expense, and the plans and objectives of management for future operations and capital expenditures are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this Quarterly Report on Form 10-Q are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. These forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q and are subject to a number of important factors that could cause actual results to differ materially from those in the forward-looking statements, including:

 

 

1.

changes in the automotive industry and economic or competitive conditions;

 

2.

our ability to develop new technologies and products, and the development of either effective alternative turbochargers or new replacement technologies;

 

3.

failure to protect our intellectual property or allegations that we have infringed the intellectual property of others, and our ability to license necessary intellectual property from third parties;

 

4.

potential material losses and costs as a result of any warranty claims and product liability actions brought against us;

 

5.

significant failure or inability to comply with the specifications and manufacturing requirements of our original equipment manufacturer customers or by increases or decreases to the inventory levels maintained by our customers;

 

6.

volume of products we produce and market demand for such products and prices we charge and the margins we realize from our sales of our products;

 

7.

loss of or a significant reduction in purchases by our largest customers, material nonpayment or nonperformance by any our key customers, and difficulty collecting receivables;

 

8.

inaccuracies in estimates of volumes of awarded business;

 

9.

work stoppages, other disruptions or the need to relocate any of our facilities;

 

10.

supplier dependency;

 

11.

failure to meet our minimum delivery requirements under our supply agreements;

 

12.

failure to increase productivity or successfully execute repositioning projects or manage our workforce;

 

13.

potential material environmental liabilities and hazards;

 

14.

natural disasters and physical impacts of climate change;

 

15.

pandemics, including without limitation the COVID-19 pandemic, and effects on our workforce and supply chain;

 

16.

technical difficulties or failures, including cybersecurity risks;

 

17.

the outcome of and costs associated with pending and potential material litigation matters, including our pending lawsuit against Honeywell;

 

18.

changes in legislation or government regulations or policies, including with respect to CO2 reduction targets in Europe as part of the Green Deal objectives or other similar changes which may contribute to a proportionately higher level of battery electric vehicles;

4


 

 

19.

risks related to international operations and our investment in foreign markets, including risks related to the withdrawal of the United Kingdom from the European Union;

 

20.

risks related to our agreements with Honeywell, such as the indemnification and reimbursement agreement and tax matters agreement;

 

21.

the terms of our indebtedness and our ability to access capital markets;

 

22.

unforeseen adverse tax effects;

 

23.

costs related to operating as a standalone public company and failure to achieve benefits expected from the Spin-Off;

 

24.

our leveraged capital structure and liabilities to Honeywell may pose significant challenges to our overall strategic and financial flexibility and have a material adverse effect on our business, liquidity position and financial position;

 

25.

inability to recruit and retain qualified personnel;

 

26.

the ability to obtain Bankruptcy Court approval in the Chapter 11 Cases with respect to the Debtors’ motions, the outcome of the Bankruptcy Court’s rulings in the Chapter 11 Cases and the outcome of the Chapter 11 Cases in general, including the length of time the Debtors will operate in the Chapter 11 Cases;

 

27.

restrictions on our operations as a result of the Chapter 11 Cases, the Stalking Horse Purchase Agreement and the DIP Credit Agreement;

 

28.

ability to complete a sale transaction (including in accordance with the Stalking Horse Purchase Agreement) or realize adequate consideration for such sale with the approval of the Bankruptcy Court;

 

29.

the outcome of our litigation against Honeywell in the Chapter 11 Cases;

 

30.

the potential adverse effects of extended operation during the Chapter 11 Cases on our business, financial condition, results of operations and liquidity, including potential loss of customers and suppliers, management and other key personnel;

 

31.

the availability of additional financing to maintain our operations if the DIP Term Loan Facility should become unavailable or insufficient;

 

32.

the potential to experience increased levels of employee attrition as a result of the Chapter 11 Cases;

 

33.

ability to utilize our net operating loss carryforwards in future years;

 

34.

other litigation and the inherent risks involved in a bankruptcy process, including the possibility of converting to a proceeding under Chapter 7 of the Bankruptcy Code;

 

35.

the effect of the Chapter 11 Cases on the trading price and liquidity of our securities; and

 

36.

the other factors described under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2019, as updated in this Quarterly Report on Form 10-Q, and in our other filings with the Securities and Exchange Commission.

You should read this Quarterly Report on Form 10-Q and the documents that we reference herein completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

5


 

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

GARRETT MOTION INC.

(Debtor-in-Possession)

CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS

(Unaudited)

 

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

(Dollars in millions, except per share amounts)

 

Net sales (Note 4)

 

 

804

 

 

 

781

 

 

 

2,026

 

 

 

2,418

 

Cost of goods sold

 

 

652

 

 

 

609

 

 

 

1,648

 

 

 

1,868

 

Gross profit

 

$

152

 

 

$

172

 

 

$

378

 

 

$

550

 

Selling, general and administrative expenses

 

 

103

 

 

 

68

 

 

 

215

 

 

 

186

 

Other expense, net (Note 6)

 

 

14

 

 

 

18

 

 

 

45

 

 

 

54

 

Interest expense (excludes contractual interest for the three and nine months ended September 30, 2020 of $0) (Note 2)

 

 

20

 

 

 

18

 

 

 

56

 

 

 

52

 

Non-operating expense (income)

 

 

1

 

 

 

(4

)

 

 

(7

)

 

 

2

 

Reorganization items, net

 

 

4

 

 

 

 

 

 

4

 

 

 

 

Income before taxes

 

$

10

 

 

$

72

 

 

$

65

 

 

$

256

 

Tax (benefit) expense (Note 7)

 

 

(1

)

 

 

34

 

 

 

11

 

 

 

79

 

Net income

 

$

11

 

 

$

38

 

 

$

54

 

 

$

177

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per common share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.15

 

 

$

0.51

 

 

$

0.72

 

 

$

2.37

 

Diluted

 

$

0.14

 

 

$

0.50

 

 

$

0.71

 

 

$

2.34

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

75,739,152

 

 

 

74,753,593

 

 

 

75,456,358

 

 

 

74,528,740

 

Diluted

 

 

75,943,994

 

 

 

75,704,457

 

 

 

76,123,548

 

 

 

75,700,652

 

 

The Notes to the Consolidated Interim Financial Statements are an integral part of this statement.

6


 

GARRETT MOTION INC.

(Debtor-in-Possession)

CONSOLIDATED INTERIM STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(Unaudited)

 

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

(Dollars in millions)

 

Net income

 

$

11

 

 

$

38

 

 

$

54

 

 

$

177

 

Foreign exchange translation adjustment

 

 

(100

)

 

 

102

 

 

 

(111

)

 

 

127

 

Defined benefit pension plan adjustment, net of tax (Note 19)

 

 

 

 

 

 

 

 

 

 

 

1

 

Changes in fair value of effective cash flow hedges, net of tax

   (Note 15)

 

 

(6

)

 

 

8

 

 

 

(8

)

 

 

10

 

Total other comprehensive (loss) income, net of tax

 

$

(106

)

 

$

110

 

 

$

(119

)

 

$

138

 

Comprehensive (loss) income

 

$

(95

)

 

$

148

 

 

$

(65

)

 

$

315

 

 

The Notes to the Consolidated Interim Financial Statements are an integral part of this statement.

7


 

GARRETT MOTION INC.

(Debtor-in-Possession)

CONSOLIDATED INTERIM BALANCE SHEETS

(Unaudited)

 

 

 

September 30,

2020

 

 

December 31,

2019

 

 

 

(Dollars in millions)

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

312

 

 

$

187

 

Restricted cash

 

 

3

 

 

 

 

Accounts, notes and other receivables – net (Note 8)

 

 

710

 

 

 

707

 

Inventories – net (Note 10)

 

 

237

 

 

 

220

 

Other current assets

 

 

130

 

 

 

85

 

Total current assets

 

 

1,392

 

 

 

1,199

 

Investments and long-term receivables

 

 

34

 

 

 

36

 

Property, plant and equipment – net

 

 

465

 

 

 

471

 

Goodwill

 

 

193

 

 

 

193

 

Deferred income taxes

 

 

265

 

 

 

268

 

Other assets (Note 11)

 

 

118

 

 

 

108

 

Total assets

 

$

2,467

 

 

$

2,275

 

LIABILITIES

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

461

 

 

$

1,009

 

Borrowings under revolving credit facility

 

 

370

 

 

 

 

Current maturities of long-term debt

 

 

 

 

 

4

 

Obligations payable to Honeywell, current (Note 18)

 

 

 

 

 

69

 

Accrued liabilities (Note 12)

 

 

201

 

 

 

310

 

Total current liabilities

 

 

1,032

 

 

 

1,392

 

Long-term debt

 

 

1,045

 

 

 

1,409

 

Deferred income taxes

 

 

2

 

 

 

51

 

Obligations payable to Honeywell (Note 18)

 

 

 

 

 

1,282

 

Other liabilities (Note 13)

 

 

114

 

 

 

274

 

Total liabilities not subject to compromise

 

$

2,193

 

 

$

4,408

 

Liabilities subject to compromise

 

 

2,470

 

 

 

 

Total liabilities

 

$

4,663

 

 

$

4,408

 

COMMITMENTS AND CONTINGENCIES (Note 18)

 

 

 

 

 

 

 

 

EQUITY (DEFICIT)

 

 

 

 

 

 

 

 

Common stock, par value $0.001; 400,000,000 shares authorized, 76,202,169 and

  74,911,139 issued and 75,788,279 and 74,826,329 outstanding as of September 30,

  2020 and December 31, 2019, respectively

 

 

 

 

 

 

Additional paid-in capital

 

 

26

 

 

 

19

 

Retained earnings

 

 

(2,233

)

 

 

(2,282

)

Accumulated other comprehensive income (Note 16)

 

 

11

 

 

 

130

 

Total stockholders' deficit

 

 

(2,196

)

 

 

(2,133

)

Total liabilities and stockholders' deficit

 

$

2,467

 

 

$

2,275

 

 

The Notes to the Consolidated Interim Financial Statements are an integral part of this statement.

8


 

GARRETT MOTION INC.

(Debtor-in-Possession)

CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

For the Nine Months Ended September30,

 

 

 

2020

 

 

2019

 

 

 

(Dollars in millions)

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net income

 

$

54

 

 

$

177

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

Non-cash reorganization items, net

 

 

4

 

 

 

 

Deferred income taxes

 

 

(25

)

 

 

4

 

Depreciation

 

 

60

 

 

 

55

 

Amortization of deferred issuance costs

 

 

5

 

 

 

5

 

Foreign exchange loss

 

 

(15

)

 

 

32

 

Stock compensation expense

 

 

8

 

 

 

14

 

Pension expense

 

 

1

 

 

 

4

 

Other

 

 

9

 

 

 

7

 

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

Accounts, notes and other receivables

 

 

(35

)

 

 

(29

)

Inventories

 

 

(26

)

 

 

(33

)

Other assets

 

 

(54

)

 

 

7

 

Accounts payable

 

 

(126

)

 

 

18

 

Accrued liabilities

 

 

(22

)

 

 

(48

)

Obligations payable to Honeywell

 

 

6

 

 

 

(84

)

Other liabilities

 

 

20

 

 

 

(4

)

Net cash (used for) provided by operating activities

 

$

(136

)

 

$

125

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Expenditures for property, plant and equipment

 

 

(79

)

 

 

(74

)

Other

 

 

 

 

 

12

 

Net cash used for investing activities

 

$

(79

)

 

$

(62

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Proceeds from revolving credit facility

 

 

1,449

 

 

 

550

 

Payments of revolving credit facility

 

 

(1,100

)

 

 

(550

)

Payments of long-term debt

 

 

(2

)

 

 

(62

)

Debtor-in-possession financing fees

 

 

(4

)

 

 

 

Other

 

 

(3

)

 

 

 

Net cash provided by (used for) financing activities

 

 

340

 

 

 

(62

)

Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash

 

 

3

 

 

 

(7

)

Net increase/(decrease) in cash, cash equivalents and restricted cash

 

 

128

 

 

 

(6

)

Cash and cash equivalents at beginning of period

 

 

187

 

 

 

196

 

Cash, cash equivalents and restricted cash at end of period

 

$

315

 

 

$

190

 

Supplemental Cash Flow Disclosure:

 

 

 

 

 

 

 

 

Reorganization items paid

 

 

 

 

 

 

 

The Notes to the Consolidated Interim Financial Statements are an integral part of this statement.

 

 

9


 

GARRETT MOTION INC.

(Debtor-in-Possession)

CONSOLIDATED INTERIM STATEMENTS OF EQUITY (DEFICIT)

(Unaudited)

(in millions)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

Common Stock

 

 

Paid-in

 

 

Retained

 

 

Comprehensive

 

 

Total

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Earnings

 

 

Income/(Loss)

 

 

Deficit

 

 

 

(in millions)

 

Balance at December 31, 2018

 

 

74

 

 

 

 

 

 

5

 

 

 

(2,595

)

 

 

73

 

 

 

(2,517

)

Net income

 

 

 

 

 

 

 

 

 

 

 

73

 

 

 

 

 

 

73

 

Other comprehensive income, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

63

 

 

 

63

 

Stock-based compensation

 

 

1

 

 

 

 

 

 

5

 

 

 

 

 

 

 

 

 

5

 

Balance at March 31, 2019

 

 

75

 

 

 

 

 

 

10

 

 

 

(2,522

)

 

 

136

 

 

 

(2,376

)

Net income

 

 

 

 

 

 

 

 

 

 

 

66

 

 

 

 

 

 

66

 

Other comprehensive income, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(35

)

 

 

(35

)

Stock-based compensation

 

 

 

 

 

 

 

 

4

 

 

 

 

 

 

 

 

 

4

 

Balance at June 30, 2019

 

 

75

 

 

 

 

 

 

14

 

 

 

(2,456

)

 

 

101

 

 

 

(2,341

)

Net income

 

 

 

 

 

 

 

 

 

 

 

38

 

 

 

 

 

 

38

 

Other comprehensive income, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

110

 

 

 

110

 

Stock-based compensation

 

 

 

 

 

 

 

 

5

 

 

 

 

 

 

 

 

 

5

 

Balance at September 30, 2019

 

 

75

 

 

 

 

 

 

19

 

 

 

(2,418

)

 

 

211

 

 

 

(2,188

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2019

 

 

75

 

 

 

 

 

 

19

 

 

 

(2,282

)

 

 

130

 

 

 

(2,133

)

Net income

 

 

 

 

 

 

 

 

 

 

 

52

 

 

 

 

 

 

52

 

Other comprehensive income, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

39

 

 

 

39

 

Stock-based compensation

 

 

 

 

 

 

 

 

2

 

 

 

 

 

 

 

 

 

2

 

Tax withholding related to vesting of restricted

   stock units and other

 

 

 

 

 

 

 

 

(1

)

 

 

 

 

 

 

 

 

(1

)

Adoption impact of ASU 2016-13, Financial

   Instruments - Credit Losses

 

 

 

 

 

 

 

 

 

 

 

(5

)

 

 

 

 

 

(5

)

Balance at March 31, 2020

 

 

75

 

 

 

 

 

 

20

 

 

 

(2,235

)

 

 

169

 

 

 

(2,046

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

(9

)

 

 

 

 

 

(9

)

Other comprehensive loss, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(52

)

 

 

(52

)

Stock-based compensation

 

 

 

 

 

 

 

 

4

 

 

 

 

 

 

 

 

 

4

 

Balance at June 30, 2020

 

 

75

 

 

 

 

 

 

24

 

 

 

(2,244

)

 

 

117

 

 

 

(2,103

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

11

 

 

 

 

 

 

11

 

Other comprehensive loss, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(106

)

 

 

(106

)

Stock-based compensation

 

 

 

 

 

 

 

 

2

 

 

 

 

 

 

 

 

 

2

 

Balance at September 30, 2020

 

 

75

 

 

 

 

 

 

26

 

 

 

(2,233

)

 

 

11

 

 

 

(2,196

)

 

The Notes to the Consolidated Interim Financial Statements are an integral part of this statement.

10


 

GARRETT MOTION INC.

(Debtor-in-Possession)

NOTES TO CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(Unaudited)

(Dollars in millions, except per share amounts)

 

Note 1. Background and Basis of Presentation

 

Background

Garrett Motion Inc. (the “Company” or “Garrett”) designs, manufactures and sells highly engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (“OEMs”) and the global vehicle independent aftermarket, as well as automotive software solutions. These OEMs in turn ship to consumers globally. We are a global technology leader with significant expertise in delivering products across gasoline, diesel, natural gas and electric (hybrid and fuel cell) powertrains. These products are key enablers for fuel economy and emission standards compliance.

 

COVID-19

In December 2019, a strain of novel coronavirus disease, COVID-19, was identified in Wuhan, China. This virus has been declared a pandemic and has spread across the world, including throughout Asia, the United States and Europe. Our business operations have been materially disrupted and our revenues have decreased significantly as a result of the COVID-19 pandemic and related response measures, and we expect our financial performance in the quarter ending December 31, 2020, and in future fiscal quarters, to be materially negatively affected by the pandemic and its impact on the global automotive industry.

On June 12, 2020, the Company entered into an amendment (the “2020 Amendment”) to its Credit Agreement, dated as of September 27, 2018 (as amended, the “Credit Agreement”) by and among the Company, Garrett LX I S.à r.l., Garrett LX II S.à r.l., Garrett LX III S.à r.l., Garrett Borrowing LLC, and Garrett Motion Sàrl (f/k/a Honeywell Technologies Sàrl), the lenders and issuing banks party thereto and JPMorgan Chase Bank, N.A., as administrative agent, consisting of:

 

a seven-year term B loan facility, consisting of a tranche denominated in Euro of €375 million and a tranche denominated in U.S. Dollars of $425 million (the “Term B Facility”);

 

a five-year term A loan facility in an aggregate principal amount of €330 million (the “Term A Facility” and, together with the Term B Facility, the “Term Loan Facilities”); and

 

a five-year revolving credit facility in an aggregate principal amount of €430 million (the “Revolving Facility” and, together with the Term Loan Facilities, the “Senior Credit Facilities”).

The primary purpose for entering into the 2020 Amendment was to obtain covenant relief with respect to the total leverage ratio and interest coverage ratios under the Credit Agreement as a result of the impact of the COVID-19 pandemic and the Company’s leveraged capital structure.

The 2020 Amendment qualified as a debt modification that did not result in an extinguishment or have a material impact on our Consolidated Interim Financial Statements.

The commencement of the Chapter 11 Cases (as defined below) constituted an event of default that accelerated the Company’s obligations, as applicable, under the Credit Agreement. The Credit Agreement provides that as a result of the commencement of the Chapter 11 Cases, the principal, interest and all other amounts due thereunder shall be immediately due and payable. Any efforts to enforce the payment obligations under the Credit Agreement are automatically stayed as a result of the Chapter 11 Cases, and the creditors’ rights of enforcement in respect of the Credit Agreement are subject to the applicable provisions of the Bankruptcy Code.

Voluntary Filing Under Chapter 11

 

On September 20, 2020 (the “Petition Date”), the Company and certain of its subsidiaries (collectively, the “Debtors”) each filed a voluntary petition for relief under chapter 11 of title 11 of the United States Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the Southern District of New York (the “Bankruptcy Court”). The Debtors’ chapter 11 cases (the “Chapter 11 Cases”) are being jointly administered under the caption “In re: Garrett Motion Inc., 20-12212.”  On September 22 and 24, 2020, the Bankruptcy Court entered orders granting interim approval of certain forms of relief requested by the Debtors, enabling the Debtors to conduct their business activities in the ordinary course, subject to the terms and conditions of such orders, including authorizing the Debtors to pay employee wages and benefits, to pay taxes and certain governmental fees and charges, to continue to operate the Debtors’ cash management system in the ordinary course, to maintain certain customer programs, and to pay the prepetition claims of

11


 

certain of the Debtors’ vendors. On October 20, 21 and 26, 2020, the Bankruptcy Court entered orders granting such relief on a final basis. For goods and services provided following the Petition Date, the Debtors continue to pay vendors under normal terms.

 

The Consolidated Interim Financial Statements included herein have been prepared in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic No. 852, Reorganizations. See Note 2, Reorganization and Chapter 11 Proceedings, for further details.

Delisting from NYSE

On September 20, 2020, the Company was notified by the New York Stock Exchange (the “NYSE”) that, as a result of the Chapter 11 Cases, and in accordance with Section 802.01D of the NYSE Listed Company Manual, that the NYSE had commenced proceedings to delist the Company’s common stock from the NYSE. The NYSE indefinitely suspended trading of the Company’s common stock on September 21, 2020. The Company determined not to appeal the NYSE’s determination. On October 8, 2020, the NYSE filed a Form 25-NSE with the Securities and Exchange Commission, which removed the Company’s common stock from listing and registration on the NYSE effective as of the opening of business on October 19, 2020.

Going Concern

The accompanying Consolidated Interim Financial Statements have been prepared assuming that the Company will continue as a going concern and contemplate the realization of assets and the satisfaction of liabilities in the normal course of business. Liabilities subject to compromise will be resolved in connection with the Chapter 11 Cases. The Company’s ability to continue as a going concern is contingent upon the Company’s ability to successfully implement a plan of reorganization in the Chapter 11 Cases, among other factors. As a result of the Chapter 11 Cases, the realization of assets and the satisfaction of liabilities are subject to uncertainty. While operating as debtors-in-possession under the Bankruptcy Code, the Company may sell or otherwise dispose of or liquidate assets or settle liabilities, subject to the approval of the Bankruptcy Court or as otherwise permitted in the ordinary course of business, for amounts other than those reflected in the accompanying Consolidated Interim Financial Statements. Further, any plan of reorganization in the Chapter 11 Cases could materially change the amounts and classifications of assets and liabilities reported in the Consolidated Interim Financial Statements. The accompanying Consolidated Interim Financial Statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities or any other adjustments that might be necessary should the Company be unable to continue as a going concern or as a consequence of the Chapter 11 Cases. As a result of our financial condition, uncertainty related to the impacts of COVID-19, and the risks and uncertainties surrounding the Chapter 11 Cases, substantial doubt exists that we will be able to continue as a going concern.

                  

 

Basis of Presentation

The Consolidated Interim Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). All amounts presented are in millions, except per share amounts.

Asbestos-related expenses, net of probable insurance recoveries, are presented within Other expense, net in the Consolidated Interim Statement of Operations. Honeywell is subject to certain asbestos-related and environmental-related liabilities, primarily related to its legacy Bendix business. In conjunction with the Spin-Off, certain operations that were part of the Bendix business, along with the ownership of the Bendix trademark, as well as certain operations that were part of other legacy elements of the Business, were transferred to us. The accounting for the majority of our asbestos-related liability payments and accounts payable reflect the terms of the indemnification and reimbursement agreement with Honeywell entered into on September 12, 2018 (the “Subordinated Asbestos Indemnity Agreement”), under which Garrett ASASCO is required to make payments to Honeywell in amounts equal to 90% of Honeywell’s asbestos-related liability payments and accounts payable, primarily related to the Bendix business in the United States, as well as certain environmental-related liability payments and accounts payable and non-United States asbestos-related liability payments and accounts payable, in each case related to legacy elements of the Business, including the legal costs of defending and resolving such liabilities, less 90% of Honeywell’s net insurance receipts and, as may be applicable, certain other recoveries associated with such liabilities. The Subordinated Asbestos Indemnity Agreement provides that the agreement will terminate upon the earlier of (x) December 31, 2048 or (y) December 31st of the third consecutive year during which certain amounts owed to Honeywell during each such year were less than $25 million as converted into Euros in accordance with the terms of the agreement.  We are currently engaged in litigation against Honeywell in connection with the Subordinated Asbestos Indemnity Agreement. For additional information, see Note 18, Commitments and Contingencies.

The preparation of the financial statements in conformity with GAAP requires management to make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases these estimates on assumptions that it believes to be reasonable under the circumstances, including considerations for the impact from the outbreak of the COVID-19 pandemic on the Company's business due to various global macroeconomic, operational and supply chain risks as a result of COVID-19. Actual results could differ from the original estimates, requiring adjustments to these balances in future periods. Furthermore, while operating as “debtors-in-possession” under Chapter 11, the Debtors may sell or otherwise dispose of or liquidate assets or settle liabilities, subject to the approval of the Bankruptcy Court or as otherwise permitted in the ordinary course of business and subject to

12


 

restrictions of the debtor in possession (“DIP”) financing, for amounts other than those reflected in the accompanying unaudited Consolidated Interim Financial Statements. Any such actions occurring during the Chapter 11 Cases, including through a plan of reorganization confirmed by the Bankruptcy Court could materially impact the amounts and classifications of assets and liabilities reported in the unaudited Consolidated Interim Financial Statements.

The Consolidated Interim Financial Statements are unaudited; however, in the opinion of management, they contain all the adjustments (consisting of those of a normal recurring nature) considered necessary to state fairly the financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP applicable to interim periods. The Consolidated Interim Financial Statements should be read in conjunction with the audited annual Consolidated and Combined Financial Statements for the year ended December 31, 2019 included in our Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on February 27, 2020 (our “2019 Form 10-K”). The results of operations for the three and nine months ended September 30, 2020 and cash flows for the nine months ended September 30, 2020 should not necessarily be taken as indicative of the entire year.

We report our quarterly financial information using a calendar convention: the first, second and third quarters are consistently reported as ending on March 31, June 30 and September 30. It has been our practice to establish actual quarterly closing dates using a predetermined fiscal calendar, which requires our businesses to close their books on a Saturday in order to minimize the potentially disruptive effects of quarterly closing on our business processes. The effects of this practice are generally not significant to reported results for any quarter and only exist within a reporting year. For differences in actual closing dates that are material to year-over-year comparisons of quarterly or year-to-date results, such differences have been adjusted for the three months ended September 30, 2020. Our actual closing dates for the three months ended September 30, 2020 and 2019 were September 26, 2020 and September 28, 2019, respectively.

 

2. Reorganization and Chapter 11 Proceedings

Key Events and Voluntary Petition for Reorganization

Due to the Company´s highly leveraged capital structure resulting from the Spin-Off, the Company began a strategic review process assisted by external financial advisers before the COVID-19 pandemic. The pandemic accelerated the review process to include the careful monitoring of liquidity and the consideration of potential court-supervised restructuring processes.

The strategic review process lasted months and considered a wide variety of options, including strategic mergers and stand-alone recapitalizations, both out-of-court and with the assistance of chapter 11. The result of the Company’s strategic review process was the decision to commence a pre-filing marketing process for a cash sale of the business in chapter 11, with the proceeds of the sale and any litigation recoveries related to the spin-off to be distributed to stakeholders. After the bidding process, the Company selected a winning bid of $2.1 billion from affiliates of KPS Capital Partners, LP, (collectively, the “Stalking Horse Bidder”).

As described in greater detail below, the Stalking Horse Bidder and certain of the Debtors (the “Sellers”) entered into a share and asset purchase agreement (the “Stalking Horse Purchase Agreement”) on the Petition Date. The Stalking Horse Purchase Agreement contemplates a combined stock and asset plan sale of the Company, subject to overbid and public auction (the “Auction”) in the Chapter 11 Cases. As discussed in greater detail below, on October 19, 2020, the Company received a proposal from the Stalking Horse Bidder to revise its bid following the Bankruptcy Court’s entry on October 24, 2020 of an order approving bidding procedures and stalking horse protections to, among other things, increase consideration by $500 million (for total consideration of $2.6 billion) and offer the Company’s existing stockholders the opportunity to co-invest in the reorganized business (the “Stalking Horse Bidder Revised Proposal”). The Stalking Horse Purchase Agreement and the Stalking Horse Bidder Revised Proposal remain subject to Bankruptcy Court approval and to higher and better bids, and the Company remains free to solicit competing acquisition proposals, as well as stand-alone plan of reorganization proposals from stakeholders, prior to the Auction. One such stand-alone plan proposal that the Company has received and is evaluating is the proposal contemplated by a coordination agreement entered into by Honeywell International Inc., Centerbridge Partners, L.P. and Oaktree Capital Management L.P. (collectively, the “Bidding Group”) on October 16, 2020, as amended and restated on October 20, 2020 (the “Alternative Proposal”).  The Company continues to evaluate the Alternative Proposal and expects to engage with the Bidding Group on the terms of the Alternative Proposal.

Following entry into the Stalking Horse Purchase Agreement, the Chapter 11 Cases were filed on the Petition Date. The Debtors filed certain motions and applications intended to limit the disruption of the Chapter 11 Cases on its operations. Since the commencement of the Chapter 11 Cases, the Debtors have continued to operate their businesses as “debtors-in-possession” under the jurisdiction of the Bankruptcy Court and in accordance with the applicable provisions of the Bankruptcy Code and orders of the Bankruptcy Court.

The Bankruptcy Court has granted the first day relief we requested that was designed primarily to mitigate the impact of Chapter 11 Cases on our operations, customers and employees. As a result, we are able to conduct normal business activities and pay all associated obligations for the period following the Petition Date and we are also authorized to pay prepetition employee wages and benefits and certain vendors and suppliers in the ordinary course for goods and services provided prior to the Petition Date. During the pendency of the Chapter 11 Cases, all transactions outside of the ordinary course of business require the prior approval of Bankruptcy Court.

13


 

Stalking Horse Purchase Agreement and Stalking Horse Bidder Revised Proposal

On the Petition Date, the “Sellers” entered into the “Stalking Horse Purchase Agreement” with the Stalking Horse Bidder, pursuant to which the Stalking Horse Bidder has agreed to purchase, subject to the terms and conditions contained therein, all of the equity interests in each of Garrett LX I S.à r.l., and Garrett Transportation I Inc. (subject to an election by the Stalking Horse Bidder to purchase substantially all of the assets of Garrett Transportation I Inc., instead of its equity), along with certain other assets and liabilities of the Debtors pursuant to a plan of reorganization under the Bankruptcy Code (the “Acquired Assets”).

The acquisition of the Acquired Assets pursuant to the Stalking Horse Purchase Agreement is subject to approval of the Bankruptcy Court and an auction to solicit higher or otherwise better bids. If the Debtors receive additional bids, the Debtors expect to conduct an auction for the Acquired Assets no later than December 18, 2020. The Stalking Horse Purchase Agreement serves as the minimum or floor bid on which the Debtors, their creditors, suppliers, vendors, and other bidders may rely. Other interested bidders are permitted to participate in the auction if they submit qualifying offers that are higher or otherwise better than the transaction pursuant to the Stalking Horse Purchase Agreement.

Under the terms of the Stalking Horse Purchase Agreement, the Stalking Horse Bidder agreed, absent any higher or otherwise better bid, to purchase the Acquired Assets from the Sellers for $2.1 billion, subject to certain adjustments in accordance with the terms and conditions of the Stalking Horse Purchase Agreement, plus the assumption of specified liabilities. The Stalking Horse Purchase Agreement also provides that, if, among other reasons, the Company terminates the Stalking Horse Purchase Agreement in favor of an alternative transaction, the Company will pay to the Stalking Horse Bidder a break-up fee equal to $63 million and reimburse certain reasonable, documented, out-of-pocket costs and expenses, including those incurred by the Stalking Horse Bidder in connection with the negotiation, drafting, and execution of the Stalking Horse Purchase Agreement.

 

The Stalking Horse Purchase Agreement contains customary representations, warranties and covenants. The Stalking Horse Purchase Agreement may be terminated, subject to certain exceptions: (i) by the mutual written consent of the parties; (ii) by any party, by giving written notice to the other party if (a) any court of competent jurisdiction or other competent governmental authority issues a final, non-appealable order prohibiting the transactions or (b) if the closing has not occurred prior to March 31, 2021; (iii) by any party, for certain material breaches by the other parties of representations and warranties or covenants that remain uncured; (iv) by any party, if (a) the Sellers enter into a definitive agreement with respect to an alternative transaction (including because the Stalking Horse Bidder is not the prevailing party at the conclusion of the auction) or (b) the Bankruptcy Court approves an alternative transaction; (v) by the Stalking Horse Bidder if (a) certain milestones related to the approval of the transactions by the Bankruptcy Court are not met, (b) the Bankruptcy Cases are dismissed or converted to cases under Chapter 7 of the Bankruptcy Code (and neither such dismissal or conversion contemplates the transaction) or (c) Sellers withdraw or seek to withdraw any motion seeking Bankruptcy Court material relief contemplated in the Stalking Horse Purchase Agreement; or (vi) by the Stalking Horse Bidder if the Restructuring Support Agreement (the “RSA”) is terminated. If a termination occurs pursuant to (iii) (regarding a breach by Sellers), (iv) or (v)(a) (but only with regards to a certain milestone) or (v)(c), such termination will be subject to the Stalking Horse Bidder’s right to receive the termination payment and expense reimbursement payment. If a termination occurs pursuant to (iii) (regarding breach by the Stalking Horse Bidder), such termination will be subject to the Company’s right to receive a reverse termination payment equal to $105 million. Among other conditions, the transaction contemplated by the Stalking Horse Purchase Agreement is subject to approval by the Bankruptcy Court. Accordingly, no assurance can be given that the transaction described therein will be consummated.

On October 19, 2020, the Company received the Stalking Horse Bidder Revised Proposal.  Under the terms and conditions of the Stalking Horse Bidder Revised Proposal:

 

The Stalking Horse Bidder would increase the base purchase price for the Acquired Assets by $500 million, from $2.1 billion to $2.6 billion (in each case subject to adjustment as provided in the Stalking Horse Purchase Agreement). The Stalking Horse Bidder would also purchase an entity (Garrett ASASCO Inc.) that directly holds (and after the closing will retain) the Company’s claims against Honeywell International Inc. in connection with the disputed Subordinated Asbestos Indemnity Agreement (as defined below) and Tax Matters Agreement (as defined below).

 

Upon completion of the sale, the Stalking Horse Bidder would list the new parent company on a recognized U.S. stock exchange.

 

The Stalking Horse Bidder would make available to the Company’s existing stockholders an equity co-investment opportunity on the same economic terms as the Stalking Horse Bidder, allowing the Company’s stockholders to continue to hold shares in the publicly-listed reorganized business. The Stalking Horse Bidder would offer co-investment in an aggregate amount of up to $350 million, $100 million of which would be available to all of the Company’s existing stockholders on a pro rata basis. The Stalking Horse Bidder has indicated that it expects the Company’s existing stockholders would own approximately 24% of outstanding common equity of the new parent company assuming maximum co-investment (subject to adjustment).

 

The anticipated dates for the Company’s competitive auction process would be extended to provide additional time to assess higher or better offers. The anticipated auction date would be no later than December 18, 2020 rather than November 24, 2020, with other dates adjusted accordingly.

14


 

 

The costs and expenses for which the Company is obligated to reimburse the Stalking Horse Bidder in certain circumstances in which the Stalking Horse Purchase Agreement is terminated would be capped at $21 million.

The Stalking Horse Bidder Revised Proposal was conditioned on Bankruptcy Court approval of our proposed bidding procedures and the stalking horse protections, which were approved by the Bankruptcy Court in an order entered on October 24, 2020. The Stalking Horse Purchase Agreement and the Stalking Horse Bidder Revised Proposal remain subject to Bankruptcy Court approval and higher or better offers in the Chapter 11 Cases. The Company expects to work with the Stalking Horse Bidder to amend the Stalking Horse Purchase Agreement and other transaction documentation to reflect the terms of the Stalking Horse Bidder Revised Proposal.

Restructuring Support Agreement

On the Petition Date, the Debtors entered into a Restructuring Support Agreement with consenting lenders (the “Consenting Lenders”) holding, in the aggregate, approximately 61% of the aggregate outstanding principal amount of loans under that certain Credit Agreement, dated as of September 27, 2018, (as amended, restated, supplemented or otherwise modified from time to time, the “Prepetition Credit Agreement”) by and among the Company, as Holdings, Garrett LX III S.à r.l., as Lux Borrower, Garrett Borrowing LLC, as U.S. Co-Borrower, Garrett Motion Sàrl, as Swiss Borrower, the Lenders and Issuing Banks party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent. Pursuant to the RSA, the Consenting Lenders and the Debtors have agreed to the principal terms of a financial restructuring, which will be implemented through a plan of reorganization under the Bankruptcy Code (the “Plan”) and will include the sale of all or substantially all of the assets of certain Debtors and of the stock of certain Debtors and other subsidiaries, as further described below.

The RSA provides that the Consenting Lenders will support the Debtors’ restructuring efforts, including the proposed acquisition and the Plan, as set forth in, and subject to the terms and conditions of, the RSA. In addition, the Consenting Lenders have agreed to the Debtors’ entry into the DIP Term Loan Facility (as defined below) discussed below.     

The RSA provides certain milestones for the Restructuring Transactions. Failure of the Debtors to satisfy these milestones without a waiver or consensual amendment would provide the Requisite Consenting Lenders a termination right under the RSA. These milestones, as modified from time to time, include (a) no later than 5 days after the Petition Date, the Bankruptcy Court shall have entered the DIP Order (as defined below)on an interim basis, which DIP Order shall be in the form and substance acceptable to the Requisite Consenting Lenders; (b) no later than 35 days after the Petition Date, the Bankruptcy Court shall have entered (i) an order approving the bidding procedures with respect to the Acquisition and (ii) the DIP Order on a final basis; (c) no later than November 20, 2020, the Company Parties shall have filed an Acceptable Plan, Disclosure Statement, and a motion to approve the Disclosure Statement, each of which shall be in form and substance reasonably acceptable to the Requisite Consenting Lenders; (d) no later than January 8, 2021, (i) the hearing to approve the Disclosure Statement shall have occurred and (ii) the Bankruptcy Court shall have entered an order approving the Disclosure Statement on a final basis, which shall be in form and substance reasonably acceptable to the Requisite Consenting Lenders; (e) no later than 150 days after the Petition Date, a hearing shall have occurred for approval of (x) (i) the Acquisition and (ii) confirmation of the Plan or (y) another Acceptable Plan, and within 2 Business Days thereafter, the Bankruptcy Court shall have entered the Confirmation Order on a final basis, which shall be in form and substance reasonably acceptable to the Requisite Consenting Lenders; and (f) no later than 210 days after the Petition Date, (i) the Acquisition shall have closed and (ii) the Plan Effective Date shall have occurred. Among other conditions, the transaction contemplated by the RSA is subject to approval by the Bankruptcy Court. Accordingly, no assurance can be given that the transaction described therein will be consummated.

Plan of Reorganization

Under the Bankruptcy Code, we currently have the exclusive right to file a plan of reorganization under Chapter 11 through and including 120 days after the Petition Date, and to solicit acceptances of such plan through and including 180 days after the Petition Date. These deadlines may be extended with the approval of the Bankruptcy Court.

Under the absolute priority scheme established by the Bankruptcy Code, unless our creditors agree otherwise, all of our pre-petition liabilities and post-petition liabilities must be satisfied in full before the holders of our existing common stock can receive any distribution or retain any property under a plan of reorganization. The ultimate recovery to creditors and/or shareholders, if any, will not be determined until confirmation and implementation of a plan or plans of reorganization. We can give no assurance that any recovery or distribution of any amount will be made to any of our creditors or shareholders. Our plan of reorganization could result in any of the holders of our liabilities and/or securities, including our common stock, receiving no distribution on account of their interests and cancellation of their holdings. Moreover, a plan of reorganization can be confirmed, under the Bankruptcy Code, even if the holders of our common stock vote against the plan of reorganization and even if the plan of reorganization provides that the holders of our common stock receive no distribution on account of their equity interests.

15


 

Chapter 11 Accounting

The Company has applied ASC 852 in preparing our Consolidated Interim Financial Statements. ASC 852 requires the financial statements for periods subsequent to the Petition Date to distinguish transactions and events that are directly associated with the Company's reorganization from the ongoing operations of the business. Accordingly, revenues, expenses, realized gains and losses, and provisions for losses directly resulting from the reorganization and restructuring shall be reported separately as Reorganization items, net in the Consolidated Interim Statements of Operations. In addition, the balance sheet distinguishes pre-petition liabilities subject to compromise from those pre-petition liabilities that are not subject to compromise and post-petition liabilities. Pre-petition liabilities that are not fully secured or those that have at least a possibility of not being repaid at the allowed claim amount have been classified as liabilities subject to compromise on the Consolidated Interim Balance Sheet at September 30, 2020.

Under the Bankruptcy Code, the Debtors may affirm, assume and assign or reject executory contracts and unexpired leases subject to the approval of the Bankruptcy Court and certain other conditions. Generally, the rejection of an executory contract or unexpired lease is treated as a prepetition breach of such executory contract or unexpired lease and, subject to certain exceptions, relieves the Debtors of performing their future obligations under such executory contract or unexpired lease but entitles the contract counterparty or lessor to a pre-petition general unsecured claim for damages caused by such deemed breach subject, in the case of the rejection of unexpired leases of real property, to certain caps on damages. Counterparties to such rejected contracts or leases may assert unsecured claims in the Bankruptcy Court against the applicable Debtor’s estate for such damages. Generally, the assumption or assumption and assignment of an executory contract or unexpired lease requires the Debtors to cure existing monetary defaults under such executory contract or unexpired lease and provide adequate assurance of future performance thereunder. Accordingly, any description of an executory contract or unexpired lease with a Debtor in this quarterly report, including where applicable a quantification of the Company’s obligations under any such executory contract or unexpired lease with a Debtor is qualified by any overriding rejection rights the Company has under the Bankruptcy Code.

Reorganization Items, Net

The Debtors have incurred and will continue to incur significant costs associated with the reorganization, including the write-off of original issue discount and deferred long-term debt fees on debt, a component of liabilities subject to compromise, costs of debtor-in-possession financing and legal and professional fees. The amount of these charges, which since the Petition Date are being expensed as incurred, are expected to significantly affect the Company’s results of operations. In accordance with applicable guidance, costs associated with the bankruptcy proceedings have been recorded as Reorganization items, net within the Company's Consolidated Interim Statements of Operations for the three and nine months ended September 30, 2020.

Reorganization items, net are comprised of the following for the three and nine months ended September 30, 2020:

 

 

 

Three and Nine Months

Ended September 30,

 

 

 

2020

 

Write-off of pre-petition unamortized debt issuance costs

 

$

6

 

Other

 

 

(2

)

Total reorganization items, net

 

$

4

 

 

Long-Term Debt during the Chapter 11 Cases

We are party to a Credit Agreement , dated as of September 27, 2018 (as amended, the “Credit Agreement”) by and among the Company and certain subsidiaries, the lenders and issuing banks party thereto and JPMorgan Chase Bank, N.A., as administrative agent, consisting of: a seven-year term B loan facility, consisting of a tranche denominated in Euro of €375 million and a tranche denominated in U.S. Dollars of $425 million (the “Term B Facility”); a five-year term A loan facility in an aggregate principal amount of €330 million (the “Term A Facility” and, together with the Term B Facility, the “Term Loan Facilities”); and a five-year revolving credit facility in an aggregate principal amount of €430 million (the “Revolving Facility” and, together with the Term Loan Facilities, the “Senior Secured Credit Facilities”). On September 27, 2018, we completed the offering of €350 million (approximately $410 million based on exchange rates as of September 27, 2018) in aggregate principal amount of 5.125% senior notes due 2026 (the “Senior Notes”). The principal amounts outstanding on our Senior Secured Credit Facilities and the Senior Notes as of September 30, 2020 and December 31, 2019 are as follows:

16


 

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

 

 

(Dollars in millions)

 

Senior Secured Credit Facilities (1):

 

 

 

 

 

 

 

 

Term Loans

 

 

1,045

 

 

 

1,026

 

Borrowings under revolving credit facility

 

 

370

 

 

 

 

Total consolidated Secured Debt

 

$

1,415

 

 

$

1,026

 

Long-term debt, net subject to compromise (2):

 

 

 

 

 

 

 

 

Senior Notes

 

 

407

 

 

 

387

 

Total debt, prior to reclassification to Liabilities subject to compromise

 

$

1,822

 

 

$

1,413

 

Less: current portion

 

 

 

 

 

(4

)

Less: Amounts reclassified to Liabilities subject to compromise

 

 

(407

)

 

 

 

Total long-term debt

 

$

1,415

 

 

$

1,409

 

 

 

(1)

The Term A Facility, Term B Facility and Revolving Facility are fully secured. These continue to be accounted for under ASC 470.

 

(2)

The Senior Notes are not fully secured and have been reclassified to Liabilities subject to compromise in the Company's Consolidated Interim Balance Sheet as of September 30, 2020. As of the Petition Date, the Company ceased accruing related interest expense and amortization of debt issuance costs.

Financial Statement Classification of Liabilities Subject to Compromise

As a result of the Chapter 11 Cases, the payment of pre-petition liabilities is generally subject to compromise pursuant to a plan of reorganization. Generally, actions to enforce or otherwise effect payment of pre-bankruptcy filing liabilities are stayed. Although payment of pre-petition claims generally is not permitted, the Bankruptcy Court granted the Debtors authority to pay certain pre-petition claims in designated categories and subject to certain terms and conditions. This relief generally was designed to preserve the value of the Debtors’ business and assets. Among other things, the Bankruptcy Court authorized, but did not require, the Debtors to pay certain pre-petition claims relating to employee wages and benefits, taxes, critical vendors and foreign vendors. Pre-petition liabilities that are subject to compromise are required to be reported at the amounts expected to be allowed by the Bankruptcy Court, even if they may be settled for different amounts. The amounts classified as liabilities subject to compromise may be subject to future adjustments depending on Bankruptcy Court actions, further developments with respect to disputed claims, determination of secured status of certain claims, the determination as to the value of any collateral securing claims, proof of claims or other events.

The following table presents liabilities subject to compromise as reported in the Consolidated Interim Balance Sheet at September 30, 2020:

 

 

 

September 30,

 

 

 

2020

 

Obligations payable to Honeywell (Note 18)

 

$

1,404

 

Long-term debt (1)

 

 

407

 

Accounts payable

 

 

368

 

Pension, compensation, benefit and other employee related

 

 

94

 

Uncertain tax positions and deferred taxes

 

 

62

 

Advanced discounts from suppliers

 

 

34

 

Lease liability (Note 14)

 

 

19

 

Freight Accrual

 

 

21

 

Product warranties and performance guarantees

 

 

16

 

Other

 

 

45

 

Total liabilities subject to compromise

 

$

2,470

 

 

 

(1)

Please see above Long-Term Debt during the Chapter 11 Cases sub-section for details of the pre-petition debt reported as liabilities subject to compromise.

Determination of the value at which liabilities will ultimately be settled cannot be made until the Bankruptcy Court approves the plan of reorganization. We will continue to evaluate the amount and classification of our pre-petition liabilities. Any additional liabilities that are subject to compromise will be recognized accordingly, and the aggregate amount of liabilities subject to compromise may change.

17


 

Potential Claims

The Debtors intend to file with the Bankruptcy Court schedules and statements setting forth, among other things, the assets and liabilities of each of the Sellers, subject to the assumptions to be filed in connection therewith. These schedules and statements may be subject to further amendment or modification after filing. As part of the Chapter 11 Cases, parties believing that they have claims or causes of action against the Debtors may file proofs of claim evidencing such claims. We anticipate that certain holders of pre-petition claims that are not governmental units will be required to file proofs of claim with respect to claims against the Sellers by the deadline for general claims, which is currently expected to be December 11, 2020 (the “General Bar Date”).

The Debtors' have received 12 proofs of claim as of October 26, 2020, primarily representing general unsecured claims, in an amount of approximately $1 million. As claims are filed, the claims will be reconciled to amounts recorded in the Company's accounting records. Differences in amounts recorded and claims filed by creditors will be investigated and resolved, including through the filing of objections with the Bankruptcy Court, where appropriate. The Company may ask the Bankruptcy Court to disallow claims that the Company believes are duplicative, have been later amended or superseded, are without merit, are overstated or should be disallowed for other reasons. In addition, as a result of this process, the Company may identify additional liabilities that will need to be recorded or reclassified to Liabilities subject to compromise. In the light of the substantial number of claims filed, and expected to be filed, the claims resolution process may take considerable time to complete and likely will continue after the Debtors emerge from bankruptcy.  As of October 30, the Company’s assessment of the validity of claims received has not been completed.

DIP Credit Agreement

On October 6, 2020, the Bankruptcy Court entered an order granting interim approval of the Debtors’ entry into a Senior Secured Super-Priority Debtor-in-Possession Credit Agreement (the “DIP Credit Agreement”), with the lenders party thereto (the “DIP Lenders”) and Citibank N.A. as administrative agent (the “DIP Agent”). On October 9, 2020 (the “Closing Date”), the Company, the DIP Agent and the DIP Lenders entered into the DIP Credit Agreement. The DIP Credit Agreement provides for a senior secured, super-priority term loan (the “DIP Term Loan Facility”) with a maximum principal amount of $200 million, $100 million of which was funded on the Closing Date and $100 million of which was subsequently funded on October 22, 2020 (the “Delayed Draw Borrowing Date”), following entry of the Bankruptcy Court’s final order approving the DIP Term Loan Facility on October 21, 2020. The proceeds of the DIP Term Loan Facility are to be used by the Debtors to (a) pay certain costs, premiums, fees and expenses related to the Chapter 11 Cases, (b) make payments pursuant to any interim or final order entered by the Bankruptcy Court pursuant to any “first day” motions permitting the payment by the Debtors of any prepetition amounts then due and owing; (c) make certain adequate protection payments in accordance with the DIP Credit Agreement and (d) fund working capital needs of the Debtors and their subsidiaries to the extent permitted by the DIP Credit Agreement.

The maturity date of the DIP Term Loan Facility is the earlier to occur of (a) March 31, 2021 (the “Scheduled Maturity Date”); provided, however, that upon the Company’s written request such Scheduled Maturity Date can be extended by three separate one-month extensions subject to (i) the payment of an extension fee to the Lenders equal to 0.50% of the principal amount of the Loans outstanding at the time of such extension, (ii) no default or Event of Default (as defined in the DIP Credit Agreement) existing at the time of such extension and (iii) accuracy of the representations and warranties in all material respects at the time of such extension and after giving effect thereto; and (b) the effective date of a plan of reorganization; and certain other events under the DIP Credit Agreement.

The outstanding principal amount under the DIP Term Loan Facility will bear interest at a rate equal to (x) prior to March 31, 2021, LIBOR (subject to a 1.00% LIBOR floor) plus 4.50% per annum and (y) following March 31, 2021, if the Scheduled Maturity Date has been extended at such time, LIBOR (subject to a 1.00% LIBOR floor) plus 5.50% per annum, in each case, compounded monthly and payable every 30 days in arrears. On the Closing Date, the Company paid 1.00% in commitment fees on the total commitment plus 2.00% in fees in the form of original issue discount on the initial $100 million borrowing. On the Delayed Draw Borrowing Date, date the Company paid 2.00% in fees in the form of original issue discount on the $100 million delayed draw loan. Upon an event of default, all outstanding amounts under the DIP Credit Agreement will bear interest at a rate equal to the applicable interest rate plus an additional 2.00% per annum and be payable on demand.

Pursuant to the terms of the DIP Credit Agreement, certain subsidiaries of the Company that guarantee the obligations arising under the prepetition Credit Agreement and that are Debtors in the Chapter 11 Case have guaranteed the Company’s obligations under the DIP Credit Agreement. Subject to certain exceptions, the DIP Term Loan Facility is secured by a security interest in substantially all of the assets of the Company and the guarantors. The DIP Financing is subject to certain covenants, including, without limitation, related to the incurrence of additional debt, liens, the making of restricted payments, and the Company’s failure to comply with certain bankruptcy-related covenants, in each case as set forth in the DIP Credit Agreement. The DIP Credit Agreement contains representations, warranties and events of default that are customary for debtor-in-possession facilities of this type. The DIP Financing is subject to certain prepayment events, including, without limitation, upon the sale of certain assets, in each case as set forth in the DIP Credit Agreement.

On October 12, 2020, the Company, the DIP Agent and the DIP Lenders entered into the First Amendment to the DIP Credit Agreement (the “First Amendment”). The First Amendment eliminates the obligation for the Company to pay certain fees to the DIP Lenders in connection with certain prepayment events under the DIP Credit Agreement.

18


 

Automatic Stay

Subject to certain specific exceptions under the Bankruptcy Code, the commencement of the Chapter 11 Cases automatically stayed most judicial or administrative actions against the Debtors and efforts by creditors to collect on or otherwise exercise rights or remedies with respect to pre-petition claims. Absent an order from the Bankruptcy Court, substantially all of the Debtors’ pre-petition liabilities are subject to settlement in accordance with the Bankruptcy Code.

Condensed Combined Debtor Only Financial Information

The financial statements below represent the condensed combined financial statements of the Debtors as of and for the three and nine months ended September 30, 2020. Any entities which are non-debtor entities, are not included in these condensed combined financial statements. Intercompany transactions among the Debtors have been eliminated in the financial statements contained herein. Intercompany transactions among the Debtors and the non-debtor entities have not been eliminated in the Debtors’ financial statements.

 

 

 

For the Three

Months Ended

September 30,

 

 

For the Nine

Months Ended

September 30,

 

 

 

2020

 

 

2019

 

 

 

(Dollars in millions)

 

Net sales

 

 

601

 

 

 

1,533

 

Cost of goods sold

 

 

486

 

 

 

1,264

 

Gross profit

 

$

115

 

 

$

269

 

Selling, general and administrative expenses

 

 

90

 

 

 

185

 

Other expense, net

 

 

12

 

 

 

45

 

Interest expense

 

 

20

 

 

 

59

 

Non-operating (income) expense

 

 

1

 

 

 

(118

)

Reorganization items, net

 

 

4

 

 

 

4

 

Income before taxes

 

$

(12

)

 

$

94

 

Tax expense

 

 

(17

)

 

 

(14

)

Net income

 

$

5

 

 

$

108

 

19


 

 

 

 

September 30,

2020

 

 

 

(Dollars in millions)

 

ASSETS

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

222

 

Restricted cash

 

 

2

 

Accounts, notes and other receivables – net

 

 

388

 

Accounts and other receivables from non-debtor affiliates

 

 

42

 

Inventories – net

 

 

172

 

Other current assets

 

 

89

 

Total current assets

 

 

915

 

Investments and long-term receivables

 

 

10

 

Investment in subsidiaries

 

 

883

 

Property, plant and equipment – net

 

 

301

 

Goodwill

 

 

197

 

Deferred income taxes

 

 

232

 

Other assets

 

 

99

 

Total assets

 

$

2,637

 

LIABILITIES

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

 

$

36

 

Borrowings under revolving credit facility

 

 

370

 

Current maturities of long-term debt

 

 

 

Obligations payable to Honeywell, current

 

 

 

Accrued liabilities

 

 

75

 

Total current liabilities

 

 

481

 

Long-term debt

 

 

1,045

 

Deferred income taxes

 

 

 

Obligations payable to Honeywell

 

 

 

Other liabilities

 

 

22

 

Total liabilities not subject to compromise

 

$

1,548

 

Liabilities subject to compromise

 

 

 

External

 

 

2,470

 

With non-debtor affiliates

 

 

355

 

Total liabilities subject to compromise

 

$

2,825

 

Total liabilities

 

$

4,373

 

COMMITMENTS AND CONTINGENCIES (Note 18)

 

 

 

 

EQUITY (DEFICIT)

 

 

 

 

Total deficit attributable to the Debtors

 

 

(1,736

)

Total liabilities and deficit

 

$

2,637

 

20


 

 

 

 

For the Nine Months Ended September 30,

 

 

 

2020

 

 

 

(Dollars in millions)

 

Cash Flows from operating activities:

 

 

 

 

Net cash used for operating activities

 

$

(78

)

Cash Flows from investing activities:

 

 

 

 

Expenditures for property, plant and equipment

 

 

(45

)

Other

 

 

 

Net cash used for investing activities

 

$

(45

)

Cash Flows from financing activities:

 

 

 

 

Proceeds from debtor-in-possession financing

 

 

 

Proceeds from revolving credit facility

 

 

1,437

 

Payments of revolving credit facility

 

 

(1,088

)

Payments of long-term debt

 

 

(2

)

Debtor-in-possession financing fees

 

 

(4

)

Other

 

 

(3

)

Net cash provided by financing activities

 

 

340

 

Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash

 

 

6

 

Net increase in cash, cash equivalents and restricted cash

 

 

223

 

Cash and cash equivalents at beginning of period

 

 

1

 

Cash, cash equivalents and restricted cash at end of period

 

$

224

 

 

Note 3. Summary of Significant Accounting Policies

The accounting policies of the Company are set forth in Note 2 to the audited annual Consolidated and Combined Financial Statements for the year ended December 31, 2019 included in our 2019 Form 10-K. We include herein certain updates to those policies.

Trade Receivables and Allowance for Doubtful Accounts—Trade accounts receivable are recorded at the invoiced amount as a result of transactions with customers. Garrett maintains allowances for doubtful accounts for estimated losses as a result of a customer’s inability to make required payments. As of January 1, 2020, Garrett adopted ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The new guidance requires an entity to recognize as an allowance its estimate of lifetime expected credit losses rather than incurred losses. The guidance is also applicable to contract assets such as unbilled receivables. Consistent with the new guidance, Garrett estimates losses from doubtful accounts expected over the contractual life of the receivables based on days past due as measured from the contractual due date and collection history. Garrett also takes into consideration changes in economic conditions that may not be reflected in historical trends (for example, customers in bankruptcy, liquidation or reorganization). Receivables are written-off against the allowance for doubtful accounts when they are determined uncollectible. Such determination includes analysis and consideration of the particular conditions of the account, including time intervals since last collection, customer performance against agreed upon payment plans, solvency of customer and any bankruptcy proceedings. 

Recently Adopted Accounting Pronouncements

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement, which amends certain disclosure requirements related to fair value measures. The guidance is effective for fiscal years beginning after December 15, 2019, including interim periods within that fiscal year. Effective January 1, 2020, the Company adopted the new guidance. The adoption did not have an impact on our Consolidated Interim Balance Sheets, Consolidated Interim Statements of Operations and related Notes to the Consolidated Interim Financial Statements.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires measurement and recognition of expected credit losses for financial assets held. The guidance is effective for fiscal years beginning after December 15, 2019, including interim periods within that fiscal year. Early adoption is permitted. Adoption of the new standard resulted in an increase in the allowance for doubtful accounts of $5 million which was recognized as a cumulative-effect adjustment to opening retained earnings as of January 1, 2020.  

21


 

Recently Issued Accounting Pronouncements

In August 2018, the FASB issued ASU 2018-14, Compensation-Retirement Benefits Defined Benefit Plans – General (Subtopic 715-20), which amends certain disclosure requirements related to the defined benefit pension and other postretirement plans. The guidance is effective for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. Early adoption is permitted. The Company is currently evaluating the impact on its disclosures.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, provide optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other transactions affected by reference rate reform. The amendments in this Update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. The Company is currently evaluating the impact on our hedging relationships, other transactions, and disclosures.

 

Note 4. Revenue Recognition and Contracts with Customers

 

Disaggregated Revenue

Net sales by region (determined based on country of shipment) and channel are as follows:

 

 

 

Three months ended September 30, 2020

 

 

 

OEM

 

 

Aftermarket

 

 

Other

 

 

Total

 

United States

 

$

83

 

 

$

38

 

 

$

2

 

 

$

123

 

Europe

 

 

370

 

 

 

34

 

 

 

8

 

 

 

412

 

Asia

 

 

245

 

 

 

10

 

 

 

6

 

 

 

261

 

Other International

 

 

3

 

 

 

5

 

 

 

 

 

 

8

 

 

 

$

701

 

 

$

87

 

 

$

16

 

 

$

804

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine months ended September 30, 2020

 

 

 

OEM

 

 

Aftermarket

 

 

Other

 

 

Total

 

United States

 

$

208

 

 

$

110

 

 

$

3

 

 

$

321

 

Europe

 

 

924

 

 

 

86

 

 

 

23

 

 

 

1,033

 

Asia

 

 

606

 

 

 

29

 

 

 

17

 

 

 

652

 

Other International

 

 

6

 

 

 

14

 

 

 

 

 

 

20

 

 

 

$

1,744

 

 

$

239

 

 

$

43

 

 

$

2,026

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended September 30, 2019

 

 

 

OEM

 

 

Aftermarket

 

 

Other

 

 

Total

 

United States

 

$

72

 

 

$

45

 

 

$

2

 

 

$

119

 

Europe

 

 

388

 

 

 

34

 

 

 

9

 

 

 

431

 

Asia

 

 

202

 

 

 

13

 

 

 

7

 

 

 

222

 

Other International

 

 

4

 

 

 

5

 

 

 

 

 

 

9

 

 

 

$

666

 

 

$

97

 

 

$

18

 

 

$

781

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine months ended September 30, 2019

 

 

 

OEM

 

 

Aftermarket

 

 

Other

 

 

Total

 

United States

 

$

232

 

 

$

139

 

 

$

5

 

 

$

376

 

Europe

 

 

1,233

 

 

 

102

 

 

 

29

 

 

 

1,364

 

Asia

 

 

591

 

 

 

39

 

 

 

21

 

 

 

651

 

Other International

 

 

12

 

 

 

15

 

 

 

 

 

 

27

 

 

 

$

2,068

 

 

$

295

 

 

$

55

 

 

$

2,418

 

 

22


 

Contract Balances

The following table summarizes our contract assets and liabilities balances:

 

 

 

2020

 

Contract assets—January 1

 

$

6

 

Contract assets—September 30

 

 

48

 

Change in contract assets—Increase/(Decrease)

 

 

42

 

Contract liabilities—January 1

 

$

(3

)

Contract liabilities—September 30

 

 

(1

)

Change in contract liabilities—(Increase)/Decrease

 

 

2

 

 

Note 5. Research, Development & Engineering

 

Garrett conducts research, development and engineering (“RD&E”) activities, which consist primarily of the development of new products and product applications. RD&E costs are charged to expense as incurred unless the Company has a contractual guarantee for reimbursement from the customer. Customer reimbursements are netted against gross RD&E expenditures as they are considered a recovery of cost. Such costs are included in Cost of goods sold as follows:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Research and development costs

 

$

27

 

 

$

31

 

 

$

79

 

 

$

92

 

Engineering-related expenses

 

 

2

 

 

 

4

 

 

 

9

 

 

 

8

 

 

 

$

29

 

 

$

35

 

 

$

88

 

 

$

100

 

 

Note 6. Other Expense, Net

 

 

 

Three Months Ended 

September 30,

 

 

Nine Months 

Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Indemnification related — post Spin-Off

 

$

14

 

 

$

18

 

 

$

41

 

 

$

54

 

Indemnification related — litigation

 

 

 

 

 

 

 

 

3

 

 

 

 

Factoring and notes receivables discount fees

 

 

 

 

 

 

 

 

1

 

 

 

 

 

 

$

14

 

 

$

18

 

 

$

45

 

 

$

54

 

 

Note 7. Income Taxes

 

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

(Dollars in millions)

 

Tax (benefit) expense

 

$

(1

)

 

$

34

 

 

$

11

 

 

$

79

 

Effective tax rate

 

 

(10.0

)%

 

 

47.2

%

 

 

16.9

%

 

 

30.9

%

 

The effective tax rate for the three months ended September 30, 2020 is lower than the effective tax rate for the three months ended September 30, 2019 primarily because of a decrease in withholding taxes related to undistributed earnings, partially offset by true ups from local filings.  The effective tax rate for the nine months ended September 30, 2020 is lower than the effective tax rate for the nine months ended September 30, 2019 because of a decrease in withholding taxes related to undistributed earnings, partially offset by an increase in tax reserves and non-deductible expenses that are not impacted proportionately with lower pre-tax book income.

The effective tax rate for the three months ended September 30, 2020 was lower than the U.S. federal statutory rate of 21% primarily due to a reduction of withholding taxes on undistributed earnings.

23


 

The effective tax rate for the nine months ended September 30, 2019 was higher than the U.S. federal statutory rate of 21% primarily due to non-deductible expenses and tax reserves, partially offset by lower withholding taxes on undistributed earnings and non-U.S. earnings taxed at lower rates.

The effective tax rate can vary from quarter to quarter due to changes in the Company’s global mix of earnings, impacts of Covid-19, the resolution of income tax audits, changes in tax laws (including updated guidance on U.S. tax reform), deductions related to employee share-based payments, internal restructurings and pension mark-to-market adjustments.

In connection with the global outbreak of COVID-19, many countries have enacted legislation to provide various forms of emergency economic relief, including the CARES Act in the United States, that may provide financial benefits to the Company. At this time, we do not expect such benefits to have a material impact to the Company.

Note 8. Accounts, Notes and Other Receivables—Net

 

 

 

September 30,

2020

 

 

December 31,

2019

 

Trade receivables

 

$

587

 

 

$

574

 

Notes receivables

 

 

66

 

 

 

68

 

Other receivables

 

 

68

 

 

 

69

 

 

 

$

721

 

 

$

711

 

Less—Allowance for doubtful accounts

 

 

(11

)

 

 

(4

)

 

 

$

710

 

 

$

707

 

 

Trade Receivables include $48 million and $4 million of unbilled balances as of September 30, 2020 and December 31, 2019, respectively. These amounts are billed in accordance with the terms of customer contracts to which they relate. Unbilled receivables include $48 million and $6 million of contract assets as of September 30, 2020 and December 31, 2019, respectively.  See Note 4, Revenue Recognition and Contracts with Customers.

 

Note 9. Factoring and Notes Receivable

 

The Company entered into arrangements with financial institutions to sell eligible trade receivable. During the periods ended September 30, 2020 and December 31, 2019, the Company sold $128 and $27 million of eligible receivables, respectively, without recourse, and accounted for these arrangements as true sales.

 

The Company also received guaranteed bank notes without recourse, in settlement of accounts receivables, primarily in the Asia Pacific region. The Company can hold the bank notes until maturity, exchange them with suppliers to settle liabilities, or sell them to third party financial institutions in exchange for cash. During the periods ended September 30, 2020 and December 31, 2019, the Company sold $51 and $105 million of bank notes, respectively, without recourse, and accounted for these as true sales.

 

Note 10. Inventories—Net

 

 

 

September 30,

2020

 

 

December 31,

2019

 

Raw materials

 

$

159

 

 

$

142

 

Work in process

 

 

20

 

 

 

18

 

Finished products

 

 

100

 

 

 

85

 

 

 

$

279

 

 

$

245

 

Less—Reserves

 

 

(42

)

 

 

(25

)

 

 

$

237

 

 

$

220

 

 

 

24


 

Note 11. Other Assets

 

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Advanced discounts to customers, non-current

 

$

67

 

 

$

62

 

Operating right-of-use assets (Note 14)

 

 

39

 

 

 

35

 

Deferred DIP financing fees

 

 

4

 

 

 

 

Other

 

 

8

 

 

 

11

 

 

 

$

118

 

 

$

108

 

 

Note 12. Accrued Liabilities

 

 

 

September 30,

2020

 

 

December 31,

2019

 

Customer pricing reserve

 

$

88

 

 

$

90

 

Compensation, benefit and other employee related

 

 

51

 

 

 

64

 

Repositioning

 

 

2

 

 

 

4

 

Product warranties and performance guarantees

 

 

13

 

 

 

29

 

Taxes

 

 

15

 

 

 

33

 

Advanced discounts from suppliers, current

 

 

5

 

 

 

19

 

Customer advances and deferred income(a)

 

 

2

 

 

 

12

 

Accrued interest

 

 

1

 

 

 

5

 

Short-term lease liability (Note 14)

 

 

5

 

 

 

8

 

Other (primarily operating expenses)

 

 

19

 

 

 

46

 

 

 

$

201

 

 

$

310

 

 

(a)

Customer advances and deferred income include $1 million and $3 million of contract liabilities as of September 30, 2020 and December 31, 2019, respectively. See Note 4, Revenue Recognition and Contracts with Customers.

The Company accrued repositioning costs related to projects to optimize its product costs and right-size its organizational structure. Expenses related to the repositioning accruals are included in Cost of goods sold in our Consolidated Interim Statements of Operations.

 

 

 

Severance Costs

 

 

Exit

Costs

 

 

Total

 

Balance at December 31, 2018

 

$

13

 

 

$

2

 

 

$

15

 

Charges

 

 

3

 

 

 

 

 

 

3

 

Usage—cash

 

 

(7

)

 

 

(2

)

 

 

(9

)

Adjustments and reclassifications

 

 

(6

)

 

 

1

 

 

 

(5

)

Foreign currency translation

 

 

 

 

 

 

 

 

 

Balance at September 30, 2019

 

$

3

 

 

$

1

 

 

$

4

 

 

 

 

Severance Costs

 

 

Exit

Costs

 

 

Total

 

Balance at December 31, 2019

 

$

3

 

 

$

1

 

 

$

4

 

Charges

 

 

8

 

 

 

 

 

 

8

 

Usage—cash

 

 

(6

)

 

 

 

 

 

(6

)

Foreign currency translation

 

 

 

 

 

 

 

 

 

Less: Amounts reclassified to Liabilities subject to compromise

 

 

(4

)

 

 

 

 

 

(4

)

Balance at September 30, 2020

 

$

1

 

 

$

1

 

 

$

2

 

 

 

25


 

Note 13. Other Liabilities

 

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Pension and other employee related

 

$

13

 

 

$

94

 

Advanced discounts from suppliers

 

 

12

 

 

 

46

 

Uncertain tax positions

 

 

42

 

 

 

79

 

Long-term lease liability (Note 14)

 

 

15

 

 

 

28

 

Undesignated cross-currency and interest rate swaps (Note 15)

 

 

22

 

 

 

2

 

Other

 

 

10

 

 

 

25

 

 

 

$

114

 

 

$

274

 

 

 

Note 14. Leases

We have operating leases for real estate and machinery and equipment. Our leases have remaining lease terms of up to 10 years, some of which include options to extend the leases for up to two years, and some of which include options to terminate the leases within the year.

The components of lease expense are as follows:

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Operating lease cost

 

$

5

 

 

$

4

 

 

$

11

 

 

$

10

 

 

Supplemental cash flow information related to operating leases is as follows:

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Cash paid for amounts included in the

   measurement of lease liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating cash outflows from operating

   leases

 

$

4

 

 

$

3

 

 

$

9

 

 

$

9

 

Right-of-use assets obtained in exchange for

    lease obligations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating leases

 

$

1

 

 

$

2

 

 

$

6

 

 

$

10

 

 

Supplemental balance sheet information related to operating leases is as follows:

 

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Other assets

 

$

39

 

 

$

35

 

Accrued liabilities

 

 

5

 

 

 

8

 

Other liabilities

 

 

15

 

 

 

28

 

Liabilities subject to compromise

 

 

19

 

 

 

 

 

 

 

September 30,

 

December 31,

 

 

2020

 

2019

Weighted-average lease term

 

5.23

 

6.30

Weighted-average discount rate

 

6.16

 

6.36

 

26


 

Maturities of operating lease liabilities were as follows:

 

 

 

September 30,

2020

 

2020

 

$

4

 

2021

 

 

11

 

2022

 

 

9

 

2023

 

 

6

 

2024

 

 

5

 

Thereafter

 

 

11

 

Total lease payments

 

 

46

 

Less imputed interest

 

 

(7

)

 

 

$

39

 

 

 

Note 15. Financial Instruments and Fair Value Measures

Our credit, market and foreign currency risk management policies are described in Note 18, Financial Instruments and Fair Value Measures, of the notes to the audited annual Consolidated Financial Statements for the year ended December 31, 2019 included in our 2019 Form 10-K. At September 30, 2020 and December 31, 2019, we had contracts with aggregate gross notional amounts of $373 million and $1,820 million, respectively, to limit interest rate risk and to exchange foreign currencies, principally the U.S. Dollar, Swiss Franc, Euro, Chinese Yuan, Japanese Yen, Mexican Peso, New Romanian Leu, Czech Koruna, Australian Dollar and Korean Won.

Financial and nonfinancial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The following table sets forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of September 30, 2020 and December 31, 2019:

 

 

 

 

 

 

 

 

 

 

 

Fair Value

 

 

 

 

Notional Amounts

 

 

Assets

 

 

Liabilities

 

 

 

 

September 30,

2020

 

 

December 31,

2019

 

 

September 30,

2020

 

 

December 31,

2019

 

 

September 30,

2020

 

 

December 31,

2019

 

 

Designated forward currency exchange

   contracts

 

$

39

 

 

$

392

 

 

 

 

 

$

5

 

(a)

$

1

 

 

$

1

 

(b)

Undesignated instruments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Undesignated cross-currency swap

 

 

44

 

 

 

420

 

 

 

 

 

 

 

(c)

 

2

 

 

 

1

 

(d)

Undesignated interest rate swap

 

 

116

 

 

 

561

 

 

 

 

 

 

 

 

 

 

 

 

1

 

(d)

Undesignated forward currency exchange

   contracts

 

 

174

 

 

 

447

 

 

 

2

 

 

 

2

 

(a)

 

 

 

 

3

 

(b)

 

 

$

373

 

 

$

1,820

 

 

$

2

 

 

$

7

 

 

$

3

 

 

$

6

 

 

 

 

(a)

Recorded within Other current assets in the Company’s Consolidated Interim Balance Sheets

 

(b)

Recorded within Accrued liabilities in the Company’s Consolidated Interim Balance Sheets

 

(c)

Recorded within Other assets in the Company’s Consolidated Interim Balance Sheets

 

(d)

Recorded within Other liabilities in the Company´s Consolidated Interim Balance Sheets

 

The foreign currency exchange, interest rate swap and cross-currency swap contracts are valued using market observable inputs. As such, these derivative instruments are classified within Level 2. The assumptions used in measuring fair value of the cross-currency swap are considered Level 2 inputs, which are based upon market observable interest rate curves, cross currency basis curves, credit default swap curves, and foreign exchange rates.

 

As a result of our voluntary filing for Chapter 11 protection, all foreign exchange, interest rate swap, and cross-currency swap contracts were stayed as of the Petition Date. As noted in the table above, the majority were terminated at or prior to September 30, 2020. All outstanding amounts as of September 30, 2020 are classified as Other Liabilities and are fully secured and payable upon emergence of the Chapter 11 cases.  Any valuation difference from our Petition Date to the termination date will be reflected in Reorganization items, net. See Note 2, Reorganization and Chapter 11 Proceedings, for additional information.

 

27


 

A number of our forward currency exchange contracts are also designated as accounting hedges.  Upon termination, these amounts have been dedesignated.  As the Company still anticipates the forecasted transaction to commence, the amounts in accumulated comprehensive incomes will be released based on our original forecast.    

The carrying value of Cash, cash equivalents and restricted cash, Account receivables and Notes and Other receivables contained in the Consolidated Balance Sheets approximates fair value.

The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value:

 

 

 

September 30, 2020

 

 

 

Carrying Value

 

 

Fair Value

 

Liabilities not subject to compromise:

 

 

 

 

 

 

 

 

Terms Loans A and B

 

$

1,045

 

 

$

1,036

 

Liabilities subject to compromise:

 

 

 

 

 

 

 

 

Senior Notes

 

$

407

 

 

$

385

 

 

The Company determined the fair value of certain of its long-term debt and related current maturities utilizing transactions in the listed markets for similar liabilities. As such, the fair value of the long-term debt and related current maturities is considered Level 2.

 

Note 16. Accumulated Other Comprehensive Income (Loss)

Changes in Accumulated Other Comprehensive Income (Loss) by Component

 

 

 

Foreign

Exchange

Translation

Adjustment

 

 

Changes in

Fair Value of

Effective

Cash Flow

Hedges

 

 

Pension

Adjustments

 

 

Total Accumulated

Other

Comprehensive

Income (Loss)

 

Balance at December 31, 2018

 

$

86

 

 

$

 

 

$

(13

)

 

$

73

 

Other comprehensive income before

   reclassifications

 

 

127

 

 

 

9

 

 

 

 

 

 

136

 

Amounts reclassified from accumulated other

   comprehensive income

 

 

 

 

 

1

 

 

 

1

 

 

 

2

 

Net current period other comprehensive income

 

 

127

 

 

 

10

 

 

 

1

 

 

 

138

 

Balance at September 30, 2019

 

$

213

 

 

$

10

 

 

$

(12

)

 

$

211

 

 

 

 

Foreign

Exchange

Translation

Adjustment

 

 

Changes in

Fair Value of

Effective

Cash Flow

Hedges

 

 

Pension

Adjustments

 

 

Total Accumulated

Other

Comprehensive

Income (Loss)

 

Balance at December 31, 2019

 

$

153

 

 

$

4

 

 

$

(27

)

 

$

130

 

Other comprehensive (loss) before

   reclassifications

 

 

(111

)

 

 

(8

)

 

 

 

 

 

(119

)

Amounts reclassified from accumulated other

   comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

Net current period other comprehensive (loss)

 

 

(111

)

 

 

(8

)

 

 

 

 

 

 

(119

)

Balance at September 30, 2020

 

$

42

 

 

$

(4

)

 

$

(27

)

 

$

11

 

 

28


 

Note 17. Earnings Per Share

The details of the earnings per share (“EPS”) calculations for the three and nine months ended September 30, 2020 and 2019 are as follows:

 

 

 

Three Months

Ended September 30,

 

 

Nine Months

Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Basic

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income

 

$

11

 

 

$

38

 

 

$

54

 

 

$

177

 

Weighted average common shares outstanding

 

 

75,739,152

 

 

 

74,753,593

 

 

 

75,456,358

 

 

 

74,528,740

 

EPS – Basic

 

$

0.15

 

 

$

0.51

 

 

$

0.72

 

 

$

2.37

 

 

 

 

Three Months

Ended September 30,

 

 

Nine Months

Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Diluted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income

 

$

11

 

 

$

38

 

 

$

54

 

 

$

177

 

Weighted average common shares outstanding – Basic

 

 

75,739,152

 

 

 

74,753,593

 

 

 

75,456,358

 

 

 

74,528,740

 

Dilutive effect of unvested RSUs and other contingently

   issuable shares

 

 

204,842

 

 

 

950,864

 

 

 

667,190

 

 

 

1,171,912

 

Weighted average common shares outstanding – Diluted

 

 

75,943,994

 

 

 

75,704,457

 

 

 

76,123,548

 

 

 

75,700,652

 

EPS – Diluted

 

$

0.14

 

 

$

0.50

 

 

$

0.71

 

 

$

2.34

 

 

Diluted EPS is computed based upon the weighted average number of common shares outstanding for the period plus the dilutive effect of common stock equivalents using the treasury stock method and the average market price of our common stock for the period.

 

The diluted earnings per share calculations exclude the effect of stock options when the options’ assumed proceeds exceed the average market price of the common shares during the period. For the three and nine months ended September 30, 2020, the weighted number of stock options excluded from the computations was 425,866 and 435,021, respectively. These stock options were outstanding for the three and nine months ended September 30, 2020, respectively.

 

Note 18. Commitments and Contingencies

Chapter 11 Proceedings

Commencement of the Chapter 11 Cases automatically stayed the proceedings and actions against us that are described below, in addition to actions seeking to collect pre-petition indebtedness or to exercise control over the property of the Company’s bankruptcy estates. The plan contemplated by the RSA, if confirmed, will provide for the treatment of claims against the Company’s bankruptcy estates, including pre-petition liabilities that have not been satisfied or addressed during the Chapter 11 Cases.

See Note 1 Background and Basis of Presentation and Note 2, Reorganization and Chapter 11 Proceedings for additional information on the Chapter 11 Cases, the RSA, the Stalking Horse Purchase Agreement and the DIP Credit Agreement.

 

Obligations payable to Honeywell

Honeywell is a defendant in asbestos-related personal injury actions mainly related to its legacy Bendix friction materials (“Bendix”) business. The Bendix business manufactured automotive brake linings that contained chrysotile asbestos in an encapsulated form. Claimants consist largely of individuals who allege exposure to asbestos from brakes from either performing or being in the vicinity of individuals who performed brake replacements. Certain operations that were part of the Bendix business were transferred to Garrett.

29


 

In connection with the Spin-Off, Garrett ASASCO, a wholly owned indirect subsidiary of the Company, entered into the Subordinated Asbestos Indemnity Agreement with Honeywell on September 12, 2018. As of the Spin-Off date of October 1, 2018, Garrett ASASCO is obligated to make payments to Honeywell in amounts equal to 90% of Honeywell’s asbestos-related liability payments and accounts payable, primarily related to the Bendix business in the United States, as well as certain environmental-related liability payments and accounts payable and non-United States asbestos-related liability payments and accounts payable, in each case related to legacy elements of the Business, including the legal costs of defending and resolving such liabilities, less 90% of Honeywell’s net insurance receipts and, as may be applicable, certain other recoveries associated with such liabilities. Pursuant to the terms of this Subordinated Asbestos Indemnity Agreement, Garrett ASASCO is responsible for paying to Honeywell such amounts, up to a cap of an amount equal to the Euro-to-U.S. dollar exchange rate determined by Honeywell as of a date within two business days prior to the date of the Distribution (1.16977 USD = 1 EUR) equivalent of $175 million in respect of such liabilities arising in any given calendar year. The payments that Garrett ASASCO is required to make to Honeywell pursuant to the terms of the Subordinated Asbestos Indemnity Agreement will not be deductible for U.S. federal income tax purposes. The Subordinated Asbestos Indemnity Agreement provides that the agreement will terminate upon the earlier of (x) December 31, 2048 or (y) December 31st of the third consecutive year during which certain amounts owed to Honeywell during each such year were less than $25 million as converted into Euros in accordance with the terms of the agreement. During the first quarter of 2020, Garrett ASASCO paid Honeywell the Euro-equivalent of $35 million in connection with the Subordinated Asbestos Indemnity Agreement. Honeywell and Garrett agreed to defer the payment under the Subordinated Asbestos Indemnity Agreement due May 1, 2020 to December 31, 2020 (the “Q2 Payment”).  We do not expect Garrett ASASCO to make payments to Honeywell under the Subordinated Asbestos Indemnity Agreement during the pendency of the Chapter 11 Cases. The plan contemplated by the RSA, if confirmed, will provide for the treatment of claims against the Company’s bankruptcy estates under the Subordinated Asbestos Indemnity Agreement, including pre-petition liabilities under the Subordinated Asbestos Indemnity Agreement that have not been satisfied or addressed during the Chapter 11 Cases.

On December 2, 2019, the Company and its subsidiary Garrett ASASCO, filed a Summons with Notice in the Commercial Division of the Supreme Court of the State of New York, County of New York (the “NY Supreme Court”) commencing an action (the “Action”) against Honeywell, certain of Honeywell’s subsidiaries and certain of Honeywell’s employees for declaratory judgment, breach of contract, breach of fiduciary duties, aiding and abetting breach of fiduciary duties, corporate waste, breach of the implied covenant of good faith and fair dealing, and unjust enrichment. On January 15, 2020, the Company and Garrett ASASCO, filed a Complaint in the NY Supreme Court in connection with the Action. The lawsuit arises from the Subordinated Asbestos Indemnity Agreement. The Company is seeking declaratory relief; compensatory damages in an amount to be determined at trial; rescission of the Subordinated Asbestos Indemnity Agreement; attorneys’ fees and costs and such other and further relief as the Court may deem just and proper. There can be no assurance as to the time and resources that will be required to pursue these claims or the ultimate outcome of the lawsuit. Among other claims, Garrett asserts that Honeywell is not entitled to indemnification because it improperly seeks indemnification for amounts attributable to punitive damages and intentional misconduct, and because it has failed to establish other prerequisites for indemnification under New York law. Specifically, the claim asserts that Honeywell has failed to establish its right to indemnity for each and every asbestos settlement of the thousands for which it seeks indemnification. The Action seeks to establish that the Subordinated Asbestos Indemnity Agreement is not enforceable, in whole or in part. On March 5, 2020, Honeywell filed a “Notice of Motion to Dismiss Garrett’s Complaint.” The parties agreed to certain schedules for the case that provided that Garrett would file an amended complaint, then Honeywell would have an opportunity to file another motion to dismiss in response.  On September 20, 2020, Garrett and certain of its subsidiaries each filed the Chapter 11 Cases. On September 23, 2020, Garrett removed the case to the United States District Court for the Southern District of New York, and on September 24, 2020, the case was referred to the Bankruptcy Court, where the case is currently pending.  On October 13, 2020, Honeywell filed a motion to dismiss in the Bankruptcy Court.  Garrett does not believe Honeywell’s motion has merit, and Garrett plans to respond.  A pre-trial conference took place on October 22, 2020.  The Court is expected to hear argument on Honeywell’s pending motion to dismiss on November 18, 2020.  

On September 12, 2018, we also entered into a tax matters agreement with Honeywell (the “Tax Matters Agreement”), which governs the respective rights, responsibilities and obligations of Honeywell and us after the Spin-Off with respect to all tax matters (including tax liabilities, tax attributes, tax returns and tax contests). The Tax Matters Agreement generally provides that, following the Spin-Off date of October 1, 2018, we are responsible and will indemnify Honeywell for all taxes, including income taxes, sales taxes, value-added and payroll taxes, relating to Garrett for all periods, including periods prior to the completion date of the Spin-Off. Among other items, as a result of the mandatory transition tax imposed by the Tax Cuts and Jobs Act, Garrett ASASCO is required to make payments to a subsidiary of Honeywell in the amount representing the net tax liability of Honeywell under the mandatory transition tax attributable to us, as determined by Honeywell. We estimate that Garrett ASASCO’s total aggregate payments to Honeywell with respect to the mandatory transition tax will be $240 million with $200 million in payments remaining as of September 30, 2020. Under the terms of the Tax Matters Agreement, Garrett ASASCO is required to pay this amount in Euros, without interest, in five annual installments, each equal to 8% of the aggregate amount, followed by three additional annual installments equal to 15%, 20% and 25% of the aggregate amount, respectively. Following the Spin-Off in October 2018, Garrett ASASCO paid the first annual installment in October 2018, with subsequent annual installments to be paid in April of each year. The annual installment due on April 1, 2020 has been deferred to December 31, 2020 in agreement with Honeywell. We do not expect Garrett ASASCO to make payments to Honeywell under the Tax Matters Agreement during the pendency of the Chapter 11 Cases. The plan contemplated by the RSA, if confirmed, will provide for the treatment of claims against the Company’s bankruptcy estates under the Tax Matters Agreement, including pre-petition liabilities under the Tax Matters Agreement that have not been satisfied or addressed during the Chapter 11 Cases. In addition, the Tax Matters Agreement addresses the allocation of liability for taxes incurred as a result of restructuring activities undertaken to effectuate the Spin-Off. The Tax Matters Agreement also provides that we are required to indemnify Honeywell for certain taxes (and reasonable expenses) resulting from the failure of the Spin-Off and related internal transactions to qualify for their intended tax treatment under U.S. federal, state and local income tax law, as well as foreign tax law. Further, the Tax Matters Agreement also imposes certain restrictions on us and our subsidiaries (including restrictions on share issuances, redemptions or repurchases, business combinations, sales of assets and similar transactions) that are designed to address compliance with Section 355 of the Internal Revenue Code of 1986, as amended, and are intended to preserve the tax-free nature of the Spin-Off.

30


 

On July 17, 2020, we provided notice to Honeywell asserting that Honeywell has caused material breaches of the Tax Matters Agreement and that the Tax Matters Agreement is unenforceable.

The following table summarizes our Obligation payable to Honeywell related to these agreements. As of September 30, 2020, all amounts have been reclassified to Liabilities subject to compromise on the Consolidated Interim Balance Sheets:

 

 

 

Nine Months Ended September 30, 2020

 

 

 

Asbestos and

environmental

 

 

Tax Matters

 

 

Total

 

Beginning of year

 

$

1,090

 

 

$

261

 

 

 

1,351

 

Accrual for update to estimated liability

 

 

 

 

 

 

 

 

 

Legal fees expensed

 

 

41

 

 

 

 

 

 

41

 

Payments to Honeywell

 

 

(35

)

 

 

 

 

 

(35

)

Currency translation adjustment

 

 

37

 

 

 

10

 

 

 

47

 

End of period

 

$

1,133

 

 

$

271

 

 

$

1,404

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current

 

 

2

 

 

 

38

 

 

 

40

 

Non-current

 

 

1,131

 

 

 

233

 

 

 

1,364

 

Total

 

$

1,133

 

 

$

271

 

 

$

1,404

 

 

Asbestos Matters

The accounting for the majority of our asbestos-related liability payments and accounts payable reflect the terms of the Subordinated Asbestos Indemnity Agreement with Honeywell entered into by Garrett ASASCO on September 12, 2018, under which Garrett ASASCO is required to make payments to Honeywell in amounts equal to 90% of Honeywell’s asbestos-related liability payments and accounts payable, primarily related to the Bendix business in the United States, as well as certain environmental-related liability payments and accounts payable and non-United States asbestos-related liability payments and accounts payable, in each case related to legacy elements of the Business, including the legal costs of defending and resolving such liabilities, less 90% of Honeywell’s net insurance receipts and, as may be applicable, certain other recoveries associated with such liabilities. The Subordinated Asbestos Indemnity Agreement provides that the agreement will terminate upon the earlier of (x) December 31, 2048 or (y) December 31st of the third consecutive year during which certain amounts owed to Honeywell during each such year were less than $25 million as converted into Euros in accordance with the terms of the agreement.

The following tables present information regarding Bendix related asbestos claims activity:

 

 

 

Nine Months

Ended September 30,

 

 

Year Ended

December 31,

 

Claims Activity

 

2020

 

 

2019

 

Claims Unresolved at the beginning of the period

 

 

6,480

 

 

 

6,209

 

Claims Filed

 

 

1,621

 

 

 

2,659

 

Claims Resolved

 

 

(1,680

)

 

 

(2,388

)

Claims Unresolved at the end of the period

 

 

6,421

 

 

 

6,480

 

 

 

 

Nine Months

Ended September 30,

 

 

Years Ended

December 31,

 

Disease Distribution of Unresolved Claims

 

2020

 

 

2019

 

Mesothelioma and Other Cancer Claims

 

 

3,404

 

 

 

3,399

 

Nonmalignant Claims

 

 

3,017

 

 

 

3,081

 

Total Claims

 

 

6,421

 

 

 

6,480

 

 

31


 

Honeywell has experienced average resolutions per claim excluding legal costs as follows:

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

 

2016

 

 

 

 

 

 

 

 

 

 

 

(in whole dollars)

 

Malignant claims

 

$

50,200

 

 

$

55,300

 

 

$

56,000

 

 

$

44,000

 

Nonmalignant claims

 

$

3,900

 

 

$

4,700

 

 

$

2,800

 

 

$

4,485

 

 

It is not possible to predict whether resolution values for Bendix-related asbestos claims will increase, decrease or stabilize in the future.

Securities Litigation

On September 25, 2020, a putative class action securities complaint was filed against Garrett Motion Inc. and certain current and former Garrett officers and directors, in the United States District Court for the Southern District of New York.  The case bears the caption: Steven Husson, Individually and On Behalf of All Others Similarly Situated, v. Garrett Motion Inc., Olivier Rabiller, Alessandro Gili, Peter Bracke, Sean Deason, and Su Ping Lu, Case No. 1:20-cv-07992-JPC (SDNY) (the “Husson Action”).  The Husson Action asserts claims under Sections 10(b) and 20(a) of the Exchange Act, for securities fraud and control person liability.  On September 28, 2020, the plaintiff sought to voluntarily dismiss his claim against Garrett Motion Inc.; this request has been referred to the judge for approval. On October 5, 2020, another putative class action securities complaint was filed against certain current and former Garrett officers and directors, in the United States District Court for the Southern District of New York.  This case bears the caption: The Gabelli Asset Fund, The Gabelli Dividend & Income Trust, The Gabelli Value 25 Fund Inc., The Gabelli Equity Trust Inc., SM Investors LP and SM Investors II LP, on behalf of themselves and all others similarly situated, v. Su Ping Lu, Olivier Rabiller, Alessandro Gili, Peter Bracke, Sean Deason, Craig Balis, Thierry Mabru, Russell James, Carlos M. Cardoso, Maura J. Clark, Courtney M. Enghauser, Susan L. Main, Carsten Reinhardt, and Scott A. Tozier, Case No. 1:20-cv-08296-JPC (SDNY) (the “Gabelli Action”).  The Gabelli Action also asserts claims under Sections 10(b) and 20(a) of the Exchange Act.  Based on the publicly-available dockets, service has not yet been effected for either the Husson Action or the Gabelli Action.   The Company believes it has meritorious defenses to the claims of the plaintiffs and any liability for the alleged claims is not currently probable or reasonably estimable.

Other Matters

We are subject to other lawsuits, investigations and disputes arising out of the conduct of our business, including matters relating to commercial transactions, government contracts, product liability, prior acquisitions and divestitures, employee benefit plans, intellectual property, and environmental, health and safety matters. We recognize a liability for any contingency that is probable of occurrence and reasonably estimable. We continually assess the likelihood of adverse judgments of outcomes in these matters, as well as potential ranges of possible losses (taking into consideration any insurance recoveries), based on a careful analysis of each matter with the assistance of outside legal counsel and, if applicable, other experts.

In September 2020, the Brazilian tax authorities issued an infraction notice against Garrett Motion Industria Automotiva Brasil Ltda, challenging the use of certain tax credits between January 2017 and February 2020. The infraction notice results in a loss contingency that may or may not ultimately be incurred by the Company. The estimated total amount of the contingency as of September 30, 2020 was $27 million including penalties and interest. The Company plans to appeal the infraction notice. However, the Company believes, based on management’s assessment and the advice of external legal counsel, that it has meritorious arguments in connection with the infraction notice and any liability for the infraction notice is currently not probable. Accordingly, no accrual is required at this time.

Note 19. Pension Benefits

We sponsor several funded U.S. and non-U.S. defined benefit pension plans. Significant plans outside of the U.S. are in Switzerland and Ireland. Other pension plans outside of the U.S. are not material to the Company either individually or in the aggregate.

Our general funding policy for qualified defined benefit pension plans is to contribute amounts at least sufficient to satisfy regulatory funding standards. We are not required to make any contributions to our U.S. pension plan in 2020. We expect to make contributions of cash and/or marketable securities of approximately $7 million to our non-U.S. pension plans to satisfy regulatory funding standards in 2020, of which $6 million has been contributed through the first nine months of the year.

Net periodic benefit costs for our significant defined benefit plans include the following components:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

32


 

 

 

U.S. Plans

 

 

Non-U.S. Plan,

 

 

U.S. Plans

 

 

Non-U.S. Plan,

 

 

 

2020

 

2019

 

 

2020

 

 

2019

 

 

2020

 

2019

 

 

2020

 

 

2019

 

Service cost

 

$

 

$

 

 

$

2

 

 

$

1

 

 

$

1

 

$

 

 

$

7

 

 

$

3

 

Interest cost

 

 

1

 

 

 

 

 

 

 

 

 

 

 

4

 

 

1

 

 

 

1

 

 

 

1

 

Expected return on plan assets

 

 

(3

)

 

(1

)

 

 

(1

)

 

 

(1

)

 

 

(8

)

 

(2

)

 

 

(4

)

 

 

(2

)

Amortization of prior service (credit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

(2

)

$

(1

)

 

$

1

 

 

$

 

 

$

(3

)

$

(1

)

 

$

4

 

 

$

2

 

 

 

For both our U.S. and non-U.S. defined benefit pension plans, we estimate the service and interest cost components of net period benefit (income) cost by utilizing a full yield curve approach in the estimation of these cost components by applying the specific spot rates along the yield curve used in the determination of the pension benefit obligation to their underlying projected cash flows. This approach provides a more precise measurement of service and interest costs by improving the correlation between projected cash flows and their corresponding spot rates.

Note 20. China Variable Interest Entity

 

On September 20, 2018 in preparation of the Spin-Off, we entered into an agreement by and between Honeywell and Garrett (the “China Purchase Agreement”) in which Honeywell agreed to sell to Garrett 100% of the equity interests of Honeywell Transportation Investment (China) Co., Ltd. (“Garrett China”) consisting of our primary operations in China, in exchange for upfront consideration of 8,444,077 shares of our common stock. No further consideration from Garrett was due. The China Purchase Agreement was amended to extend the date of the transfer of the equity interests in Garrett China from September 20, 2019 to June 30, 2020.

 

Prior to the transfer of the equity interests, Garrett China was considered a variable interest entity for which Garrett is the primary beneficiary because the China Purchase Agreement provided Garrett control to direct the management and operation of Garrett China as well as all economic benefits and losses. The intent of the agreement was to place Garrett in the same position as if it already owned 100% of the equity interests of Garrett China. As the agreement was effective prior to the Spin-Off date while the Company and Garrett China were under common control of Honeywell, the assets and liabilities of Garrett China were recognized at their carrying amounts.

 

On June 3, 2020 Honeywell transferred 100% of the equity interests of Garrett China in accordance with the China Purchase Agreement.  Following the transfer, Garrett continues to consolidate Garrett China. However, Garrett China is no longer considered to be a variable interest entity as Garrett now owns 100% of the equity interests.  There was no change in the basis of the net assets of Garrett China as the transaction did not result in a change of control under U.S. GAAP.

33


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations, which we refer to as our “MD&A,” should be read in conjunction with our Consolidated Interim Financial Statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q as well as the audited annual Consolidated and Combined Financial Statements for the year ended December 31, 2019, included in our Form 10-K, as filed with the Securities and Exchange Commission on February 27, 2020 (our “2019 Form 10-K”). Some of the information contained in this discussion and analysis or set forth elsewhere in this Quarterly Report on Form 10-Q, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. As a result of many important factors, including those set forth in the “Risk Factors” section of our 2019 Form 10-K and this Quarterly Report on Form 10-Q, our actual results could differ materially from the results described in, or implied, by these forward-looking statements.

The following, Management’s Discussion and Analysis of Financial Condition and Results of Operations is intended to help you understand the results of operations and financial condition of Garrett Motion Inc. for the three and nine months ended September 30, 2020.

Overview and Business Trends

Garrett designs, manufactures and sells highly engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (“OEMs”) and the global vehicle independent aftermarket as well as automotive software solutions. These OEMs in turn ship to consumers globally. We are a global technology leader with significant expertise in delivering products across gasoline, diesel, natural gas and electric (hybrid and fuel cell) powertrains. These products are key enablers for fuel economy and emission standards compliance.

Market penetration of vehicles with a turbocharger is expected to increase from approximately 49% in 2019 to approximately 55% by 2023, according to IHS Markit (“IHS”), which we believe will allow the turbocharger market to grow at a faster rate than overall automobile production. We expect that the powertrain mix evolution trends will remain mostly unchanged, which should support the turbocharger industry in the short to medium term. In particular, the phasing out of battery electric vehicles (“BEV”) incentive in China from June 2019 and the change in new energy vehicles (“NEV”) credit policy in November 2019, have significantly reduced BEV sales in China. In Europe, the COVID-19 stimulus packages are mostly directed to electric vehicles, but we do not expect a material adverse impact on the turbocharger market in the short term, as selling price, charging time, charging infrastructure availability and profitability issues for OEMs remain challenges. However, in the long term, a revision of CO2 reduction targets by 2030 proposed by the E.U. could drive an increase of BEV penetration in Europe beyond currently forecasted levels. The turbocharger market volume growth is expected to be particularly strong in China and other high-growth regions in the same period.

In the short to medium term, we believe that turbo penetration will grow as turbos remain one of the most cost-efficient levers to improve the fuel efficiency of conventional Gasoline and Diesel vehicles as well as hybrid and fuel-cell vehicles. Growth in the turbo market is expected in all regions, with special mention for high-growth regions in Asia, where rising income levels continue to drive long-term automotive and vehicle content demand. While these positive factors do not isolate the turbo industry from fluctuations in global vehicle production volumes, such factors may mitigate the negative impact of macroeconomic cycles, or the negative impact of a shift from light vehicle Diesel to light vehicle Gasoline engines.

In addition, specific to Garrett’s reorganization and Chapter 11 Cases (as defined below), financial situation and high debt leverage, we have seen an increase in potential risk developing with some OEMs questioning whether to award (or award less) new business to Garrett in the next few years, which has impacted our long term revenue expectations. In the shorter term, financial stability concerns could also drive some OEMs to consider dual sourcing some of the high volume engine platforms, already awarded to Garrett, in order to balance perceived supply risk and possibly shift volumes to the second source supplier.

Reorganization and Chapter 11 Proceedings

On September 20, 2020 (the “Petition Date”), Garrett Motion Inc. and certain of its subsidiaries (collectively, the “Debtors”) each filed a Restructuring Support Agreement (the “RSA”) and a voluntary petition for relief under chapter 11 of title 11 of the United States Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the Southern District of New York (the “Bankruptcy Court”). The Debtors’ chapter 11 cases (the “Chapter 11 Cases”) are being jointly administered under the caption “In re: Garrett Motion Inc., 20-12212.”  

34


 

On the Petition Date, certain of the Debtors also entered into a share and asset purchase agreement (the “Stalking Horse Purchase Agreement”) with AMP Intermediate B.V. (the “Stalking Horse Bidder”) and AMP U.S. Holdings, LLC, each affiliates of KPS Capital Partners, LP, pursuant to which the Stalking Horse Bidder has agreed to purchase, subject to the terms and conditions contained therein, all of the equity interests in each of Garrett LX I S.à r.l., and Garrett Transportation I Inc. (subject to an election by the Stalking Horse Bidder to purchase substantially all of the assets of Garrett Transportation I Inc., instead of its equity), along with certain other assets and liabilities of the Debtors pursuant to a plan of reorganization under the Bankruptcy Code (the “Acquired Assets”).

On October 19, we received a proposal from the Stalking Horse Bidder to revise the terms of the Stalking Horse Purchase Agreement following approval of our proposed bidding procedures and stalking horse protections by the Bankruptcy Court (the “Stalking Horse Bidder Revised Proposal”).  Under the terms and conditions of the Stalking Horse Bidder Revised Proposal:

 

The Stalking Horse Bidder would increase the base purchase price for the Acquired Assets by $500 million, from $2.1 billion to $2.6 billion (in each case subject to adjustment as provided in the Stalking Horse Purchase Agreement). The Stalking Horse Bidder would also purchase an entity (Garrett ASASCO Inc.) that directly holds (and after the closing will retain) our claims against Honeywell International Inc. in connection with the disputed Subordinated Asbestos Indemnity Agreement (as defined below) and Tax Matters Agreement (as defined below).

 

Upon completion of the sale, the Stalking Horse Bidder would list the new parent company on a recognized U.S. stock exchange.

 

The Stalking Horse Bidder would make available to our existing stockholders an equity co-investment opportunity on the same economic terms as the Stalking Horse Bidder, allowing our stockholders to continue to hold shares in the publicly-listed reorganized business. The Stalking Horse Bidder would offer co-investment in an aggregate amount of up to $350 million, $100 million of which would be available to all of our existing stockholders on a pro rata basis. The Stalking Horse Bidder has indicated that it expects our existing stockholders would own approximately 24% of outstanding common equity of the new parent company assuming maximum co-investment (subject to adjustment).

 

The anticipated dates for our competitive auction process would be extended to provide us with additional time to assess higher or better offers. The anticipated auction date would be December 18, 2020 rather than November 24, 2020, with other dates adjusted accordingly.

 

The costs and expenses for which we are obligated to reimburse the Stalking Horse Bidder in certain circumstances in which the Stalking Horse Purchase Agreement is terminated would be capped at $21 million.

The Stalking Horse Bidder Revised Proposal was conditioned on Bankruptcy Court approval of our proposed bidding procedures and the stalking horse protections, which were approved by the Bankruptcy Court in an order entered on October 24, 2020. The Stalking Horse Purchase Agreement and the Stalking Horse Bidder Revised Proposal remain subject to Bankruptcy Court Approval and higher or better offers in Chapter 11 Cases. We expect to work with the Stalking Horse Bidder to amend the Stalking Horse Purchase Agreement and other transaction documentation to reflect the terms of the Stalking Horse Bidder Revised Proposal.

On October 16, 2020, we were made aware that Honeywell International Inc., Centerbridge Partners, L.P. and Oaktree Capital Management L.P. (collectively, the “Bidding Group”) had entered into a coordination agreement, which was amended and restated on October 21, 2020, in anticipation of submitting to the Company an alternative proposal for a plan of reorganization (the “Alternative Proposal”).  We continue to evaluate the Alternative Proposal and expect to further engage with the Bidding Group on the terms of the Alternative Proposal.  

For additional information regarding the Chapter 11 Cases, reorganization and the Stalking Horse Purchase Agreement, see “Explanatory Note” and Note 2, Reorganization and Chapter 11 Proceedings of the Notes to the Consolidated Interim Financial Statements.

Impact of COVID-19 Pandemic

The ongoing global COVID-19 pandemic has created unparalleled challenges for the auto industry in the short-term. In the three months ended March 31, 2020, our manufacturing facility in Wuhan, China was shut down for six weeks in February and March and we saw diminished production in our Shanghai, China facility for that same time period, which adversely impacted our net sales for the period. During the second quarter, our facilities in China re-opened, however our manufacturing facilities in Mexicali, Mexico and Pune, India were shut down for five weeks and our manufacturing facilities in Europe operated at reduced capacity. In the third quarter, the fast recovery observed in all geographies has enabled us to ramp up production in most of our production sites to normal levels. However, if the COVID-19 pandemic drives new lockdown measures impacting our manufacturing facilities, our facilities may

35


 

be forced to shut down or operate at reduced capacity again. Additional or continued facilities closures or reductions in operation could significantly reduce our production volumes and have a material adverse impact on our business, results of operations and financial condition. Additional or continued facilities closures or reductions in operation could significantly reduce our production volumes and have a material adverse impact on our business, results of operations and financial condition.

Analyst consensus for the full year 2020 calls for a 22% decrease in light vehicle production, and of about 20% decline for commercial vehicles, a larger drop than during the financial crisis in 2008 and 2009. Recovery appears to be faster in the U.S. and China compared to Europe.  As a result, we expect a contraction of approximately 15% of turbocharger industry volume in 2020. The health and safety of our employees, customers, and suppliers is our top priority. In parallel, we are continuously updating various scenarios for vehicle demand and OEM production volumes through 2020 and 2021. Each scenario is backed with contingency plans that we believe will allow us to react swiftly to changes in customer demand while protecting Garrett’s long-term growth potential. In addition, we have implemented cost control measures and cash management actions, including:

 

Postponing capital expenditures;

 

Optimizing working capital requirements;

 

Lowering discretionary spending;

 

Flexing organizational costs by implementing short-term working schemes;

 

Reducing temporary workforce and contract service workers; and

 

Restricting external hiring.

 

The following charts show our percentage of revenues by geographic region and product line for the three and nine months ended September 30, 2020 and the percentage change from the prior year comparable period.

 

By Geography

 

 

 

36


 

 

By Product Line

 

 

 

We are a global business that generated revenues of approximately $0.8 billion and $2 billion for the three and nine months ended September 30, 2020 respectively.

 

Light vehicle products (which includes Diesel and Gas products, including products for passenger cars, SUVs, light trucks, and other products) accounted for approximately 69% and 67% of our revenues for the three and nine months ended September 30, 2020. Commercial vehicle products (products for on-highway trucks and off-highway trucks, construction, agriculture and power-generation machines) accounted for 18% and 19% of our revenues for the three and nine months ended September 30, 2020.

 

Our OEM sales contributed approximately 87% and 86% of our revenues while our aftermarket and other products contributed 11% and 12% of our revenues for the three and nine months ended September 30, 2020.

 

Approximately 51% and 51% of our revenues came from sales to customers located in Europe, 33% and 32% from sales to customers located in Asia, 15% and 16% from sales to customers in North America, and 1% and 1% from sales to customers in other international markets for the three and nine months ended September 30, 2020.

Basis of Presentation

The Consolidated Interim Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). All amounts presented are in millions, except per share amounts.

Liabilities under the Subordinated Asbestos Indemnity Agreement

The accounting for the majority of our asbestos-related liability payments and accounts payable reflect the terms of the indemnification and reimbursement agreement with Honeywell (as amended, the “Subordinated Asbestos Indemnity Agreement”), under which Garrett ASASCO is required to make payments to Honeywell in amounts equal to 90% of Honeywell’s asbestos-related liability payments and accounts payable, primarily related to the Bendix business in the United States, as well as certain environmental-related liability payments and accounts payable and non-United States asbestos-related liability payments and accounts payable, in each case related to legacy elements of the Business, including the legal costs of defending and resolving such liabilities, less 90% of Honeywell’s net insurance receipts and, as may be applicable, certain other recoveries associated with such liabilities. The Subordinated Asbestos Indemnity Agreement provides that the agreement will terminate upon the earlier of (x) December 31, 2048 or (y) December 31st of the third consecutive year during which certain amounts owed to Honeywell during each such year were less than $25 million as converted into Euros in accordance with the terms of the agreement. During the first quarter of 2020, Garrett ASASCO paid Honeywell the Euro-equivalent of $35 million in connection with the Subordinated Asbestos Indemnity Agreement. Honeywell and Garrett agreed to defer the payment from Garrett ASASCO under the Subordinated Asbestos Indemnity Agreement due May 1, 2020 to December 31, 2020 (the “Q2 Payment”).  We do not expect Garrett ASASCO to make payments to Honeywell under the Subordinated Asbestos Indemnity Agreement during the pendency of the Chapter 11 Cases. The plan contemplated by the RSA, if confirmed, will provide for the treatment of claims against the Company’s bankruptcy estates under the Subordinated Asbestos Indemnity Agreement, including pre-petition liabilities under the Subordinated Asbestos Indemnity Agreement that have not been satisfied or addressed during the Chapter 11 Cases.

 

On December 2, 2019, the Company and Garrett ASASCO, filed a Summons with Notice in the Commercial Division of the Supreme Court of the State of New York, County of New York (the “NY Supreme Court”) commencing an action (the “Action”) against Honeywell, certain of Honeywell’s subsidiaries and certain of Honeywell’s employees for declaratory judgment, breach of contract, breach of fiduciary duties, aiding and abetting breach of fiduciary duties, corporate waste, breach of the implied covenant of good faith and fair dealing, and unjust enrichment. On January 15, 2020, the Company and Garrett ASASCO, filed a Complaint in the NY Supreme Court in connection with the Action. The lawsuit arises from the Subordinated Asbestos Indemnity Agreement. The

37


 

Company is seeking declaratory relief; compensatory damages in an amount to be determined at trial; rescission of the Subordinated Asbestos Indemnity Agreement; attorneys’ fees and costs and such other and further relief as the Court may deem just and proper. There can be no assurance as to the time and resources that will be required to pursue these claims or the ultimate outcome of the lawsuit. Among other claims, Garrett asserts that Honeywell is not entitled to indemnification because it improperly seeks indemnification for amounts attributable to punitive damages and intentional misconduct, and because it has failed to establish other prerequisites for indemnification under New York law. Specifically, the claim asserts that Honeywell has failed to establish its right to indemnity for each and every asbestos settlement of the thousands for which it seeks indemnification. The Action seeks to establish that the Subordinated Asbestos Indemnity Agreement is not enforceable, in whole or in part. On March 5, 2020, Honeywell filed a “Notice of Motion to Dismiss Garrett’s Complaint.” The parties agreed to certain schedules for the case that provided that Garrett would file an amended complaint, then Honeywell would have an opportunity to file another motion to dismiss in response.  On September 20, 2020, Garrett and certain of its subsidiaries each filed a voluntary petition for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of New York.  On September 23, 2020, Garrett removed the Action to the United States District Court for the Southern District of New York, and on September 24, 2020, the Action was referred to the Bankruptcy Court, where the case is currently pending.  On October 13, 2020, Honeywell filed a motion to dismiss the Action in the Bankruptcy Court.  Garrett does not believe Honeywell’s motion has merit, and Garrett plans to respond.  A pre-trial conference took place on October 22, 2020. The Court is expected to hear argument on Honeywell’s pending motion to dismiss on November 18, 2020.  

 

Results of Operations for the three and nine months ended September 30, 2020 compared with the three and nine months ended September 30, 2019

Net Sales

 

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended  September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

(Dollars in millions)

 

Net sales

 

$

804

 

 

$

781

 

 

$

2,026

 

 

$

2,418

 

% change compared with prior period

 

 

2.9

%

 

 

 

 

 

 

(16.2

)%

 

 

 

 

 

The change in net sales compared to prior year period is attributable to the following:

 

 

 

For the Three

Months Ended

September 30, 2020

 

 

For the Nine

Months Ended

September 30, 2020

 

Volume

 

 

1.1

%

 

 

(15.5

%)

Price

 

 

(0.8

%)

 

 

(0.3

%)

Foreign Currency Translation

 

 

2.6

%

 

 

(0.4

%)

 

 

 

2.9

%

 

 

(16.2

%)

 

Three Months Ended September 30, 2020 compared with Three Months Ended September 30, 2019

 

Our net sales increased for the three months ended September 30, 2020 compared to the prior year period by $23 million or 2.9% (including a favorable impact of 2.6% due to foreign currency translation). The increase in sales was primarily driven by light vehicles OEM products increase of $28 million, commercial vehicles OEM products increase of $7 million, partially offset by aftermarket products net sales decline of $10 million and other products decline of $2 million.

 

Our light vehicles OEM products increase was primarily driven by higher gasoline volumes in China, as a result of increased turbocharger penetration in gasoline engines and new product launches, partially offset by lower volumes in Europe. The increase in net sales for commercial vehicles was mainly driven by higher volumes in China and North America. The decrease in aftermarket product sales was primarily driven by volume decreases in North America. The decrease in other net sales was primarily driven by a decrease in prototype volumes.

 

The production of our facilities in China has increased significantly, with an increase in net sales of 53% compared to the three months ended September 30, 2019.

38


 

Nine Months Ended September 30, 2020 compared with Nine Months Ended September 30, 2019

 

Our net sales decreased for the nine months ended September 30, 2020 compared to the prior year period by $392 million or 16.2% (including a negative impact of 0.4% due to foreign currency translation). The decrease in sales was primarily driven by light vehicles OEM products decline of $238 million, commercial vehicles OEM products decline of $86 million, aftermarket products decline of $56 million and other products decline of $12 million.

 

Our light vehicles OEM product decline was primarily driven by lower diesel volumes in Europe and Asia and lower gasoline volumes in Europe and North America, partially offset by increased gasoline volumes in China as a result of increased turbocharger penetration in gasoline engines and new product launches. The decrease in net sales for commercial vehicles was mainly driven by lower volumes in Europe and North America. The decrease in aftermarket product sales was primarily driven by volume decreases in Europe and North America. The decrease in other net sales was primarily driven by a decrease in prototype volumes.

Due to the Covid-19 pandemic, our manufacturing facility in Wuhan, China, was shut down for six weeks in February and March 2020 and we saw diminished production in our Shanghai, China facility for the same time period, which were the primary drivers of the decrease in sales in the Asia region during the three months ended March 31, 2020. Since our facilities in China re-opened in the middle of March, the production of those facilities in China has recovered significantly with an increase in net sales of 32% compared to the nine months ended September 30, 2019.

Our manufacturing facilities in Mexicali, Mexico and Pune, India were shut down for five weeks in April and May 2020 and we saw diminished production in our European manufacturing facilities for that same time period, which were the primary drivers of the decrease in sales in the Europe and North America regions during the nine months ended September 30, 2020.

Cost of Goods Sold

 

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

(Dollars in millions)

 

Cost of goods sold

 

$

652

 

 

$

609

 

 

$

1,648

 

 

$

1,868

 

% change compared with prior period

 

 

7.1

%

 

 

0.5

%

 

 

(11.8

)%

 

 

(5.3

)%

Gross profit percentage

 

 

18.9

%

 

 

22.0

%

 

 

18.7

%

 

 

22.7

%

 

Three Months Ended September 30, 2020 compared with Three Months Ended September 30, 2019

 

Costs of goods sold increased in the three months ended September 30, 2020 compared to the prior year period by $43 million or 7.1% primarily due to an increase in direct material costs of $25 million and a $13 million increase in other fixed costs (primarily related to government incentives and tax recoveries recognized in the three months ended September 30, 2019).

Gross profit percentage decreased by 3.1 percentage points primarily due to the unfavorable impact of mix and price (2.7 percentage points) and one-time fixed costs (1.5 percentage points), partially offset by the favorable impact of productivity (0.9 percentage points) and the favorable impact of foreign exchange rates (0.2 percentage points)

Nine Months Ended September 30, 2020 compared with Nine Months Ended September 30, 2019

 

Costs of goods sold decreased in the nine months ended September 30, 2020 compared to the prior year period by $220 million or 11.8% primarily due to a decrease in direct material costs and labor costs of $210 million, driven by decreased volumes.

Gross profit percentage decreased by 4 percentage points primarily due to unfavorable impacts from mix and price (2.4 percentage points),  unfavorable impacts from inflation (0.6 percentage points), unfavorable impact from repositioning costs (0.2 percentage points), and other factors (1.4 percentage points), including higher costs from premium freight and higher one time fixed costs, partially offset by the favorable impacts from foreign and exchange rates (0.2 percentage points) and favorable impact of productivity including lower volume leverage (0.3 percentage points).

39


 

Selling, General and Administrative Expenses

 

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

(Dollars in millions)

 

Selling, general and administrative expense

 

$

103

 

 

$

68

 

 

$

215

 

 

$

186

 

% of sales

 

 

12.8

%

 

 

8.7

%

 

 

10.6

%

 

 

7.7

%

 

Three Months Ended September 30, 2020 compared with Three Months Ended September 30, 2019

 

Selling, general and administrative expenses increased in the three months ended September 30, 2020 compared to the prior year period by $35 million, mainly due to an increase of $44 million of professional services fees, primarily related to the Chapter 11 Cases in the current year period, partially offset by $9 million of cost saving actions implemented to ease the impact of COVID-19 on our financial performance, including merit freezes, state funded lay-offs, unpaid leaves and reductions in travel expenses and professional services, as well as one-time Spin-off costs incurred in the prior year period.

Nine Months Ended September 30, 2020 compared with Nine Months Ended September 30, 2019

 

Selling, general and administrative expenses increased in the nine months ended September 30, 2020 compared to the prior year period by $29 million, mainly due to an increase of $53 million of professional service fees, primarily related to the Chapter 11 Cases in the current year period, partially offset by $25 million of cost saving actions implemented to ease the impact of COVID-19 on our financial performance, including merit freezes, state funded lay-offs, unpaid leaves and reductions in travel expenses and professional services, as well as one-time Spin-off costs incurred in the prior year period.

Other Expense, Net

 

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

(Dollars in millions)

 

Other expense, net

 

$

14

 

 

$

18

 

 

$

45

 

 

$

54

 

% of sales

 

 

1.7

%

 

 

2.3

%

 

 

2.2

%

 

 

2.2

%

 

Three Months Ended September 30, 2020 compared with Three Months Ended September 30, 2019

 

Other expense, net decreased in the three months ended September 30, 2020 compared to the prior year period by $4 million. The decrease was attributable to the decrease in indemnification litigation-related expenses.

 

Nine Months Ended September 30, 2020 compared with Nine Months Ended September 30, 2019

Other expense, net decreased in the nine months ended September 30, 2020 compared to the prior year period by $9 million. The decrease was attributable to the decrease in legal fees incurred in connection with the Subordinated Asbestos Indemnity Agreement.

Interest Expense

 

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

(Dollars in millions)

 

Interest expense

 

$

20

 

 

$

18

 

 

$

56

 

 

$

52

 

 

40


 

Three Months Ended September 30, 2020 compared with Three Months Ended September 30, 2019

 

Interest expense increased in the three months ended September 30, 2020 compared to the prior year period by $2 million, mainly due to higher outstanding Revolving Facility (as defined below) drawings, amortization of fees related to the amendment, dated June 12, 2020 (the “2020 Amendment”), to our Credit Agreement, dated September 27, 2018 (as amended, the “Credit Agreement”), cancellations of cross-currency interest rate swaps in connection with the Chapter 11 Cases, partially offset by lower interest expense on our Term Loan Facilities (as defined below) due to partial prepayments in 2019.

 

Nine Months Ended September 30, 2020 compared with Nine Months Ended September 30, 2019

 

Interest expense increased in the nine months ended September 30, 2020 compared to the prior year period by $4 million, mainly due to higher interest expense due to the full draw down of our Revolving Facility and fees related to the 2020 Amendment, partially offset by lower interest expense on our Term Loan Facilities due to partial prepayments in 2019.

Non-operating expense (income)

 

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

(Dollars in millions)

 

Non-operating expense (income)

 

$

1

 

 

$

(4

)

 

$

(7

)

 

$

2

 

 

Three Months Ended September 30, 2020 compared with Three Months Ended September 30, 2019

 

Non-operating (income) expense for the three months ended September 30, 2020 decreased to an expense of $1 million from income of $4 million in the prior year period, primarily due to impacts from changes in foreign exchange rates, net of hedging.

Nine Months Ended September 30, 2020 compared with Nine Months Ended September 30, 2019

 

Non-operating (income) expense for the nine months ended September 30, 2020 increased to income of $7 million from an expense of $2 million in the prior year period, primarily due to impacts from changes in foreign exchange rates, net of hedging.

Reorganization items, net

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

(Dollars in millions)

 

Reorganization items, net

 

$

4

 

 

$

-

 

 

$

4

 

 

$

 

 

Three Months Ended September 30, 2020 compared with Three Months Ended September 30, 2019

 

Reorganization items, net for the three months ended September 30, 2020 were $4 million, representing the write-off of the unamortized deferred high yield debt issuance cost.

 

Nine Months Ended September 30, 2020 compared with Nine Months Ended September 30, 2019

 

Reorganization items, net for the nine months ended September 30, 2020 were $4 million, representing the write-off of the unamortized deferred high yield debt issuance cost.

 

Tax Expense

 

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

(Dollars in millions)

 

Tax (benefit) expense

 

$

(1

)

 

$

34

 

 

$

11

 

 

$

79

 

Effective tax rate

 

 

(10.0

)%

 

 

47.2

%

 

 

16.9

%

 

 

30.9

%

 

41


 

See Note 7, Income Taxes of the Notes to the Consolidated Interim Financial Statements for a discussion of the change in effective tax rates for the three and nine months ended September 30, 2020 versus the prior year periods.

Net Income

 

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

(Dollars in millions)

 

Net Income

 

$

11

 

 

$

38

 

 

$

54

 

 

$

177

 

 

Three Months Ended September 30, 2020 compared with Three Months Ended September 30, 2019

 

As a result of the factors described above, net income was $11 million for the three months ended September 30, 2020 as compared to net income of $38 million for the three months ended September 30, 2019.

Nine Months Ended September 30, 2020 compared with Nine Months Ended September 30, 2019

 

As a result of the factors described above, net income was $54 million for the nine months ended September 30, 2020 as compared to net income of $177 million for the nine months ended September 30, 2019.

Non-GAAP Measures

It is management’s intent to provide non-GAAP financial information to supplement the understanding of our business operations and performance, and it should be considered by the reader in addition to, but not instead of, the financial statements prepared in accordance with GAAP. Each non-GAAP financial measure is presented along with the most directly comparable GAAP measure so as not to imply that more emphasis should be placed on the non-GAAP measure. The non-GAAP financial information presented may be determined or calculated differently by other companies and may not be comparable to other similarly titled measures used by other companies. Additionally, the non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for analysis of the Company’s operating results as reported under GAAP.

EBITDA and Adjusted EBITDA(1)(2)

 

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

(Dollars in millions)

 

Net income — GAAP

 

$

11

 

 

$

38

 

 

$

54

 

 

$

177

 

Net interest expense (income)

 

 

19

 

 

 

16

 

 

 

53

 

 

 

46

 

Tax expense

 

 

(1

)

 

 

34

 

 

 

11

 

 

 

79

 

Depreciation

 

 

23

 

 

 

20

 

 

 

60

 

 

 

55

 

EBITDA (Non-GAAP)

 

$

52

 

 

$

108

 

 

$

178

 

 

$

357

 

Other expense, net (which consists of indemnification,

   asbestos and environmental expenses)(3)

 

 

14

 

 

 

18

 

 

 

44

 

 

 

54

 

Non-operating (income) expense(2)(4)

 

 

(3

)

 

 

 

 

 

(8

)

 

 

 

Reorganization items, net

 

 

4

 

 

 

 

 

 

4

 

 

 

 

Stock compensation expense(5)

 

 

2

 

 

 

5

 

 

 

8

 

 

 

14

 

Repositioning charges(6)

 

 

2

 

 

 

 

 

 

8

 

 

 

3

 

Foreign exchange (gain) loss on debt, net of related hedging

   (gain) loss

 

 

5

 

 

 

 

 

 

4

 

 

 

8

 

Spin-off costs(7)(8)

 

 

 

 

 

2

 

 

 

 

 

 

10

 

Professional service costs(9)

 

 

44

 

 

 

 

 

 

53

 

 

 

 

Adjusted EBITDA (Non-GAAP)

 

$

120

 

 

$

133

 

 

$

291

 

 

$

446

 

 

(1)

We evaluate performance on the basis of EBITDA and Adjusted EBITDA. We define “EBITDA” as our net income (loss) calculated in accordance with U.S. GAAP, plus the sum of net interest expense (income), tax expense and depreciation. We define “Adjusted EBITDA” as EBITDA, plus the sum of non-operating expense (income), other expenses, net (which primarily consists of indemnification, asbestos and environmental expenses), stock compensation expense, repositioning charges, foreign exchange gain (loss) on debt, net of related hedging (gain) loss, Spin-Off costs and professional services costs. We believe that EBITDA and Adjusted EBITDA are important indicators of operating performance and provide useful information for investors because:

42


 

 

o

EBITDA and Adjusted EBITDA exclude the effects of income taxes, as well as the effects of financing and investing activities by eliminating the effects of interest and depreciation expenses and therefore more closely measure our operational performance; and

 

o

certain adjustment items, while periodically affecting our results, may vary significantly from period to period and have disproportionate effect in a given period, which affects comparability of our results.

In addition, our management may use Adjusted EBITDA in setting performance incentive targets in order to align performance measurement with operational performance.

(2)

We have elected to change our definition of Adjusted EBITDA to exclude the non-service component of pension expense. Non-service pension expense is comprised of interest costs, expected return on plan assets and actuarial gains/losses. The components of non-service pension expense are primarily tied to financial market performance, changes in market interest rates and investment performance. The service cost component of our pension plans remains in Adjusted EBITDA. We consider the non-service component of pension expense to be outside the performance of our ongoing core business operations and believe that presenting Adjusted EBITDA including only the service component of pension expense, in addition to our GAAP operating results, provides increased transparency as to the operating costs of providing pension benefits to our employees and the underlying trends in our operating business performance. As a result, the prior periods presented were recast to conform to the current year presentation.

 

(3)

The accounting for the majority of our asbestos-related liability payments and accounts payable reflect the terms of the Subordinated Asbestos Indemnity Agreement with Honeywell entered into on September 12, 2018, under which Garrett ASASCO is required to make payments to Honeywell in amounts equal to 90% of Honeywell’s asbestos-related liability payments and accounts payable, primarily related to the Bendix business in the United States, as well as certain environmental-related liability payments and accounts payable and non-United States asbestos-related liability payments and accounts payable, in each case related to legacy elements of the Business, including the legal costs of defending and resolving such liabilities, less 90% of Honeywell’s net insurance receipts and, as may be applicable, certain other recoveries associated with such liabilities. See Note 18, Commitments and Contingencies of Notes to the Consolidated Interim Financial Statements.

 

(4)

Non-operating (income) expense adjustment includes the non-service component of pension expense and other expense, net and excludes interest income, equity income of affiliates, and the impact of foreign exchange.

 

(5)

Stock compensation expense adjustment includes only non-cash expenses.

 

(6)

Repositioning charges adjustment primarily includes severance costs related to restructuring projects to improve future productivity.

 

(7)

During the fourth quarter of 2019 additional spin-off costs related to the first three quarters of 2019 were identified and included within the adjustment for the three and twelve months end December 31, 2019 as presented in our 2019 Form 10K.  As a result, the three and nine months ended September 30, 2019 were recast to include these additional costs.

 

(8)

Spin-Off costs primarily include costs incurred for the set-up of the IT, Legal, Finance, Communications and Human Resources functions after the Spin-Off from Honeywell on October 1, 2018.

 

(9)

Professional service costs consist of professional service fees to support strategic planning for the Company. We consider these costs to be unrelated to our ongoing core business operations.

 

 

Three Months Ended September 30, 2020 compared with Three Months Ended September 30, 2019

Adjusted EBITDA (non-GAAP) decreased by $13 million for the three months ended September 30, 2020 compared to the prior year period. The decrease was primarily due to higher selling, general and administrative expenses ($35 million) and price ($6 million), partially offset by the favorable impact of productivity, net of mix ($19 million), lower research and development expenses ($4 million), foreign exchange including prior year´s hedge gains ($4 million) and favorable impacts of sales volume ($1 million).

 

Nine Months Ended September 30, 2020 compared with Nine Months Ended September 30, 2019

 

Adjusted EBITDA (non-GAAP) decreased by $155 million for the nine months ended September 30, 2020 compared to the prior year period. The decrease was primarily due to unfavorable impacts of volume ($132 million), selling, general and administrative expenses ($29 million), inflation ($11 million) and price ($7 million), partially offset by the favorable impact of lower research and development expenses ($13 million), productivity, net of mix ($5 million) and foreign exchange rates including prior year’s hedge losses ($6 million).

 

43


 

Cash flow from operations less Expenditures for property, plant and equipment (1)

 

 

 

For the Nine Months

Ended September 30,

 

 

 

2020

 

 

2019

 

 

 

(Dollars in millions)

 

Net cash (used for) provided by operating activities —

   GAAP

 

 

(136

)

 

 

125

 

Expenditures for property, plant and equipment

 

 

(79

)

 

 

(74

)

Cash flow from operations less Expenditures for property,

   plant and equipment (Non-GAAP)

 

$

(215

)

 

$

51

 

 

(1)

Cash flow from operations less Expenditures for property, plant and equipment is a non-GAAP financial measure that reflects an additional way of viewing our liquidity that, when viewed with our GAAP results, provides a supplemental understanding of factors and trends affecting our cash flows. Cash flow from operations less Expenditures for property, plant and equipment is calculated by subtracting Expenditures for property, plant and equipment from Net cash provided by (used for) operating activities. We believe it is a more conservative measure of cash flow, and therefore useful to investors, because purchases of fixed assets are necessary for ongoing operations. We believe it is important to view Cash flow from operations less Expenditures for property, plant and equipment as a supplement to our Consolidated and Combined Statements of Cash Flows.

 

Cash flow from operations less Expenditures for property, plant and equipment (non-GAAP) decreased by $266 million for the nine months ended September 30, 2020 versus the prior year period, primarily due to the unfavorable impact from working capital of $143 million, a decrease in net income, net of deferred taxes of $152 million, and an unfavorable impact of $56 million in prepaid Directors and officers insurance, employee continuity awards and prepayments to suppliers, partially offset by delayed Obligations payable to Honeywell of $90 million. Additionally, Expenditures for property, plant and equipment expenses increased by $5 million.

 

Liquidity and Capital Resources

As described above, the commencement of the Chapter 11 Cases described above constituted an event of default that accelerated the Company’s obligations, as applicable, under the Credit Agreement and the Company’s 5.125% senior notes due 2026 (the “Senior Notes”). The Credit Agreement and Senior Notes provide that as a result of the commencement of the Chapter 11 Cases, the principal, interest and all other amounts due thereunder shall be immediately due and payable. Any efforts to enforce the payment obligations under the Credit Agreement and Senior Notes are automatically stayed as a result of the Chapter 11 Cases, and the creditors’ rights of enforcement in respect of the Credit Agreement and Senior Notes are subject to the applicable provisions of the Bankruptcy Code.

We expect that our cash requirements in the fourth quarter of 2020 will primarily be to fund operating activities, working capital, and capital expenditures. We have historically funded our cash requirements, which included requirements to meet our obligations under our debt instruments and the Subordinated Asbestos Indemnity Agreement described below, as well as the tax matters agreement with Honeywell (the “Tax Matters Agreement”), through the combination of cash flows from operating activities, available cash balances and available borrowings through our debt agreements. During the Chapter 11 Cases, our principal sources of liquidity are expected to be limited to cash flow from operations, cash on hand and borrowings under the DIP Credit Agreement (as defined below). Based on our current expectations, we believe these principal sources of liquidity during the Chapter 11 Cases will be sufficient to fund our operations during the pendency of the Chapter 11 Cases.

Senior Secured Credit Facilities

On September 27, 2018, we entered into a Credit Agreement by and among us, certain of our subsidiaries, the lenders and issuing banks party thereto and JPMorgan Chase Bank, N.A., as administrative agent. The Credit Agreement was amended on June 12, 2020. The Credit Agreement provides for senior secured financing of approximately the Euro equivalent of $1,254 million, consisting of (i) a seven-year senior secured first-lien term B loan facility, which consists of a tranche denominated in Euro of €375 million and a tranche denominated in U.S. Dollars of $425 million (the “Term B Facility”), (ii) a five-year senior secured first-lien term A loan facility in an aggregate principal amount of €330 million (the “Term A Facility” and, together with the Term B Facility, the “Term Loan Facilities”) and (iii) a five-year senior secured first-lien revolving credit facility in an aggregate principal amount of €430 million with revolving loans to the Swiss Borrower (as defined in the Credit Agreement), to be made available in a number of currencies including Australian Dollars, Euros, Pounds Sterling, Swiss Francs, U.S. Dollars and Yen (the “Revolving Facility” and, together with the Term Loan Facilities, the “Senior Secured Credit Facilities”).

The Senior Secured Credit Facilities are subject to an interest rate, at our option and subject to certain conditions and limitations, of either (a) base rate determined by reference to the highest of (1) the rate of interest last quoted by The Wall Street Journal as the

44


 

“prime rate” in the United States, (2) the greater of the federal funds effective rate and the overnight bank funding rate, plus 0.5% and (3) the one month adjusted LIBOR rate, plus 1% per annum (“ABR”), (b) an adjusted LIBOR rate (“LIBOR”) (which shall not be less than zero), or (c) an adjusted EURIBOR rate (“EURIBOR”) (which shall not be less than zero), in each case, plus an applicable margin. Pursuant to the 2020 Amendment, (i) the margin applicable to loans under the Term B Facility will increase by 75 basis points through the maturity date and (ii) the margin applicable to loans under the Revolving Facility and Term A Facility will increase by 25 basis points until the Company delivers consolidated financial statements as of and for its first fiscal quarter ending on or after the last day of the Relief Period (as defined below). Pursuant to the 2020 Amendment, the margin applicable to loans under our Senior Secured Credit Facilities increased by 25 basis points on September 4, 2020 following a downgrade in our corporate credit rating by S&P Global ratings.

The applicable margin for the U.S. Dollar tranche of the Term B Facility is currently 3.50% per annum (for LIBOR loans) and 2.50% per annum (for ABR loans) while that for the euro tranche of the Term B Facility is currently 3.75% per annum (for EURIBOR loans). The applicable margin for each of the Term A Facility and the Revolving Facility varies based on our leverage ratio which is increased by 25 basis points until the Company delivers consolidated financial statements as of and for its first fiscal quarter ending on or after the last day of the Relief Period. Accordingly, the interest rates for the Senior Secured Credit Facilities will fluctuate during the term of the Credit Agreement based on changes in the ABR, LIBOR, EURIBOR or future changes in our corporate rating or leverage ratio.

The commencement of the Chapter 11 Cases described above constituted an event of default that accelerated the Company’s obligations and terminated undrawn commitments, as applicable, under the Credit Agreement. The Credit Agreement provides that as a result of the commencement of the Chapter 11 Cases, the principal, interest and all other amounts due thereunder shall be immediately due and payable. Any efforts to enforce the payment obligations under the Credit Agreement are automatically stayed as a result of the Chapter 11 Cases, and the creditors’ rights of enforcement in respect of the Credit Agreement are subject to the applicable provisions of the Bankruptcy Code.

During the Chapter 11 Cases and pursuant to an order of the Bankruptcy Court, we make monthly payments of interest at the contractual non-default rate of interest on loans and certain other obligations under our Senior Secured Credit Facilities.

Senior Notes

On September 27, 2018, we completed the offering of €350 million (approximately $410 million based on exchange rates as of September 27, 2018) in aggregate principal amount of Senior Notes. The Senior Notes bear interest at a fixed annual interest rate of 5.125% and mature on October 15, 2026.

The Senior Notes were issued pursuant to an Indenture, dated September 27, 2018, which, among other things and subject to certain limitations and exceptions, limits our ability and the ability of our restricted subsidiaries to: (i) incur, assume or guarantee additional indebtedness or issue certain disqualified equity interests and preferred shares, (ii) pay dividends or distributions on, or redeem or repurchase, capital stock and make other restricted payments, (iii) make investments, (iv) consummate certain asset sales or transfers, (v) engage in certain transactions with affiliates, (vi) grant or assume certain liens on assets to secure debt unless the notes are secured equally and ratably (vii) restrict dividends and other payments by certain of their subsidiaries and (vii) consolidate, merge, sell or otherwise dispose of all or substantially all of our or our restricted subsidiaries’ assets.

The commencement of the Chapter 11 Cases described above constituted an event of default that accelerated the Company’s obligations, as applicable, under the Senior Notes. The Senior Notes provide that as a result of the commencement of the Chapter 11 Cases, the principal, interest and all other amounts due thereunder shall be immediately due and payable. Any efforts to enforce the payment obligations under the Senior Notes are automatically stayed as a result of the Chapter 11 Cases, and the creditors’ rights of enforcement in respect of the Senior Notes are subject to the applicable provisions of the Bankruptcy Code.

DIP Credit Agreement

On October 6, 2020, the Bankruptcy Court entered an order granting interim approval of the Debtors’ entry into a Senior Secured Super-Priority Debtor-in-Possession Credit Agreement (the “DIP Credit Agreement”), with the lenders party thereto (the “DIP Lenders”) and Citibank N.A. as administrative agent (the “DIP Agent”). On October 9, 2020 (the “Closing Date”), the Company, the DIP Agent and the DIP Lenders entered into the DIP Credit Agreement. The DIP Credit Agreement provides for a senior secured, super-priority term loan (the “DIP Term Loan Facility”) with a maximum principal amount of $200 million, $100 million of which was funded on the Closing Date and $100 million of which was subsequently funded on October 26, 2020, following entry of the Bankruptcy Court’s final order approving the DIP Term Loan Facility on October 23, 2020. The proceeds of the DIP Term Loan Facility are to be used by the Debtors to (a) pay certain costs, premiums, fees and expenses related to the Chapter 11 Cases, (b) make payments pursuant to any interim or final order entered by the Bankruptcy Court pursuant to any “first day” motions permitting the payment by the Debtors of any prepetition amounts then due and owing; (c) make certain adequate protection payments in accordance with the DIP Credit Agreement and (d) fund working capital needs of the Debtors and their subsidiaries to the extent permitted by the DIP Credit Agreement. On October 12, 2020, the Company, the DIP Agent and the DIP Lenders entered into the First

45


 

Amendment to the DIP Credit Agreement (the “First Amendment”). The First Amendment eliminates the obligation for the Company to pay certain fees to the DIP Lenders in connection with certain prepayment events under the DIP Credit Agreement. For additional information regarding the terms of the DIP Credit Agreement, see Note 2, Restructuring and Chapter 11 Proceedings of the Notes to the Consolidated Interim Financial Statements.

Delisting from NYSE

On September 20, 2020, we were notified by the New York Stock Exchange (the “NYSE”) that, as a result of the Chapter 11 Cases, and in accordance with Section 802.01D of the NYSE Listed Company Manual, that NYSE had commenced proceedings to delist our common stock from the NYSE. The NYSE indefinitely suspended trading of our common stock on September 21, 2020. We determined not to appeal the NYSE’s determination. On October 8, 2020, the NYSE filed a Form 25-NSE with the Securities and Exchange Commission, which removed our common stock from listing and registration on the NYSE effective as of the opening of business on October 19, 2020. The delisting of our common stock from NYSE has and could continue to limit the liquidity of our common stock, increase the volatility in the price of our common stock, and hinder our ability to raise capital.

Subordinated Asbestos Indemnity Agreement

On September 12, 2018, Garrett ASASCO entered into the Subordinated Asbestos Indemnity Agreement, under which Garrett ASASCO is required to make certain payments to Honeywell in amounts equal to 90% of Honeywell’s asbestos-related liability payments and accounts payable, primarily related to the Bendix business in the United States, as well as certain environmental-related liability payments and accounts payable and non-United States asbestos-related liability payments and accounts payable, in each case related to legacy elements of the Business, including the legal costs of defending and resolving such liabilities, less 90% of Honeywell’s net insurance receipts and, as may be applicable, certain other recoveries associated with such liabilities. Pursuant to the terms of the Subordinated Asbestos Indemnity Agreement, Garrett ASASCO is responsible for paying to Honeywell such amounts, up to a cap of an amount equal to the Distribution Date Currency Exchange Rate (1.16977 USD = 1 EUR) equivalent of $175 million (exclusive of any late payment fees) in respect of such liabilities arising in any given calendar year. This Subordinated Asbestos Indemnity Agreement may have material adverse effects on our liquidity and cash flows and on our results of operations, regardless of whether we experience a decline in net sales. See “We are subject to risks associated with the Indemnification and Reimbursement Agreement, pursuant to which we are required to make substantial cash payments to Honeywell, measured in substantial part by reference to estimates by Honeywell of certain of its liabilities” under “Risk Factors” in our 2019 Form 10-K. In addition, the payments that Garrett ASASCO is required to make to Honeywell pursuant to the terms of the Subordinated Asbestos Indemnity Agreement will not be deductible for U.S. federal income tax purposes. The Subordinated Asbestos Indemnity Agreement provides that the agreement will terminate upon the earlier of (x) December 31, 2048 or (y) December 31st of the third consecutive year during which certain amounts owed to Honeywell during each such year were less than $25 million as converted into Euros in accordance with the terms of the agreement.

During the first quarter of 2020, Garrett ASASCO paid Honeywell the Euro-equivalent of $35 million in connection with the Subordinated Asbestos Indemnity Agreement. In January 2020 we received from Honeywell the 2019 Prior Year Aggregate Loss Statement (as defined in the Subordinated Asbestos Indemnity Agreement) which confirmed that the payments made to Honeywell as required by the Subordinated Asbestos Indemnity Agreement in 2019 included an overpayment of $33 million.  This payment will be deducted from the Q2 Payment and will reduce the cash payments payable to Honeywell in 2020.  Honeywell and Garrett have agreed to defer the Q2 Payment due May 1, 2020 to December 31, 2020.   We do not expect Garrett ASASCO to make payments to Honeywell under the Subordinated Asbestos Indemnity Agreement during the pendency of the Chapter 11 Cases. The plan contemplated by the RSA, if confirmed, will provide for the treatment of claims against the Company’s bankruptcy estates under the Subordinated Asbestos Indemnity Agreement, including pre-petition liabilities under the Subordinated Asbestos Indemnity Agreement that have not been satisfied or addressed during the Chapter 11 Cases.

We are currently engaged in litigation against Honeywell in connection with the Subordinated Asbestos Indemnity Agreement. For additional information, see Part II, Item 1. Legal Proceedings.

Tax Matters Agreement

On September 12, 2018, we entered into a Tax Matters Agreement, which governs the respective rights, responsibilities and obligations of Honeywell and us after the Spin-Off with respect to all tax matters (including tax liabilities, tax attributes, tax returns and tax contests).

The Tax Matters Agreement generally provides that we are responsible and will indemnify Honeywell for all taxes, including income taxes, sales taxes, VAT and payroll taxes, relating to Garrett for all periods, including periods prior to the completion date of the Spin-Off. Among other items, as a result of the mandatory transition tax imposed by the Tax Cuts and Jobs Act, Garrett ASASCO is required to make payments to a subsidiary of Honeywell in the amount representing the net tax liability of Honeywell under the mandatory transition tax attributable to us, as determined by Honeywell. We estimate that Garrett ASASCO’s total aggregate payments to Honeywell with respect to the mandatory transition tax will be $240 million with $200 million in payments remaining as

46


 

of December 31, 2019. Under the terms of the Tax Matters Agreement, Garrett ASASCO is required to pay this amount in Euros, without interest, in five annual installments, each equal to 8% of the aggregate amount, followed by three additional annual installments equal to 15%, 20% and 25% of the aggregate amount, respectively. Garrett ASASCO paid the first annual installment in October 2018 and subsequent annual installments are due in April of each year. The annual installment due on April 1, 2020 has been deferred to December 31, 2020 in agreement with Honeywell. We do not expect Garrett ASASCO to make payments to Honeywell under the Tax Matters Agreement during the pendency of the Chapter 11 Cases. The plan contemplated by the RSA, if confirmed, will provide for the treatment of claims against the Company’s bankruptcy estates under the Tax Matters Agreement, including pre-petition liabilities under the Tax Matters Agreement that have not been satisfied or addressed during the Chapter 11 Cases.

In addition, the Tax Matters Agreement addresses the allocation of liability for taxes incurred as a result of restructuring activities undertaken to effectuate the Spin-Off. The Tax Matters Agreement also provides that we are required to indemnify Honeywell for certain taxes (and reasonable expenses) resulting from the failure of the Spin-Off and related internal transactions to qualify for their intended tax treatment under U.S. federal, state and local income tax law, as well as foreign tax law. Further, the Tax Matters Agreement also imposes certain restrictions on us and our subsidiaries (including restrictions on share issuances, redemptions or repurchases, business combinations, sales of assets and similar transactions) that are designed to address compliance with Section 355 of the Internal Revenue Code of 1986, as amended, and are intended to preserve the tax-free nature of the Spin-Off.

On July 17, 2020, we provided notice to Honeywell asserting that Honeywell has caused material breaches of the Tax Matters Agreement and that the Tax Matters Agreement is unenforceable.

Cash Flow Summary for the Nine Months Ended September 30, 2020 and 2019

 

 

 

For the Nine Months

Ended September 30,

 

 

 

2020

 

 

2019

 

 

 

(Dollars in millions)

 

Cash (used for) provided by:

 

 

 

 

 

 

 

 

Operating activities

 

 

(136

)

 

 

125

 

Investing activities

 

 

(79

)

 

 

(62

)

Financing activities

 

 

340

 

 

 

(62

)

Effect of exchange rate changes on cash and restricted cash

 

 

3

 

 

 

(7

)

Net decrease in cash, cash equivalents and restricted cash

 

$

128

 

 

$

(6

)

 

Cash used for operating activities increased by $261 million for the nine months ended September 30, 2020 versus the prior year period, primarily due to an unfavorable impact from working capital of $143 million and a decrease in net income, net of deferred taxes of $152 million, an unfavorable impact of $56 million in prepaid Directors and officers insurance, employee continuity awards and prepayments to suppliers, partially offset by delayed Obligations payable to Honeywell of $90 million.

Cash used for investing activities increased by $17 million for the nine months ended September 30, 2020 versus the prior year period, primarily due to an unfavorable impact from a prior year settlement received on the re-couponing of our cross currency swap contract of $19 million.

 

Cash provided by financing activities increased by $402 million for the nine months ended September 30, 2020 versus the prior year period. The increase was driven by a draw down, net of payments, on our Revolving Facility of $349 million and payments of long-term debt during the nine months ended September 30, 2020 totaling $2 million, as compared to $62 million of such payments during the prior year period.

Seasonality

Our business is typically moderately seasonal. Our primary North American customers historically reduce production during the month of July and halt operations for approximately one week in December; our European customers generally reduce production during the months of July and August and for one week in December; and our Chinese customers often reduce production during the period surrounding the Chinese New Year. Shut-down periods in the rest of the world generally vary by country. In addition, automotive production is traditionally reduced in the months of July, August and September due to the launch of parts production for new vehicle models. Accordingly, our results have historically reflected this seasonality. Our sales predictability in the short term might also be impacted by sudden changes in customer demand, driven by our OEM customers’ supply chain management.

We also typically experience seasonality in cash flow, as a relatively small portion of our full year cash flow is typically generated in the first quarter of the year and a relatively large portion in the last quarter. This seasonality in cash flow is mostly caused by timing of supplier payments for capital expenditures, changes in working capital balances related to the sales seasonality discussed

47


 

above, and the impact of incentive payments to management. Additionally, tax payments are due based on jurisdictional requirements which vary in timing throughout the year.

Contractual Obligations and Probable Liability Payments

Other than with respect to the anticipated timing of our payments under the Subordinated Asbestos Indemnity Agreement as described elsewhere in this Quarterly Report on Form 10-Q, the additional borrowing under the Credit Agreement and DIP Credit Agreement as described above or otherwise as a result of the Chapter 11 Cases, there have been no material changes to our contractual obligations from those described in our 2019 Form 10-K.

 

Capital Expenditures

We believe our capital spending in recent years has been sufficient to maintain efficient production capacity, to implement important product and process redesigns and to expand capacity to meet increased demand. Productivity projects have freed up capacity in our manufacturing facilities and are expected to continue to do so. We expect to continue investing to expand and modernize our existing facilities and invest in our facilities to create capacity for new product development.

In light of the near-term impact of the COVID-19 pandemic, we have reviewed current capital expenditure programs and re-phased some programs related to future capacity expansion and long-term development programs. We expect this to materially reduce new capital expenditures in 2020 without having an adverse effect on our ability to deliver long-term projects on time. In addition, the Stalking Horse Purchase Agreement contains customary representations, warranties and covenants including with respect to our capital expenditures.  

Off-Balance Sheet Arrangements

We do not engage in any off-balance sheet financial arrangements that have or are reasonably likely to have a material current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Critical Accounting Policies

The preparation of our Consolidated Interim Financial Statements in accordance with generally accepted accounting principles is based on the selection and application of accounting policies that require us to make significant estimates and assumptions about the effects of matters that are inherently uncertain. Actual results could differ from our estimates and assumptions, and any such differences could be material to our financial statements. Our critical accounting policies are summarized in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section of our 2019 Form 10-K. In connection with the filing of the Chapter 11 Cases on the Petition Date, the Consolidated Interim Financial Statements included herein have been prepared in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic No. 852, Reorganizations. See Note 2, Reorganization and Chapter 11 Proceedings, of the Consolidated Interim Financial Statements for further details.

Recent Accounting Pronouncements

See Note 3, Summary of Significant Accounting Policies of the Notes to Consolidated Interim Financial Statements for further discussion of recent accounting pronouncements.

Other Matters

Litigation and Environmental Matters

See Note 18, Commitments and Contingencies of the Notes to the Consolidated Interim Financial Statements for a discussion of environmental, asbestos and other litigation matters.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

For a discussion of the Company’s quantitative and qualitative disclosures about market risks, see Item 7A Quantitative and Qualitative Disclosures About Market Risks, in our Annual Report on Form 10-K for the year ended December 31, 2019. As a result of the Chapter 11 case commencement, the Company has lost the ability to enter into hedging contracts. The hedging motion has been

48


 

approved and will enable limited hedging transaction, fully cash collateralized, until emergence. The Company is therefore exposed to foreign exchange fluctuations.

 

Item 4. Controls and Procedures.

In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

 

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on management's evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of September 30, 2020.

There were no changes in the Company’s internal control over financial reporting that occurred during the quarter ended September 30, 2020 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

49


 

PART II—OTHER INFORMATION

On December 2, 2019, the Company and its subsidiary, Garrett ASASCO Inc., filed a Summons with Notice in the Commercial Division of the Supreme Court of the State of New York, County of New York (the “NY Supreme Court”) commencing an action (the “Action”) against Honeywell, certain of Honeywell’s subsidiaries and certain of Honeywell’s employees for declaratory judgment, breach of contract, breach of fiduciary duties, aiding and abetting breach of fiduciary duties, corporate waste, breach of the implied covenant of good faith and fair dealing, and unjust enrichment. On January 15, 2020, the Company and Garrett ASASCO Inc. filed a Complaint in the NY Supreme Court in connection with the Action. The lawsuit arises from the Subordinated Asbestos Indemnity Agreement. The Company is seeking declaratory relief, compensatory damages in an amount to be determined at trial rescission of the Subordinated Asbestos Indemnity Agreement, attorneys’ fees and costs, and such other and further relief as the Court may deem just and proper. Among other claims, Garrett asserts that Honeywell is not entitled to indemnification because it improperly seeks indemnification for amounts attributable to punitive damages and intentional misconduct, and because it has failed to establish other prerequisites for indemnification under New York law. Specifically, the claim asserts that Honeywell has failed to establish its right to indemnity for each and every asbestos settlement of the thousands for which it seeks indemnification. The Action seeks to establish that the Subordinated Asbestos Indemnity Agreement is not enforceable, in whole or in part. On March 5, 2020, Honeywell filed a “Notice of Motion to Dismiss Garrett’s Complaint.” The parties agreed to certain schedules for the case that provided that Garrett would file an amended complaint, then Honeywell would have an opportunity to file another motion to dismiss in response.  On September 20, 2020, Garrett and certain of its subsidiaries each filed a voluntary petition for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of New York.  On September 23, 2020, Garrett removed the Action to the United States District Court for the Southern District of New York, and on September 24, 2020, the Action was referred to the Bankruptcy Court, where the case is currently pending.  A pre-trial conference took place on October 22, 2020.  The Court is expected to hear argument on Honeywell’s pending motion to dismiss on November 18, 2020. The Debtors’ Chapter 11 Cases are being jointly administered under the caption “In re: Garrett Motion Inc., 20-12212.” For additional information regarding the Chapter 11 Cases, see Note 1 Background and Basis of Preparation and Note 2 Reorganization and Chapter 11 Proceedings of the Notes to the Consolidated Interim Financial Statements.

On September 25, 2020, a putative class action securities complaint was filed against Garrett Motion Inc. and certain current and former Garrett officers and directors, in the United States District Court for the Southern District of New York.  The case bears the caption: Steven Husson, Individually and On Behalf of All Others Similarly Situated, v. Garrett Motion Inc., Olivier Rabiller, Alessandro Gili, Peter Bracke, Sean Deason, and Su Ping Lu, Case No. 1:20-cv-07992-JPC (SDNY) (the “Husson Action”).  The Husson Action asserts claims under Sections 10(b) and 20(a) of the Exchange Act, for securities fraud and control person liability.  On September 28, 2020, the plaintiff sought to voluntarily dismiss his claim against Garrett Motion Inc.; this request has been referred to the judge for approval. On October 5, 2020, another putative class action securities complaint was filed against certain current and former Garrett officers and directors, in the United States District Court for the Southern District of New York.  This case bears the caption: The Gabelli Asset Fund, The Gabelli Dividend & Income Trust, The Gabelli Value 25 Fund Inc., The Gabelli Equity Trust Inc., SM Investors LP and SM Investors II LP, on behalf of themselves and all others similarly situated, v. Su Ping Lu, Olivier Rabiller, Alessandro Gili, Peter Bracke, Sean Deason, Craig Balis, Thierry Mabru, Russell James, Carlos M. Cardoso, Maura J. Clark, Courtney M. Enghauser, Susan L. Main, Carsten Reinhardt, and Scott A. Tozier, Case No. 1:20-cv-08296-JPC (SDNY) (the “Gabelli Action”).  The Gabelli Action also asserts claims under Sections 10(b) and 20(a) of the Exchange Act.  Based on the publicly-available dockets, service has not yet been effected for either the Husson Action or the Gabelli Action.  

For additional information regarding our legal proceedings, see Note 18, Commitments and Contingencies of the Notes to the Consolidated Interim Financial Statements.

We are involved in various other lawsuits, claims and proceedings incident to the operation of our businesses, including those pertaining to product liability, product safety, environmental, safety and health, intellectual property, employment, commercial and contractual matters and various other matters. Although the outcome of any such lawsuit, claim or proceeding cannot be predicted with certainty and some may be disposed of unfavorably to us, we do not currently believe that such lawsuits, claims or proceedings will have a material adverse effect on our financial position, results of operations or cash flows. We accrue for potential liabilities in a manner consistent with accounting principles generally accepted in the United States. Accordingly, we accrue for a liability when it is probable that a liability has been incurred and the amount of the liability is reasonably estimable.

Item 1A. Risk Factors.

In addition to the other information set forth in this report, you should carefully consider the factors discussed under “Risk Factors” in our 2019 Form 10-K.  These factors could materially adversely affect our business, financial condition, liquidity, results of operations and capital position, and could cause our actual results to differ materially from our historical results or the results contemplated by any forward-looking statements contained in this report.

50


 

Other than the below, there have been no material changes in the risks affecting the Company since the filing of our 2019 Form 10-K.  We are updating the risk factors included in our 2019 Form 10-K to include the following:

Our ability to successfully operate during and reorganize the Debtors in the Chapter 11 Cases is dependent upon our ability obtain Bankruptcy Court approval of the Debtors’ motions, the outcome of Bankruptcy Court rulings and the progress of the Chapter 11 Cases in general, including the length of time the Debtors will operate in the Chapter 11 Cases.

For the duration of the Chapter 11 Cases, the Debtors are subject to the supervision of the Bankruptcy Court.  The Debtors’ ability to continue to operate in the ordinary course, and for our ability to develop and execute our business plan, continue as a going concern and ultimately successfully reorganize the Debtors, are subject to:

 

our ability to obtain Bankruptcy Court approval with respect to motions filed in the Chapter 11 Cases from time to time;

 

our ability to develop, confirm and consummate a plan of reorganization under the Bankruptcy Code (the “Plan”) and the Stalking Horse Transaction (as defined below) in the timeframe contemplated by RSA and the Stalking Horse Purchase Agreement or as otherwise ordered by the Bankruptcy Court

 

the ability of third parties to seek and obtain Bankruptcy Court approval to terminate contracts and other agreements with us;

 

the ability of third parties to seek and obtain Bankruptcy Court approval to terminate or shorten the exclusivity period for us to propose and confirm a Chapter 11 plan, to appoint a Chapter 11 trustee, or to convert the Chapter 11 Cases to a Chapter 7 proceeding; and

 

the actions and decisions of our creditors and other third parties who have interests in our Chapter 11 Cases that may be inconsistent with our plans, and the Bankruptcy Court’s rulings on such actions and decisions, as applicable.

These risks and uncertainties could affect our business, operations, financial condition and our ultimate ability to successfully reorganize the Debtors in various ways.  For example, negative events associated with the Chapter 11 Cases could adversely affect the Debtors’ or our non-debtor affiliates’ relationships with suppliers, service providers, customers and other third parties, which in turn could materially adversely affect our operations and financial condition.  During the Chapter 11 Cases, the Debtors will need the prior approval of the Bankruptcy Court for transactions outside the ordinary course of business, which may limit the Debtors’ ability to respond timely to certain events or take advantage of opportunities.  Additionally, if creditors or other third parties raise significant objections or take other actions against the Debtors before the Bankruptcy Court, this could have the effect of significantly delaying our ability to confirm and consummate the Plan and the Stalking Horse Transaction (and to meet the milestones set forth in the RSA and the Stalking Horse Purchase Agreement), which could have a material adverse effect on our business, operations, financial condition and our ultimate ability to successfully reorganize the Debtors.  During the Chapter 11 Cases, we expect our financial results to continue to be volatile as restructuring activities and expenses (including legal and other advisor costs), any contract terminations and rejections, and claims assessments may significantly impact our Consolidated Interim Financial Statements. Because of the risks and uncertainties associated with the Chapter 11 Cases, we cannot accurately predict or quantify the ultimate impact of events that occur during the Chapter 11 Cases that may be inconsistent with our plans, or the ultimate length of time which the Chapter 11 Cases may continue.

The Chapter 11 Cases, the DIP Credit Agreement and the Stalking Horse Purchase Agreement limit the flexibility of our management team in running our business.

The DIP Credit Agreement imposes a number of restrictions on the Debtors. Specifically, the Debtors are subject to certain affirmative covenants, including, without limitation, covenants requiring the Debtors to provide financial information, budgets and other information to the agent and the lenders under the DIP Credit Agreement, as well as negative covenants, including, without limitation, relating to the incurrence of additional debt, liens and the making of investments and restricted payments, in each case as set forth in the DIP Credit Agreement.  [Restrictions under the DIP Credit Agreement on the ability of our non-Debtor subsidiaries to incur debt, as well as on our ability to invest in our non-Debtor subsidiaries, and repay intercompany loans owing to our non-Debtor subsidiaries, could impact the availability of liquidity to our non-Debtor affiliates.] The Debtors’ ability to comply with these provisions may be affected by events beyond our control and our failure to comply or obtain a waiver in the event we cannot comply, with a covenant could result in an event of default under the DIP Credit Agreement, which could have a material adverse effect on our business, financial condition and results of operations.  [In addition, continued compliance with or failure to obtain a waiver for covenants restricting the incurrence of debt by non-Debtor subsidiaries or the making of investments in, or the repayment of intercompany loans owing to, non-Debtor subsidiaries could limit the availability of liquidity to our non-Debtor affiliates, which could also adversely impact our business, financial condition and results of operations.]  

In addition to the restrictions applicable to the Debtors’ in the Chapter 11 Cases, we are also subject to operating covenants that apply to substantially all of our business (including the Debtors) under the Stalking Horse Purchase Agreement.  These covenants

51


 

generally require us to operate in the ordinary course of business, to refrain from taking certain enumerated actions and to affirmatively take other enumerated actions.  Such covenants limit the flexibility of our management to respond to various events and circumstances that may arise from time to time, including as a result of the Chapter 11 Cases.  There can be no assurances that we will be able to obtain appropriate waivers from such covenants as may be necessary or advisable, which could adversely impact our business and operations.

We may not be able to complete any Bankruptcy Court-approved sales of our Company or assets through the chapter 11 process, or we may not be able to realize adequate consideration for such sales, which would adversely affect our financial condition.

The Company and certain of its subsidiaries entered into the Stalking Horse Purchase Agreement pursuant to which the Stalking Horse Bidder agreed to acquire the assets of the Company and certain of its subsidiaries pursuant to the Plan (the “Stalking Horse Transaction”). On October 19, 2020, we received a proposal from the Stalking Horse Bidder to revise its bid following the Bankruptcy Court’s entry on October 24, 2020 of an order approving bidding procedures and stalking horse protections to, among other things, increase consideration by $500 million (for total consideration of $2.6 billion) and offer our existing stockholders the opportunity to co-invest in the reorganized business (the “Stalking Horse Bidder Revised Proposal”). The Stalking Horse Purchase Agreement and the Stalking Horse Bidder Revised Proposal are subject to Bankruptcy Court approval and are intended to constitute a “stalking horse” bid that is subject to higher and better bids by third parties in accordance with bidding procedures approved by the Bankruptcy Court. Such bids by third parties may include proposals for stand-alone plans of reorganization. There can be no assurance that we will be able to obtain approval and complete the proposed sale, or any other significant reorganization transaction, including as a result of objections from our stakeholders. Such objections from stakeholders could result from stakeholders’ preference for an alternative plan of reorganization than that contemplated by the Stalking Horse Purchase Agreement and the Stalking Horse Bidder Revised Proposal. One such alternative plan of reorganization could include the plan of reorganization contemplated by a coordination agreement entered into by Honeywell International Inc., Centerbridge Partners, L.P. and Oaktree Capital Management L.P. (collectively, the “Bidding Group”) on October 16, 2020, as amended and restated on October 20, 2020 (the “Alternative Proposal”).  We continue to evaluate the Alternative Proposal and expects to engage with the Bidding Group on the terms of the Alternative Proposal.

If we are unable to complete one or more sales of the Company’s assets in the Chapter 11 Cases, including in accordance with the terms of the Stalking Horse Purchase Agreement and the Stalking Horse Bidder Revised Proposal, it may be necessary to seek additional funding sources, or convert from the Chapter 11 reorganization process to a Chapter 7 liquidation process. If one or more sales of the Company’s assets are completed, they may not generate the anticipated or desired outcomes (including with respect to consideration received).

If a sales transaction, including the Stalking Horse Transaction, is approved by the Bankruptcy Court and consummated, we expect to distribute to stockholders any net sales proceeds remaining after payment of expenses and the allowed claims of creditors (including any repayment of the Company’s prepetition debt and debtor-in-possession financing out of the sales proceeds). The amount and timing of any distributions to stockholders remain uncertain and will depend on many different factors which are difficult to predict.

For more information on the Stalking Horse Bidder Revised Proposal, see Note 2, Reorganization and Chapter 11 Proceedings of the Notes to the Consolidated Interim Financial Statements.

The outcome of our litigation with Honeywell is highly uncertain and could impact recoveries available to stockholders.

In December 2019, we commenced a lawsuit against Honeywell in connection with the Subordinated Asbestos Indemnity Agreement for declaratory judgment, breach of contract, breach of fiduciary duties, aiding and abetting breach of fiduciary duties, corporate waste, breach of the implied covenant of good faith and fair dealing, and unjust enrichment. Our lawsuit seeks, among other things, to establish that the Subordinated Asbestos Indemnity Agreement is unenforceable in whole or in part because Honeywell has failed to establish the prerequisites for indemnification under New York law, and improperly seeks indemnification for amounts attributable to punitive damages and intentional misconduct.  Following the commencement of the Chapter 11 Cases, the Debtors have removed the lawsuit against Honeywell to the Bankruptcy Court, where the claims can be resolved along with other matters in the Chapter 11 Cases. Litigation with Honeywell may materially impact the amount of stockholder recoveries from the Chapter 11 Cases, and the results of such litigation are uncertain.

Under the Stalking Horse Bidder Revised Proposal, the Stalking Horse Bidder has proposed to purchase the residual interest in the bankruptcy estate of Garrett ASASCO Inc. (“ASASCO”), including the Debtors’ claims against Honeywell, by purchasing the equity interest in ASASCO. As a result, it is expected that any distributions from the bankruptcy estate of ASASCO, including any distributable proceeds remaining after payment of expenses and the allowed claims of creditors (including Honeywell) and affirmative recoveries against Honeywell, would not be available for distribution to stockholders of the Company The Stalking Horse Bidder

52


 

Revised Proposal remains subject to negotiation and entry into definitive documentation, subject to higher and better bids in the Bankruptcy Case, and the sale remains subject approval of the Bankruptcy Court.

Operating under Bankruptcy Court protection for a long period of time may harm our business.

A long period of operations under Bankruptcy Court protection could have a material adverse effect on our business, financial condition, results of operations and liquidity. During the pendency of the Chapter 11 Cases, our senior management may be required to spend a significant amount of time and effort dealing with the reorganization instead of focusing exclusively on our business operations. A prolonged period of operating under Bankruptcy Court protection also may make it more difficult to retain management and other key personnel necessary to the success and growth of our business. In addition, as the length of the Chapter 11 Cases increases, the risk that customers and suppliers will lose confidence in our ability to reorganize our business successfully may also increase, and such customers and suppliers may seek to establish alternative commercial relationships.

Delay of the Chapter 11 Cases could impact our ability to maintain our operations during the Chapter 11 Cases.

If the Chapter 11 Cases take longer than expected to conclude, the Debtors may exhaust or lose access to the DIP Term Loan Facility. Any of these factors could result in the need for substantial additional funding. A number of other factors, including the Chapter 11 Cases, our recent financial results, our substantial indebtedness and the competitive environment we face, may adversely affect the availability and terms of funding that might be available to us during the pendency of the Chapter 11 Cases. As such, we may not be able to source capital at rates acceptable to us, or at all, to fund our current operations. The inability to obtain necessary additional funding on acceptable terms could have a material adverse impact on us and on our ability to sustain our operations during the Chapter 11 Cases.

Transfers of our equity may impair our ability to utilize certain built-in losses to reduce tax payments in future years.

Certain of our assets, including stock in our subsidiaries, may have built-in losses to the extent the basis of such assets exceeds fair market value. Section 382 of the Internal Revenue Code may limit the benefit of any such built-in losses that exist at the time of an “ownership change” to the extent we or our subsidiaries are treated as having a “net unrealized built-in loss” at the time of such “ownership change.” Generally, there is an “ownership change” if one or more shareholders owning 5% or more of a corporation’s stock have aggregate increases in their ownership of such stock of more than 50 percentage points over the prior three-year period. [In an attempt to minimize the likelihood of such an “ownership change” occurring, the Company obtained an interim order from the Bankruptcy Court authorizing certain protective equity trading procedures effective as of September 25, 2020.]  However, no assurance can be given that an “ownership change” will not occur. If an “ownership change” occurs, absent an applicable exception, Section 382 would impose an annual limit on the amount of recognized built-in losses we can use to reduce our taxable income equal to the product of the total value of our outstanding equity immediately prior to the “ownership change” and the federal long-term tax-exempt interest rate in effect for the month of the “ownership change.” A number of special rules apply to calculating this limit. It is possible that any such limit could impair our ability to offset gains in the event of a sale of our assets (such as under the Stalking Horse Purchase Agreement) with such recognized built-in losses, potentially resulting adverse tax consequences.

Our ability to prosecute the Chapter 11 Cases and obtain confirmation of the Plan may be contested by third parties with litigation.

Certain of the Debtors’ creditors and other parties in interest may bring litigation against the Debtors during the course of the Chapter 11 Cases, the outcome of which is uncertain. Such litigation may prolong the Chapter 11 Cases and may make it difficult for the Debtors to reach the contractual milestones for the case within the timeframe set out in the Stalking Horse Purchase Agreement and RSA, respectively.

In certain instances, a Chapter 11 proceeding may be converted to a proceeding under Chapter 7.

There can be no assurance as to whether the Debtors will successfully reorganize under the Chapter 11 Cases. If the Bankruptcy Court finds that it would be in the best interest of creditors and/or the Debtors, the Bankruptcy Court may convert the Chapter 11 Cases to proceedings under Chapter 7. In such event, a Chapter 7 trustee would be appointed or elected to liquidate the Debtors’ assets for distribution in accordance with the priorities established by the Bankruptcy Code. The Debtors believe that liquidation under Chapter 7 would result in significantly smaller distributions being made to the Debtors’ creditors than those provided for in a Chapter 11 plan of reorganization because of (i) the likelihood that the assets would have to be sold or otherwise disposed of in a disorderly fashion over a short period of time rather than reorganizing or selling in a controlled manner the Debtors’ businesses as a going concern, (ii) additional administrative expenses involved in the appointment of a Chapter 7 trustee, and (iii) additional expenses and claims, some of which would be entitled to priority, that would be generated during the liquidation and from the rejection of leases and other executory contracts in connection with a cessation of operations.

53


 

Trading in our securities during the pendency of the Chapter 11 Cases poses substantial risks.

The Company’s stockholders are cautioned that it is possible that the Company’s stockholders will receive nothing in exchange for their common stock upon the completion of the Chapter 11 Cases and that the common stock will have no value and that trading in securities of the Company during the pendency of the Chapter 11 Cases will be highly speculative and will pose substantial risks. The delisting of our common stock from New York Stock Exchange has limited and could continue to limit the liquidity of our common stock, increase the volatility in the price of our common stock, and hinder our ability to raise capital. It is possible the Company’s outstanding common stock may be cancelled and extinguished upon confirmation of the Plan by the Bankruptcy Court. In such an event, the Company’s stockholders may be entitled to receive recovery on account of their equity interests, but the amount of any such recovery is highly uncertain and there may be no such recovery. Trading prices for the Company’s common stock and other securities may bear little or no relation to actual recovery, if any, by holders thereof in the Company’s Chapter 11 Cases. Accordingly, the Company urges extreme caution with respect to existing and future investments in its securities.

The COVID-19 pandemic has adversely impacted and is expected to further adversely impact our business and results of operations.

During 2020, the novel coronavirus disease, COVID-19, has spread across the world, including throughout Asia, the United States and Europe. The outbreak and government measures taken in response have also had a significant adverse impact, both direct and indirect, on our businesses and the economy. Our manufacturing facility in Wuhan, China was shut down for six weeks in February and March 2020 and we saw diminished production in our Shanghai, China facility for that same time period, which were the primary drivers of the decrease in sales in the Asia region during the three months ended March 31, 2020. During the second quarter while our facilities in China have re-opened, our manufacturing facilities in Mexicali, Mexico and Pune, India were shut down and our manufacturing facilities in Europe operated at reduced capacity. This significantly reduced our production volumes and had a material adverse impact on our business, results of operations and financial condition. In the third quarter, the fast recovery observed in all geographies has enabled us to ramp up production in most of our production sites to normal levels. However, if the COVID-19 pandemic drives new lockdown measures impacting our manufacturing facilities, our facilities may be forced to shut down or operate at reduced capacity again which will continue to negatively impact our revenues. We have also faced limitations on our employee resources, including because of stay-at-home orders from local governments, new Paid Time Off policies, employee furloughs, state-funded layoffs, sickness of employees or their families or the desire of employees to avoid contact with large groups of people. The pandemic has also diverted management resources and the prolonged work-from-home arrangements have created business continuity and cybersecurity risks.

 

Certain of our customers have been similarly affected and are experiencing closures and labor shortages. As a result of such closures, we have experienced weakened demand from our customers, who have not been able to accept orders or have delayed or canceled orders, which has negatively affected our revenues. If this trend continues, our revenues will continue to be negatively impacted.

 

 

The COVID-19 pandemic continues to rapidly evolve. The extent to which the outbreak impacts our business, liquidity and financial results will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the continued geographic spread of the disease, effectiveness of any vaccines, the duration of the pandemic, travel restrictions and social distancing in the European Union, China and other countries, the duration and extent of business closures or business disruptions and the effectiveness of actions taken to contain and treat the disease. If we or our customers experience prolonged shutdowns or other business disruptions beyond current expectations, our ability to conduct our business in the manner and within planned timelines could be materially and adversely impacted, and our business and financial results may continue to be adversely affected.

Our leveraged capital structure and liabilities to Honeywell may pose significant challenges to our overall strategic and financial flexibility and have a material adverse effect on our business, liquidity position and financial position.

Our leverage ratio remains high and we expect that it will remain so for at least the next several quarters. This high leverage is exacerbated by Garrett ASASCO’s significant liabilities and obligations to Honeywell under the Subordinated Indemnity Agreement and the Tax Matters Agreement. Our leveraged capital structure poses significant challenges to our overall strategic and financial flexibility and may impair our ability to gain or hold market share in the highly competitive automotive supply market. This leverage may be greater than that of some of our competitors, which may put us at a competitive disadvantage. In addition, our business has been and may continue to be significantly impacted by the COVID-19 pandemic and related response measures, which has had adverse consequences for our leverage. See “The COVID-19 pandemic has adversely impacted and is expected to further adversely impact our business and results of operations.” above for more information. The COVID-19 pandemic and related response measures may continue to have an impact, and if we are unable to manage through these challenges, our leverage ratio, capital structure or liquidity may be further adversely effected. On September 20, 2020, the Debtors filed the Chapter 11 Cases in order to address this leveraged capital structure. However, because of the risks and uncertainties associated with the Chapter 11 Cases, we cannot

54


 

accurately predict or quantify the ultimate impact of events that occur during the Chapter 11 Cases on our leverage, capital structure, liabilities or liquidity position, and we may not be successful in addressing these challenges through or following the Chapter 11 Cases. See risks related to the Chapter 11 Cases above for more information.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

Except as otherwise disclosed in this Quarterly Report on Form 10-Q or reported previously in a Current Report on Form 8-K by the Company, none.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

55


 

Item 6. Exhibits.

 

 

 

 

 

Incorporated by Reference

 

 

Exhibit

Number

 

Description

 

Form

 

File No.

 

Exhibit

 

Filing
Date

 

Filed/ Furnished

Herewith

2.1+

 

Indemnification and Reimbursement Agreement, dated September 12, 2018, by and among Honeywell ASASCO Inc., Honeywell ASASCO 2 Inc., and Honeywell International Inc.

 

8-K

 

001-38636

 

2.1

 

2/27/2020

 

 

2.2+

 

 

Tax Matters Agreement, dated September 12, 2018, by and between Honeywell International Inc., Garrett Motion Inc., and, solely for purposes of Section 3.02(g), 5.05 and 6.13(b), Honeywell ASASCO Inc. and Honeywell ASASCO 2 Inc.

 

8-K

 

001-38636

 

2.2

 

9/14/2018

 

 

 

 

2.3+

 

Share and Asset Purchase Agreement, dated as of September 20, 2020, by and among Garrett Motion Inc., Garrett Motion Holdings Inc., Garrett ASASCO Inc., Garrett Motion Holdings II Inc., AMP Intermediate B.V. and AMP U.S. Holdings, LLC.

 

8-K

 

001-38636

 

10.2

 

9/21/2020

 

 

2.4

 

Waiver Letter to Share and Asset Purchase Agreement, dated October 12, 2020, by and among Garrett Motion Inc., Garrett Motion Holdings Inc., Garrett ASASCO Inc., Garrett Motion Holdings II Inc. and AMP Intermediate B.V.

 

8-K

 

001-38636

 

10.1

 

10/13/2020

 

 

3.1

 

Amended and Restated Certificate of Incorporation of Garrett Motion Inc.

 

S-8

 

333-227619

 

4.1

 

10/1/2018

 

 

3.2

 

Amended and Restated By-laws of Garrett Motion Inc.

 

S-8

 

333-227619

 

4.2

 

10/1/2018

 

 

4.1

 

Indenture, dated as of September 27, 2018, between Garrett LX I S.à r.l, Garrett Borrowing LLC, the Company, the guarantors named therein, Deutsche Trustee Company Limited, as Trustee, Deutsche Bank AG, London Branch, as Security Agent and Paying Agent, and Deutsche Bank Luxembourg S.A., as Registrar and Transfer Agent

 

8-K

 

001-38636

 

4.1

 

10/1/2018

 

 

10.1

 

Restructuring Support Agreement, dated as of September 20, 2020, by and among Garrett Motion Inc., the Company Parties and the Consenting Lenders.

 

8-K

 

001-38636

 

10.1

 

9/21/2020

 

 

10.2

 

DIP Credit Agreement, dated as of October 9, 2020, by and among Garrett Motion Inc., the lenders party thereto and Citibank, N.A. as Administrative Agent.

 

8-K

 

001-38636

 

10.1

 

10/9/2020

 

 

10.3

 

First Amendment to the DIP Credit Agreement, dated October 12, 2020.

 

8-K

 

001-38636

 

10.1

 

10/15/2020

 

 

31.1

 

Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

 

 

*

31.2

 

Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

 

 

*

32.1

 

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

 

 

**

32.2

 

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

 

 

**

101.INS

 

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

 

 

 

 

 

 

 

 

 

*

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

 

 

 

 

 

 

 

 

 

*

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

 

 

 

 

 

 

*

56


 

 

 

 

 

Incorporated by Reference

 

 

Exhibit

Number

 

Description

 

Form

 

File No.

 

Exhibit

 

Filing
Date

 

Filed/ Furnished

Herewith

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

 

 

 

 

 

 

*

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document

 

 

 

 

 

 

 

 

 

*

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

 

 

 

 

 

 

 

104

 

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

 

 

 

 

 

 

 

 

*

 

*

Filed herewith.

**

Furnished herewith.

 

+ Portions of these exhibits have been redacted pursuant to Item 601(b)(2) of Regulation S-K. The omitted information is not material and would likely cause competitive harm to the Company if publicly disclosed. The Company hereby undertakes to furnish unredacted copies of the exhibits upon request by the Securities and Exchange Commission.

57


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Garrett Motion Inc.

 

 

 

 

Date: November 2, 2020

 

By:

/s/ Olivier Rabiller

 

 

 

Olivier Rabiller

 

 

 

President and Chief Executive Officer

 

 

 

 

Date: November 2, 2020

 

By:

/s/ Sean Deason

 

 

 

Sean Deason

 

 

 

Senior Vice President and Chief Financial Officer

 

58

gtx-ex311_9.htm

Exhibit 31.1

CERTIFICATION

I, Olivier Rabiller, certify that:

1.

I have reviewed this Quarterly Report on Form 10-Q of Garrett Motion Inc.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 

 

Date: November 2, 2020

 

By:

/s/ Olivier Rabiller

 

 

 

Olivier Rabiller

 

 

 

President and Chief Executive Officer

(principal executive officer)

 

gtx-ex312_11.htm

Exhibit 31.2

CERTIFICATION

I, Sean Deason, certify that:

1.

I have reviewed this Quarterly Report on Form 10-Q of Garrett Motion Inc.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 

 

Date: November 2, 2020

 

By:

/s/ Sean Deason

 

 

 

Sean Deason

 

 

 

Senior Vice President and Chief Financial Officer

(principal financial officer)

 

gtx-ex321_10.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Garrett Motion Inc. (the “Company”) for the period ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

 

Date: November 2, 2020

 

By:

/s/ Olivier Rabiller

 

 

 

Olivier Rabiller

 

 

 

President and Chief Executive Officer

(principal executive officer)

 

gtx-ex322_7.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Garrett Motion Inc. (the “Company”) for the period ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

 

Date: November 2, 2020

 

By:

/s/ Sean Deason

 

 

 

Sean Deason

 

 

 

Senior Vice President and Chief Financial Officer

(principal financial officer)